rank	score	disease_name	disease_identifier
1	0.9885	Long QT syndrome 6	OMIM:613693
2	0.9843	Long QT syndrome, acquired, reduced susceptibility to	OMIM:613688
2	0.9843	Long QT syndrome 2	OMIM:613688
4	0.9834	Long QT syndrome 1, acquired, susceptibility to	OMIM:192500
4	0.9834	Long QT syndrome 1	OMIM:192500
6	0.9782	Short QT syndrome 7	OMIM:620231
7	0.9781	Short QT syndrome 2	OMIM:609621
8	0.9724	Ventricular tachycardia, catecholaminergic polymorphic, 3	OMIM:614021
9	0.9705	Long QT syndrome 3	OMIM:603830
10	0.9701	Long QT syndrome 12	OMIM:612955
11	0.9699	Jervell and Lange-Nielsen syndrome	ORPHA:90647
11	0.9699	Jervell and Lange-Nielsen syndrome	ORPHA:90647
11	0.9699	Jervell and Lange-Nielsen syndrome	ORPHA:90647
14	0.9688	Long QT syndrome 5	OMIM:613695
14	0.9688	Long QT syndrome 5	OMIM:613695
16	0.9676	Long QT syndrome 8	OMIM:618447
17	0.9663	Familial short QT syndrome	ORPHA:51083
17	0.9663	Familial short QT syndrome	ORPHA:51083
17	0.9663	Familial short QT syndrome	ORPHA:51083
17	0.9663	Familial short QT syndrome	ORPHA:51083
17	0.9663	Familial short QT syndrome	ORPHA:51083
22	0.9638	Sick sinus syndrome 2	OMIM:163800
23	0.9554	Long QT syndrome 15	OMIM:616249
24	0.9511	Brugada syndrome 1	OMIM:601144
25	0.9471	Long QT syndrome 14	OMIM:616247
26	0.943	Ventricular tachycardia, catecholaminergic polymorphic, 4	OMIM:614916
27	0.9373	Very long chain acyl-CoA dehydrogenase deficiency	ORPHA:26793
28	0.9363	Jervell and Lange-Nielsen syndrome	OMIM:220400
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
29	0.9357	Brugada syndrome	ORPHA:130
51	0.9347	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration	OMIM:616878
52	0.9342	Long QT syndrome 9	OMIM:611818
53	0.9318	Jervell and Lange-Nielsen syndrome 2	OMIM:612347
53	0.9318	Jervell and Lange-Nielsen syndrome 2	OMIM:612347
55	0.9305	?Brugada syndrome 6	OMIM:613119
56	0.9272	Long QT syndrome 4	OMIM:600919
57	0.9258	Brugada syndrome 2	OMIM:611777
58	0.9232	Cardiac arrhythmia syndrome, with or without skeletal muscle weakness	OMIM:615441
59	0.9227	Andersen-Tawil syndrome	ORPHA:37553
59	0.9227	Andersen-Tawil syndrome	ORPHA:37553
61	0.9219	Andersen syndrome	OMIM:170390
62	0.9218	Ventricular fibrillation, familial, 1	OMIM:603829
63	0.9202	Brugada syndrome 3	OMIM:611875
64	0.9161	Gitelman syndrome	ORPHA:358
64	0.9161	Gitelman syndrome	ORPHA:358
66	0.9127	Atrial fibrillation, familial, 3	OMIM:607554
67	0.912	Cardiomyopathy, hypertrophic, 10	OMIM:608758
68	0.9115	Cardiomyopathy, hypertrophic, 11	OMIM:612098
69	0.9105	Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency	ORPHA:263297
70	0.9102	Short QT syndrome 1	OMIM:609620
71	0.9089	Cardiomyopathy, hypertrophic, 13	OMIM:613243
72	0.9081	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome	OMIM:115000
73	0.9068	Cardiomyopathy, hypertrophic, 8	OMIM:608751
74	0.9044	Linear skin defects with multiple congenital anomalies 3	OMIM:300952
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
75	0.9036	Romano-Ward syndrome	ORPHA:101016
95	0.9017	?Glycogen storage disease XV	OMIM:613507
96	0.9011	Atrial fibrillation, familial, 9	OMIM:613980
97	0.8981	Wolff-Parkinson-White syndrome	OMIM:194200
98	0.8978	Thyrotoxic periodic paralysis	ORPHA:79102
98	0.8978	Thyrotoxic periodic paralysis	ORPHA:79102
100	0.8967	Brugada syndrome 4	OMIM:611876
101	0.8961	Ventricular fibrillation, paroxysmal familial, 2	OMIM:612956
102	0.8958	Glycogen storage disease of heart, lethal congenital	OMIM:261740
103	0.8941	Arrhythmogenic right ventricular dysplasia 9	OMIM:609040
104	0.8933	Atrial fibrillation, familial, 17	OMIM:611819
104	0.8933	Arrhythmogenic right ventricular dysplasia 8	OMIM:607450
106	0.8927	?Sick sinus syndrome 4	OMIM:619464
107	0.8877	Lipodystrophy, congenital generalized, type 4	OMIM:613327
108	0.8837	Progressive familial heart block, type IB	OMIM:604559
109	0.8826	Cardiac conduction disease with or without dilated cardiomyopathy	OMIM:616117
110	0.8808	?Arrhythmogenic right ventricular dysplasia 12	OMIM:611528
111	0.8804	Cardiac conduction defect, nonspecific	OMIM:612838
112	0.8779	Cardiomyopathy, hypertrophic, 4	OMIM:115197
113	0.8748	Sick sinus syndrome 1	OMIM:608567
114	0.8732	Cardiomyopathy, hypertrophic 6	OMIM:600858
115	0.873	Atrial fibrillation, familial, 7	OMIM:612240
116	0.8728	Long QT syndrome 13	OMIM:613485
117	0.8718	Naxos disease	OMIM:601214
118	0.8716	Gitelman syndrome	OMIM:263800
119	0.8699	3-methylglutaconic aciduria, type V	OMIM:610198
120	0.868	Brugada syndrome 9	OMIM:616399
121	0.8637	Cardiomyopathy, dilated, 1D	OMIM:601494
122	0.8633	Familial dilated cardiomyopathy with conduction defect due to LMNA mutation	ORPHA:300751
123	0.8632	Sinoatrial node dysfunction and deafness	OMIM:614896
124	0.8628	Ventricular tachycardia, catecholaminergic polymorphic, 1	OMIM:604772
125	0.861	Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	OMIM:610476
126	0.8569	Atrial standstill 2	OMIM:615745
127	0.8568	Cardiomyopathy, hypertrophic, 16	OMIM:613838
128	0.8547	Short QT syndrome 3	OMIM:609622
129	0.8533	Danon disease	OMIM:300257
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
130	0.851	Catecholaminergic polymorphic ventricular tachycardia	ORPHA:3286
137	0.8479	Cardiomyopathy, dilated, 1E	OMIM:601154
138	0.8478	Atrial fibrillation, familial, 16	OMIM:613120
138	0.8478	Cardiomyopathy, dilated, 2F	OMIM:619747
140	0.8474	Emery-Dreifuss muscular dystrophy 1, X-linked	OMIM:310300
141	0.8462	Ventricular tachycardia, catecholaminergic polymorphic, 2	OMIM:611938
142	0.8459	Autosomal dominant hyperinsulinism due to SUR1 deficiency	ORPHA:276575
142	0.8459	Autosomal dominant hyperinsulinism due to Kir6.2 deficiency	ORPHA:276580
144	0.8452	Histiocytoid cardiomyopathy	ORPHA:137675
145	0.8414	?Ventricular tachycardia, catecholaminergic polymorphic 6	OMIM:618782
145	0.8414	Long QT syndrome 16	OMIM:618782
147	0.8394	Cardiomyopathy, hypertrophic, 23, with or without LVNC	OMIM:612158
148	0.8392	Atrial standstill	ORPHA:1344
148	0.8392	Atrial standstill	ORPHA:1344
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
150	0.8381	Familial atrial fibrillation	ORPHA:334
175	0.8378	Timothy syndrome	OMIM:601005
176	0.8377	Cardiomyopathy, familial hypertrophic, 26	OMIM:617047
177	0.8373	Cardiomyopathy, familial hypertrophic 27	OMIM:618052
178	0.8353	Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome	ORPHA:480864
179	0.8346	Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis	OMIM:615821
180	0.8331	?Atrial fibrillation 15	OMIM:615770
181	0.8325	Heart block, progressive, type IA	OMIM:113900
182	0.8271	Familial progressive cardiac conduction defect	ORPHA:871
182	0.8271	Familial progressive cardiac conduction defect	ORPHA:871
182	0.8271	Familial progressive cardiac conduction defect	ORPHA:871
182	0.8271	Familial progressive cardiac conduction defect	ORPHA:871
186	0.827	Atrial fibrillation, familial, 4	OMIM:611493
187	0.8253	Muscular dystrophy, limb-girdle, autosomal recessive 25	OMIM:616812
188	0.8243	Emery-Dreifuss muscular dystrophy 2, autosomal dominant	OMIM:181350
189	0.8223	?Long QT syndrome 11	OMIM:611820
190	0.8212	Cardiomyopathy, dilated, 1A	OMIM:115200
191	0.8202	Arrhythmogenic right ventricular dysplasia 10	OMIM:610193
192	0.8197	ATTRV122I amyloidosis	ORPHA:85451
193	0.8188	Atrial fibrillation, familial, 11	OMIM:614049
194	0.8178	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
194	0.8178	Autosomal recessive Emery-Dreifuss muscular dystrophy	ORPHA:98855
194	0.8178	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
194	0.8178	X-linked Emery-Dreifuss muscular dystrophy	ORPHA:98863
194	0.8178	X-linked Emery-Dreifuss muscular dystrophy	ORPHA:98863
194	0.8178	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
194	0.8178	Autosomal dominant Emery-Dreifuss muscular dystrophy	ORPHA:98853
201	0.8166	Atrial standstill, digenic (GJA5/SCN5A)	OMIM:108770
202	0.8163	Carnitine-acylcarnitine translocase deficiency	OMIM:212138
203	0.8149	Left ventricular noncompaction 1, with or without congenital heart defects	OMIM:604169
204	0.8126	Cardiomyopathy, hypertrophic, 17	OMIM:613873
205	0.8114	Dopamine beta-hydroxylase deficiency	ORPHA:230
206	0.8109	Smith-Lemli-Opitz syndrome	OMIM:270400
207	0.8099	Thiamine-responsive megaloblastic anemia syndrome	ORPHA:49827
208	0.8098	Infant acute respiratory distress syndrome	ORPHA:70587
208	0.8098	Infant acute respiratory distress syndrome	ORPHA:70587
208	0.8098	Infant acute respiratory distress syndrome	ORPHA:70587
211	0.808	Familial isolated restrictive cardiomyopathy	ORPHA:75249
211	0.808	Familial isolated restrictive cardiomyopathy	ORPHA:75249
211	0.808	Familial isolated restrictive cardiomyopathy	ORPHA:75249
211	0.808	Familial isolated restrictive cardiomyopathy	ORPHA:75249
211	0.808	Familial isolated restrictive cardiomyopathy	ORPHA:75249
216	0.8079	Atrial fibrillation, familial, 10	OMIM:614022
217	0.8077	Cardiomyopathy, dilated, 1V	OMIM:613697
218	0.8063	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 14	OMIM:615351
218	0.8063	Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency	ORPHA:71212
220	0.8059	Cardiomyopathy, dilated, 1G	OMIM:604145
221	0.8057	Cardiomyopathy, hypertrophic, 7	OMIM:613690
222	0.8047	Atrial septal defect 7, with or without AV conduction defects	OMIM:108900
223	0.804	Simpson-Golabi-Behmel syndrome	ORPHA:373
223	0.804	Simpson-Golabi-Behmel syndrome	ORPHA:373
225	0.8035	Ebstein malformation of the tricuspid valve	ORPHA:1880
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
226	0.8031	Atrial septal defect, ostium secundum type	ORPHA:99103
234	0.803	Myotonic dystrophy 1	OMIM:160900
235	0.8022	Atrial fibrillation, familial, 14	OMIM:615378
236	0.8018	Heart-hand syndrome, Slovenian type	ORPHA:168796
237	0.8012	Arrhythmogenic right ventricular dysplasia 5	OMIM:604400
238	0.8007	Cardiomyopathy, hypertrophic, 12	OMIM:612124
239	0.8005	Becker muscular dystrophy	OMIM:300376
240	0.7998	Mitochondrial complex I deficiency, nuclear type 13	OMIM:618235
241	0.7979	Emery-Dreifuss muscular dystrophy 7, AD	OMIM:614302
241	0.7979	Atrial septal defect 6	OMIM:613087
243	0.7968	Cardiomyopathy, hypertrophic, 18	OMIM:613874
244	0.7956	Combined oxidative phosphorylation deficiency 33	OMIM:617713
244	0.7956	Gaucher disease type 2	ORPHA:77260
244	0.7956	Mitochondrial complex IV deficiency, nuclear type 2	OMIM:604377
247	0.7946	Desminopathy	ORPHA:98909
248	0.7941	Rett syndrome, atypical	OMIM:312750
249	0.7937	?Atrial fibrillation, familial, 18	OMIM:617280
250	0.792	Duchenne muscular dystrophy	OMIM:310200
251	0.7912	Ogden syndrome	OMIM:300855
251	0.7912	GNB5-related intellectual disability-cardiac arrhythmia syndrome	ORPHA:542306
253	0.79	Cerebral creatine deficiency syndrome 1	OMIM:300352
253	0.79	Chronic atrial and intestinal dysrhythmia	OMIM:616201
255	0.7893	Dilated cardiomyopathy with ataxia	ORPHA:66634
255	0.7893	Pseudohypoparathyroidism type 1B	ORPHA:94089
255	0.7893	Pseudohypoparathyroidism type 1C	ORPHA:79444
255	0.7893	Pseudohypoparathyroidism type 1B	ORPHA:94089
259	0.7892	MGAT2-CDG	ORPHA:79329
260	0.789	Sudden infant death-dysgenesis of the testes syndrome	ORPHA:168593
261	0.7884	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
261	0.7884	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
261	0.7884	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
261	0.7884	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
261	0.7884	Autosomal dominant progressive external ophthalmoplegia	ORPHA:254892
266	0.7877	Congenital disorder of glycosylation, type It	OMIM:614921
267	0.7862	Sengers syndrome	OMIM:212350
268	0.783	Myofibrillar myopathy 10	OMIM:619040
269	0.7822	Left ventricular noncompaction 9	OMIM:611878
270	0.7821	Aortic aneurysm, familial thoracic 9	OMIM:616166
270	0.7821	Heterotaxy, visceral, 5	OMIM:270100
272	0.7801	Arrhythmogenic right ventricular dysplasia 1	OMIM:107970
273	0.7787	Cardiomyopathy, familial hypertrophic, 28	OMIM:619402
274	0.7786	Cardiomyopathy, hypertrophic, 2	OMIM:115195
275	0.7771	Combined oxidative phosphorylation deficiency 57	OMIM:620167
275	0.7771	?Combined oxidative phosphorylation deficiency 45	OMIM:618951
277	0.7768	Arthrogryposis multiplex congenita 5	OMIM:618947
278	0.7746	Martsolf syndrome 1	OMIM:212720
279	0.7744	Cardiomyopathy, hypertrophic, 20	OMIM:613876
280	0.7739	DPAGT1-CDG	ORPHA:86309
281	0.7728	Adenine phosphoribosyltransferase deficiency	ORPHA:976
282	0.7727	Naxos disease	ORPHA:34217
283	0.7725	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	OMIM:620029
284	0.7717	Cardiomyopathy, dilated, 2G	OMIM:619897
285	0.7713	?Cardiomyopathy, dilated, 2B	OMIM:614672
286	0.7709	Holt-Oram syndrome	ORPHA:392
287	0.77	3-hydroxy-3-methylglutaric aciduria	ORPHA:20
288	0.7693	Ventricular tachycardia, idiopathic	OMIM:192605
289	0.7691	Loeys-Dietz syndrome	ORPHA:60030
289	0.7691	Loeys-Dietz syndrome	ORPHA:60030
289	0.7691	Loeys-Dietz syndrome	ORPHA:60030
292	0.7686	Hyperparathyroidism-jaw tumor syndrome	ORPHA:99880
292	0.7686	Parathyroid carcinoma	ORPHA:143
294	0.768	Left ventricular noncompaction 3	OMIM:601493
295	0.7678	Atrial fibrillation, familial, 6	OMIM:612201
296	0.7675	Familial hyperaldosteronism type III	ORPHA:251274
297	0.7659	Orthostatic hypotension 1, due to DBH deficiency	OMIM:223360
298	0.7648	McLeod syndrome with or without chronic granulomatous disease	OMIM:300842
299	0.7645	Congenital myopathy 5 with cardiomyopathy	OMIM:611705
299	0.7645	Cardiomyopathy, dilated, 1NN	OMIM:615916
301	0.7641	Carnitine palmitoyl transferase 1A deficiency	ORPHA:156
301	0.7641	Cataract 46, juvenile-onset	OMIM:212500
303	0.7638	Myotonic dystrophy 2	OMIM:602668
304	0.7628	?Atrial fibrillation, familial, 12	OMIM:614050
304	0.7628	Muscular dystrophy, congenital	OMIM:613205
306	0.7625	Cardiomyopathy, hypertrophic, 22	OMIM:615248
307	0.7622	Brugada syndrome 8	OMIM:613123
308	0.7616	Malignant hyperthermia of anesthesia	ORPHA:423
308	0.7616	Malignant hyperthermia of anesthesia	ORPHA:423
310	0.7615	Cardiomyopathy, dilated, 1U	OMIM:613694
311	0.76	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	OMIM:610131
312	0.7586	Arrhythmogenic right ventricular dysplasia 14	OMIM:618920
313	0.758	Pseudohypoparathyroidism type 1A	ORPHA:79443
314	0.7563	Glycogen storage disease II	OMIM:232300
315	0.7552	Cardiomyopathy, dilated, 1P	OMIM:609909
316	0.7516	Arterial tortuosity syndrome	ORPHA:3342
317	0.7501	Thyrotoxic periodic paralysis, susceptibility to, 1	OMIM:188580
317	0.7501	Paroxysmal extreme pain disorder	OMIM:167400
319	0.7488	Left ventricular noncompaction 4	OMIM:613424
320	0.7475	Cardiomyopathy, dilated, 1MM	OMIM:615396
321	0.747	X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome	ORPHA:324410
322	0.7463	Atrial fibrillation, familial, 13	OMIM:615377
322	0.7463	Oculopharyngodistal myopathy 1	OMIM:164310
324	0.7456	Congenital heart defects, multiple types, 5	OMIM:617912
325	0.7448	CLN3 disease	ORPHA:228346
326	0.7408	Friedreich ataxia with retained reflexes	OMIM:229300
327	0.74	Malignant hyperthermia susceptibility 5	OMIM:601887
327	0.74	Hereditary pulmonary alveolar proteinosis	ORPHA:264675
327	0.74	Hereditary pulmonary alveolar proteinosis	ORPHA:264675
327	0.74	Fructose-1,6-bisphosphatase deficiency	ORPHA:348
327	0.74	Fructose-1,6-bisphosphatase deficiency	OMIM:229700
327	0.74	Variegate porphyria	OMIM:176200
327	0.74	Glycogen storage disease due to muscle glycogen phosphorylase deficiency	ORPHA:368
327	0.74	Rh deficiency syndrome	ORPHA:71275
327	0.74	Rh deficiency syndrome	ORPHA:71275
327	0.74	Rh deficiency syndrome	ORPHA:71275
327	0.74	?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures	OMIM:617072
327	0.74	Hyperthyroidism, nonautoimmune	OMIM:609152
327	0.74	Hyperthyroidism, familial gestational	OMIM:603373
340	0.7391	Congenital heart defects, nonsyndromic, 2	OMIM:614980
341	0.7386	Paragangliomas 4	OMIM:115310
341	0.7386	Paragangliomas 3	OMIM:605373
341	0.7386	Paragangliomas 1, with or without deafness	OMIM:168000
344	0.7385	Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment	OMIM:620066
345	0.7384	Aneurysm-osteoarthritis syndrome	ORPHA:284984
346	0.7381	Giant cell arteritis	ORPHA:397
346	0.7381	Giant cell arteritis	ORPHA:397
346	0.7381	Giant cell arteritis	ORPHA:397
346	0.7381	Giant cell arteritis	ORPHA:397
350	0.7378	Left ventricular noncompaction 5	OMIM:613426
351	0.7377	Sudden cardiac failure, infantile	OMIM:617222
351	0.7377	Combined oxidative phosphorylation deficiency 15	OMIM:614947
353	0.737	Pulmonary hypertension, primary, 4	OMIM:615344
354	0.7358	Cardiomyopathy, dilated, 1Z	OMIM:611879
355	0.7355	Crisponi syndrome	ORPHA:1545
355	0.7355	Cardiomyopathy, familial restrictive, 1	OMIM:115210
355	0.7355	Cardiomyopathy, hypertrophic, 3	OMIM:115196
355	0.7355	Harlequin ichthyosis	ORPHA:457
355	0.7355	Crisponi syndrome	ORPHA:1545
360	0.7351	Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency	OMIM:255100
361	0.7332	Carnitine-acylcarnitine translocase deficiency	ORPHA:159
361	0.7332	?Cardiomyopathy, dilated, 1J	OMIM:605362
361	0.7332	Biliary, renal, neurologic, and skeletal syndrome	OMIM:619534
364	0.7324	Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps	OMIM:611773
365	0.7322	Multiple endocrine neoplasia type 1	ORPHA:652
365	0.7322	Multiple endocrine neoplasia type 1	ORPHA:652
365	0.7322	Multiple endocrine neoplasia type 1	ORPHA:652
365	0.7322	Multiple endocrine neoplasia type 1	ORPHA:652
365	0.7322	Multiple endocrine neoplasia type 1	ORPHA:652
370	0.732	Linear skin defects with multiple congenital anomalies 1	OMIM:309801
371	0.7318	Malignant hyperthermia susceptibility 1	OMIM:145600
371	0.7318	Imerslund-Gräsbeck syndrome	ORPHA:35858
371	0.7318	Imerslund-Gräsbeck syndrome	ORPHA:35858
371	0.7318	Hydroxykynureninuria	ORPHA:79155
375	0.7316	?Cardiomyopathy, dilated, 1OO	OMIM:620247
376	0.7311	Cardiomyopathy, dilated, 1DD	OMIM:613172
376	0.7311	Adult-onset cervical dystonia, DYT23 type	ORPHA:420492
378	0.7308	Sarcoidosis	ORPHA:797
378	0.7308	Sarcoidosis	ORPHA:797
380	0.7305	Hypotrichosis and recurrent skin vesicles	OMIM:613102
381	0.7302	Coproporphyria	OMIM:121300
381	0.7302	?Hirschsprung disease, cardiac defects, and autonomic dysfunction	OMIM:613870
381	0.7302	Trimethylaminuria	OMIM:602079
384	0.7296	VLCAD deficiency	OMIM:201475
385	0.7276	Arrhythmogenic right ventricular dysplasia 13	OMIM:615616
386	0.7267	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1	OMIM:617877
387	0.7266	Proteus syndrome	ORPHA:744
387	0.7266	Proteus syndrome	ORPHA:744
389	0.7256	Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies	OMIM:620236
390	0.7255	Coronary artery disease, autosomal dominant, 2	OMIM:610947
391	0.7242	Hereditary coproporphyria	ORPHA:79273
392	0.7235	Scalp-ear-nipple syndrome	OMIM:181270
393	0.7227	Loeys-Dietz syndrome 3	OMIM:613795
394	0.7226	Combined oxidative phosphorylation deficiency 54	OMIM:619737
395	0.722	Stevens-Johnson syndrome	ORPHA:36426
395	0.722	Stevens-Johnson syndrome	ORPHA:36426
397	0.7219	Neuropathy, hereditary sensory and autonomic, type VI	OMIM:614653
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
398	0.7217	Leber hereditary optic neuropathy	ORPHA:104
410	0.721	CAPOS syndrome	OMIM:601338
410	0.721	CPT II deficiency, infantile	OMIM:600649
410	0.721	TSC2 angiomyolipomas, renal, modifier of	OMIM:613254
410	0.721	Muscular dystrophy, limb-girdle, autosomal recessive 27	OMIM:619566
410	0.721	?Combined oxidative phosphorylation deficiency 38	OMIM:618378
410	0.721	Cardiomyopathy, hypertrophic, 25	OMIM:607487
410	0.721	Tuberous sclerosis-1	OMIM:191100
410	0.721	Tuberous sclerosis-2	OMIM:613254
418	0.7203	Cardiomyopathy, dilated, with woolly hair and keratoderma	OMIM:605676
418	0.7203	Mitochondrial complex I deficiency, nuclear type 11	OMIM:618234
420	0.7202	Cardiomyopathy, dilated, 1L	OMIM:606685
421	0.7193	Acyl-CoA dehydrogenase 9 deficiency	ORPHA:99901
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
422	0.7174	Narcolepsy type 1	ORPHA:2073
430	0.7172	Cardiomyopathy, dilated, 1O	OMIM:608569
431	0.7164	Familial dysautonomia	ORPHA:1764
431	0.7164	Dysautonomia, familial	OMIM:223900
433	0.7158	Porphyria variegata	ORPHA:79473
434	0.7156	Porphyria, acute intermittent, nonerythroid variant	OMIM:176000
435	0.7125	Marshall-Smith syndrome	OMIM:602535
436	0.7124	Cardiomyopathy, hypertrophic, 14	OMIM:613251
437	0.7121	Tenorio syndrome	OMIM:616260
438	0.7111	Immunodeficiency 93 and hypertrophic cardiomyopathy	OMIM:619705
439	0.7103	Cardiac-urogenital syndrome	OMIM:618280
440	0.7101	Combined oxidative phosphorylation defect type 23	ORPHA:444013
441	0.7098	Congenital myopathy 7B, myosin storage, autosomal recessive	OMIM:255160
442	0.709	Hyperekplexia 3	OMIM:614618
443	0.7084	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2	OMIM:618321
444	0.7077	Carnitine palmitoyl transferase II deficiency, neonatal form	ORPHA:228308
445	0.7075	Dysferlin-related limb-girdle muscular dystrophy R2	ORPHA:268
446	0.7055	DEGCAGS syndrome	OMIM:619488
447	0.7051	Alternating hemiplegia of childhood	ORPHA:2131
447	0.7051	Alternating hemiplegia of childhood	ORPHA:2131
447	0.7051	Alternating hemiplegia of childhood	ORPHA:2131
447	0.7051	Alternating hemiplegia of childhood	ORPHA:2131
451	0.7042	Pulmonary hypertension, primary, 5	OMIM:265400
452	0.7035	Homozygous familial hypercholesterolemia	ORPHA:391665
452	0.7035	Homozygous familial hypercholesterolemia	ORPHA:391665
452	0.7035	Homozygous familial hypercholesterolemia	ORPHA:391665
452	0.7035	Homozygous familial hypercholesterolemia	ORPHA:391665
452	0.7035	Homozygous familial hypercholesterolemia	ORPHA:391665
452	0.7035	Homozygous familial hypercholesterolemia	ORPHA:391665
458	0.7033	Acute intermittent porphyria	ORPHA:79276
459	0.7031	Atrial septal defect-atrioventricular conduction defects syndrome	ORPHA:1479
460	0.7021	Pheochromocytoma	OMIM:171300
460	0.7021	Pheochromocytoma	OMIM:171300
460	0.7021	Pheochromocytoma, susceptibility to	OMIM:171300
460	0.7021	Pheochromocytoma	OMIM:171300
460	0.7021	Pheochromocytoma, susceptibility to	OMIM:171300
460	0.7021	Pheochromocytoma	OMIM:171300
466	0.7019	Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders	ORPHA:505248
467	0.7003	Truncus arteriosus	ORPHA:3384
467	0.7003	Truncus arteriosus	ORPHA:3384
469	0.6997	Cerebellar-facial-dental syndrome	ORPHA:444072
470	0.6991	Hereditary sensory and autonomic neuropathy type 4	ORPHA:642
471	0.6989	ATTRV30M amyloidosis	ORPHA:85447
471	0.6989	Tatton-Brown-Rahman syndrome	ORPHA:404443
473	0.6988	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3	OMIM:609286
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
474	0.6981	Meningioma	ORPHA:2495
485	0.6962	Cardiomyopathy, dilated, 1II	OMIM:615184
486	0.6943	Cardiomyopathy, familial restrictive, 3	OMIM:612422
487	0.6929	Erythrokeratodermia variabilis et progressiva 6	OMIM:618531
487	0.6929	Oculodentodigital dysplasia	OMIM:164200
487	0.6929	Oculodentodigital dysplasia	ORPHA:2710
487	0.6929	Emery-Dreifuss muscular dystrophy 3, autosomal recessive	OMIM:616516
487	0.6929	Myopathy, X-linked, with postural muscle atrophy	OMIM:300696
487	0.6929	Emery-Dreifuss muscular dystrophy 5, autosomal dominant	OMIM:612999
487	0.6929	Thiamine-responsive megaloblastic anemia syndrome	OMIM:249270
487	0.6929	Genetic recurrent myoglobinuria	ORPHA:99845
487	0.6929	Ulnar-mammary syndrome	OMIM:181450
487	0.6929	Ulnar-mammary syndrome	ORPHA:3138
487	0.6929	CPT deficiency, hepatic, type IA	OMIM:255120
487	0.6929	Deafness-enamel hypoplasia-nail defects syndrome	ORPHA:3220
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Genetic recurrent myoglobinuria	ORPHA:99845
487	0.6929	Genetic recurrent myoglobinuria	ORPHA:99845
487	0.6929	Carnitine palmitoyl transferase II deficiency, severe infantile form	ORPHA:228305
487	0.6929	Medium chain acyl-CoA dehydrogenase deficiency	ORPHA:42
487	0.6929	Glycogen storage disease due to aldolase A deficiency	ORPHA:57
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Autosomal dominant Charcot-Marie-Tooth disease type 2K	ORPHA:99944
487	0.6929	Genetic recurrent myoglobinuria	ORPHA:99845
487	0.6929	Mitochondrial DNA depletion syndrome 11	OMIM:615084
487	0.6929	Progressive external ophthalmoplegia-myopathy-emaciation syndrome	ORPHA:352447
487	0.6929	Isolated ATP synthase deficiency	ORPHA:254913
487	0.6929	Propionic acidemia	ORPHA:35
487	0.6929	Propionic acidemia	ORPHA:35
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	Deafness-enamel hypoplasia-nail defects syndrome	ORPHA:3220
487	0.6929	Infantile Refsum disease	ORPHA:772
487	0.6929	IVIC syndrome	ORPHA:2307
487	0.6929	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	OMIM:619184
487	0.6929	Hemochromatosis, type 4	OMIM:606069
487	0.6929	Spinocerebellar ataxia, autosomal recessive 23	OMIM:616949
487	0.6929	?Intellectual developmental disorder with short stature and variable skeletal anomalies	OMIM:618453
537	0.692	MELAS	ORPHA:550
537	0.692	MELAS	ORPHA:550
537	0.692	MELAS	ORPHA:550
537	0.692	MELAS	ORPHA:550
537	0.692	MELAS	ORPHA:550
537	0.692	MELAS	ORPHA:550
537	0.692	MELAS	ORPHA:550
544	0.6913	Familial thrombocytosis	ORPHA:71493
544	0.6913	Familial thrombocytosis	ORPHA:71493
544	0.6913	Familial thrombocytosis	ORPHA:71493
547	0.6904	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
547	0.6904	Cardiomyopathy, familial hypertrophic	OMIM:192600
547	0.6904	Congenital muscular dystrophy due to LMNA mutation	ORPHA:157973
547	0.6904	Cardiomyopathy, hypertrophic, 1	OMIM:192600
547	0.6904	Ogden syndrome	ORPHA:276432
547	0.6904	Combined oxidative phosphorylation deficiency 23	OMIM:616198
547	0.6904	DK1-CDG	ORPHA:91131
547	0.6904	Mitochondrial trifunctional protein deficiency 1	OMIM:609015
547	0.6904	Hemochromatosis, type 2A	OMIM:602390
547	0.6904	Cardiomyopathy, hypertrophic, 1, digenic	OMIM:192600
547	0.6904	Refsum disease	OMIM:266500
547	0.6904	Proteasome-associated autoinflammatory syndrome 1 and digenic forms	OMIM:256040
547	0.6904	TMEM70-related mitochondrial encephalo-cardio-myopathy	ORPHA:1194
547	0.6904	Familial Mediterranean fever	ORPHA:342
547	0.6904	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
547	0.6904	Generalized pseudohypoaldosteronism type 1	ORPHA:171876
563	0.689	Beta-thalassemia major	ORPHA:231214
563	0.689	Dominant beta-thalassemia	ORPHA:231226
565	0.6881	Supravalvular aortic stenosis	ORPHA:3193
566	0.6871	Legius syndrome	ORPHA:137605
567	0.6851	Woodhouse-Sakati syndrome	ORPHA:3464
567	0.6851	Woodhouse-Sakati syndrome	OMIM:241080
569	0.6847	Pseudoxanthoma elasticum	ORPHA:758
569	0.6847	Pseudoxanthoma elasticum	ORPHA:758
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Spondyloarthropathy, susceptibility to, 1	OMIM:106300
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
571	0.6842	Noonan syndrome	ORPHA:648
586	0.6827	?Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5	OMIM:618098
587	0.6823	Noonan syndrome with multiple lentigines	ORPHA:500
587	0.6823	Noonan syndrome with multiple lentigines	ORPHA:500
587	0.6823	Noonan syndrome with multiple lentigines	ORPHA:500
590	0.6812	Spondylometaphyseal dysplasia, Sedaghatian type	ORPHA:93317
591	0.6795	Mucopolysaccharidosis type 2, severe form	ORPHA:217085
591	0.6795	Mucopolysaccharidosis type 2, attenuated form	ORPHA:217093
593	0.6782	Myopathy, myofibrillar, 1	OMIM:601419
594	0.6769	Lodder-Merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia	OMIM:617173
594	0.6769	Lodder-Merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia	OMIM:617182
596	0.6768	Lymphedema-distichiasis syndrome	ORPHA:33001
597	0.6766	Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease	ORPHA:163746
598	0.6761	Simpson-Golabi-Behmel syndrome, type 1	OMIM:312870
598	0.6761	Noonan syndrome 5	OMIM:611553
598	0.6761	Ataxia with vitamin E deficiency	ORPHA:96
598	0.6761	Congenital myopathy with excess of muscle spindles	OMIM:218040
598	0.6761	Singleton-Merten syndrome 2	OMIM:616298
603	0.6758	Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	OMIM:615471
604	0.6757	HFE hemochromatosis, modifier of	OMIM:235200
604	0.6757	Hemochromatosis, type 1	OMIM:235200
606	0.6754	Hyperkalemic periodic paralysis	ORPHA:682
607	0.674	Spondylometaphyseal dysplasia, Sedaghatian type	OMIM:250220
608	0.6736	CPT II deficiency, lethal neonatal	OMIM:608836
609	0.6734	Barth syndrome	OMIM:302060
610	0.6731	Epilepsy, idiopathic generalized, susceptibility to, 18	OMIM:619521
610	0.6731	Distal myopathy, Tateyama type	ORPHA:488650
610	0.6731	Myopathy, distal, Tateyama type	OMIM:614321
610	0.6731	Combined oxidative phosphorylation deficiency 10	OMIM:614702
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Erythermalgia, primary	OMIM:133020
610	0.6731	Hypothyroidism due to TSH receptor mutations	ORPHA:90673
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Congenital disorder of glycosylation, type Im	OMIM:610768
610	0.6731	Congenital myopathy 2B, severe infantile, autosomal recessive	OMIM:620265
610	0.6731	Aminoacylase 1 deficiency	OMIM:609924
610	0.6731	Bohring-Opitz syndrome	ORPHA:97297
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Coenzyme Q10 deficiency, primary, 7	OMIM:616276
610	0.6731	Coenzyme Q10 deficiency, primary, 5	OMIM:614654
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Familial thyroid dyshormonogenesis	ORPHA:95716
610	0.6731	Familial thyroid dyshormonogenesis	ORPHA:95716
610	0.6731	Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency	OMIM:616277
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Mahvash disease	OMIM:619290
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Glutamine deficiency, congenital	OMIM:610015
610	0.6731	Myopathy with lactic acidosis, hereditary	OMIM:255125
610	0.6731	Familial thyroid dyshormonogenesis	ORPHA:95716
610	0.6731	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
610	0.6731	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
610	0.6731	Severe generalized junctional epidermolysis bullosa	ORPHA:79404
610	0.6731	Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	OMIM:218700
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Familial thyroid dyshormonogenesis	ORPHA:95716
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Familial thyroid dyshormonogenesis	ORPHA:95716
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Mitochondrial complex I deficiency, nuclear type 29	OMIM:618250
610	0.6731	Familial thyroid dyshormonogenesis	ORPHA:95716
610	0.6731	Isolated thyroid-stimulating hormone deficiency	ORPHA:90674
610	0.6731	Semilobar holoprosencephaly	ORPHA:220386
610	0.6731	Alobar holoprosencephaly	ORPHA:93925
610	0.6731	Midline interhemispheric variant of holoprosencephaly	ORPHA:93926
610	0.6731	Lobar holoprosencephaly	ORPHA:93924
704	0.673	Schwartz-Jampel syndrome	ORPHA:800
705	0.6721	Mitochondrial complex IV deficiency, nuclear type 4	OMIM:619048
706	0.6719	Liddle syndrome	ORPHA:526
706	0.6719	Liddle syndrome	ORPHA:526
706	0.6719	Liddle syndrome	ORPHA:526
709	0.6706	Microphthalmia with linear skin defects syndrome	ORPHA:2556
709	0.6706	Microphthalmia with linear skin defects syndrome	ORPHA:2556
709	0.6706	Microphthalmia with linear skin defects syndrome	ORPHA:2556
709	0.6706	SPECC1L-related hypertelorism syndrome	ORPHA:1519
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
713	0.67	Williams syndrome	ORPHA:904
733	0.6694	Mitochondrial trifunctional protein deficiency	ORPHA:746
733	0.6694	Mitochondrial trifunctional protein deficiency	ORPHA:746
735	0.6692	Left ventricular noncompaction 8	OMIM:615373
736	0.6685	Autosomal dominant hypocalcemia	ORPHA:428
736	0.6685	Autosomal dominant hypocalcemia	ORPHA:428
738	0.6683	Cockayne syndrome, type B	OMIM:133540
738	0.6683	Cockayne syndrome, type B	OMIM:133540
738	0.6683	Cockayne syndrome, type A	OMIM:216400
741	0.6673	Von Hippel-Lindau disease	ORPHA:892
741	0.6673	Von Hippel-Lindau disease	ORPHA:892
743	0.6671	Megalencephaly-capillary malformation-polymicrogyria syndrome	ORPHA:60040
744	0.6669	Laminin subunit alpha 2-related congenital muscular dystrophy	ORPHA:258
745	0.6659	Cutis laxa, autosomal recessive, type IB	OMIM:614437
745	0.6659	Mitochondrial complex III deficiency, nuclear type 10	OMIM:618775
747	0.6644	Multiple endocrine neoplasia IIA	OMIM:171400
747	0.6644	Adrenocortical carcinoma	ORPHA:1501
747	0.6644	Adrenocortical carcinoma	ORPHA:1501
747	0.6644	Adrenocortical carcinoma	ORPHA:1501
747	0.6644	Adrenocortical carcinoma	ORPHA:1501
747	0.6644	Adrenocortical carcinoma	ORPHA:1501
747	0.6644	Adrenocortical carcinoma	ORPHA:1501
754	0.6637	Wiskott-Aldrich syndrome	ORPHA:906
754	0.6637	Wiskott-Aldrich syndrome	ORPHA:906
756	0.6634	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
756	0.6634	Symptomatic form of HFE-related hemochromatosis	ORPHA:465508
758	0.6633	Developmental and epileptic encephalopathy 101	OMIM:619814
758	0.6633	Hamamy syndrome	OMIM:611174
760	0.6629	Congenital myopathy 22A, classic	OMIM:620351
761	0.6621	AGel amyloidosis	ORPHA:85448
761	0.6621	Classical-like Ehlers-Danlos syndrome type 1	ORPHA:230839
763	0.6594	Congenital heart defects, multiple types, 9	OMIM:620294
764	0.658	Cap myopathy	ORPHA:171881
764	0.658	Lymphedema-distichiasis syndrome	OMIM:153400
764	0.658	Cap myopathy	ORPHA:171881
764	0.658	Cap myopathy	ORPHA:171881
768	0.6572	D-glyceric aciduria	OMIM:220120
769	0.656	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	OMIM:614052
770	0.655	Rhizomelic chondrodysplasia punctata, type 5	OMIM:616716
770	0.655	Neurodevelopmental disorder with dysmorphic facies, impaired speech and hypotonia	OMIM:619005
770	0.655	DEEAH syndrome	OMIM:619004
773	0.6548	Sudden infant death with dysgenesis of the testes syndrome	OMIM:608800
774	0.6545	Familial multiple nevi flammei	ORPHA:624
775	0.6541	Fabry disease, cardiac variant	OMIM:301500
775	0.6541	Mitochondrial complex I deficiency, nuclear type 37	OMIM:619272
775	0.6541	Lipoyltransferase 1 deficiency	OMIM:616299
778	0.6433	3-methylglutaconic aciduria, type VIII	OMIM:617248
779	0.6431	Rigidity and multifocal seizure syndrome, lethal neonatal	OMIM:614498
780	0.6423	Combined oxidative phosphorylation defect type 39	ORPHA:565624
781	0.6415	Pseudo-TORCH syndrome 2	OMIM:617397
782	0.6411	Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease	OMIM:209880
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
783	0.6372	Hereditary pheochromocytoma-paraganglioma	ORPHA:29072
799	0.6366	Granulomatosis with polyangiitis	ORPHA:900
799	0.6366	Granulomatosis with polyangiitis	ORPHA:900
799	0.6366	Granulomatosis with polyangiitis	ORPHA:900
799	0.6366	Granulomatosis with polyangiitis	ORPHA:900
799	0.6366	Granulomatosis with polyangiitis	ORPHA:900
804	0.6365	Fabry disease	ORPHA:324
805	0.6332	Nestor-Guillermo progeria syndrome	OMIM:614008
806	0.6281	Cardiac valvular dysplasia 2	OMIM:620067
807	0.6233	Arterial calcification, generalized, of infancy, 2	OMIM:614473
808	0.6228	Sick sinus syndrome 3	OMIM:614090
809	0.6219	?Abnormal hair, joint laxity, and developmental delay	OMIM:261990
810	0.6114	Mucopolysaccharidosis type VI (Maroteaux-Lamy)	OMIM:253200
811	0.6103	Combined oxidative phosphorylation deficiency 39	OMIM:618397
812	0.6056	?Central hypoventilation syndrome, congenital, 2, and autonomic dysfunction	OMIM:619482
813	0.5787	Rigid spine syndrome	ORPHA:97244
813	0.5787	Rigid spine syndrome	ORPHA:97244
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
815	0.5673	Mitochondrial DNA-associated Leigh syndrome	ORPHA:255210
822	0.5584	Meier-Gorlin syndrome 7	OMIM:617063
823	0.558	Rubinstein-Taybi syndrome due to CREBBP mutations	ORPHA:353277
823	0.558	Rubinstein-Taybi syndrome due to 16p13.3 microdeletion	ORPHA:353281
823	0.558	Rubinstein-Taybi syndrome due to EP300 haploinsufficiency	ORPHA:353284
826	0.5565	Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	ORPHA:329336
826	0.5565	Refsum disease	ORPHA:773
826	0.5565	Atrophoderma vermiculata	ORPHA:79100
826	0.5565	Refsum disease	ORPHA:773
826	0.5565	Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	ORPHA:329336
831	0.5557	Late-onset distal myopathy, Markesbery-Griggs type	ORPHA:98912
831	0.5557	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
831	0.5557	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
831	0.5557	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
831	0.5557	Isolated succinate-CoQ reductase deficiency	ORPHA:3208
836	0.5448	Cutis laxa, autosomal recessive, type IID	OMIM:617403
837	0.5357	Cardiomyopathy, dilated, 1BB	OMIM:612877
838	0.5316	Sensorineural deafness with dilated cardiomyopathy	ORPHA:217622
839	0.5305	LEOPARD syndrome 1	OMIM:151100
840	0.53	Hutchinson-Gilford progeria	OMIM:176670
841	0.5289	Autosomal recessive cutis laxa type 1	ORPHA:90349
841	0.5289	Autosomal recessive cutis laxa type 1	ORPHA:90349
841	0.5289	Autosomal recessive cutis laxa type 1	ORPHA:90349
844	0.5272	Cardiomyopathy, dilated, 1I	OMIM:604765
845	0.527	Butyrylcholinesterase deficiency	ORPHA:132
846	0.523	Classic multiminicore myopathy	ORPHA:324604
846	0.523	Classic multiminicore myopathy	ORPHA:324604
846	0.523	Cardiomyopathy, dilated, 1GG	OMIM:613642
846	0.523	Classic multiminicore myopathy	ORPHA:324604
850	0.5223	Arterial calcification, generalized, of infancy, 1	OMIM:208000
850	0.5223	Morbid obesity and spermatogenic failure	OMIM:615703
852	0.5204	?Cardiomyopathy, dilated, 1M	OMIM:607482
853	0.5195	Muscle filaminopathy	ORPHA:171445
853	0.5195	?Cardiomyopathy, dilated, 2A	OMIM:611880
853	0.5195	Cardiomyopathy, dilated, 1HH	OMIM:613881
853	0.5195	POMT2-related limb-girdle muscular dystrophy R14	ORPHA:206559
857	0.5191	Scapuloperoneal myopathy, X-linked dominant	OMIM:300695
857	0.5191	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	OMIM:613158
857	0.5191	Neurodevelopmental disorder with brain anomalies, seizures, and scoliosis	OMIM:618590
857	0.5191	Plectin-related limb-girdle muscular dystrophy R17	ORPHA:254361
861	0.5184	Mucolipidosis II alpha/beta	OMIM:252500
862	0.5163	Osteogenesis imperfecta, type II	OMIM:166210
862	0.5163	Combined oxidative phosphorylation deficiency 8	OMIM:614096
862	0.5163	Osteogenesis imperfecta, type II	OMIM:166210
862	0.5163	Abetalipoproteinemia	ORPHA:14
866	0.5162	Cardiomyopathy, dilated, 1EE	OMIM:613252
867	0.5158	?Mitochondrial complex I deficiency, nuclear type 30	OMIM:301021
867	0.5158	Carvajal syndrome	ORPHA:65282
867	0.5158	Congenital generalized lipodystrophy	ORPHA:528
867	0.5158	Familial partial lipodystrophy, Dunnigan type	ORPHA:2348
867	0.5158	Generalized pustular psoriasis	ORPHA:247353
867	0.5158	Congenital myopathy 8	OMIM:618654
867	0.5158	Congenital generalized lipodystrophy	ORPHA:528
867	0.5158	Vici syndrome	OMIM:242840
867	0.5158	?Intellectual developmental disorder, X-linked syndromic 32	OMIM:300886
867	0.5158	Mitochondrial complex I deficiency, nuclear type 20	OMIM:611126
867	0.5158	Mucopolysaccharidosis-plus syndrome	OMIM:617303
867	0.5158	Carney complex, type 1	OMIM:160980
867	0.5158	Neurodegeneration with ataxia and late-onset optic atrophy	OMIM:619259
867	0.5158	Congenital generalized lipodystrophy	ORPHA:528
867	0.5158	GM1-gangliosidosis, type I	OMIM:230500
867	0.5158	Atransferrinemia	OMIM:209300
867	0.5158	Hemochromatosis, type 2B	OMIM:613313
867	0.5158	Congenital generalized lipodystrophy	ORPHA:528
867	0.5158	Spinocerebellar ataxia type 7	ORPHA:94147
867	0.5158	Congenital generalized lipodystrophy	ORPHA:528
867	0.5158	Congenital disorder of glycosylation, type IIe	OMIM:608779
867	0.5158	Mitochondrial complex IV deficiency, nuclear type 22	OMIM:619355
867	0.5158	Combined oxidative phosphorylation deficiency 17	OMIM:615440
867	0.5158	Aarskog-Scott syndrome	ORPHA:915
867	0.5158	Congenital generalized lipodystrophy	ORPHA:528
867	0.5158	Hb Bart's hydrops fetalis	ORPHA:163596
867	0.5158	Hb Bart's hydrops fetalis	ORPHA:163596
867	0.5158	Generalized pustular psoriasis	ORPHA:247353
867	0.5158	Multiple benign circumferential skin creases on limbs	ORPHA:2505
867	0.5158	?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type)	OMIM:616896
867	0.5158	Muscular dystrophy, limb-girdle, autosomal recessive 3	OMIM:608099
867	0.5158	Sialic acid storage disorder, infantile	OMIM:269920
867	0.5158	Combined oxidative phosphorylation deficiency 28	OMIM:616794
867	0.5158	CEDNIK syndrome	ORPHA:66631
867	0.5158	Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome	ORPHA:500533
867	0.5158	?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	OMIM:617156
867	0.5158	Mulibrey nanism	OMIM:253250
867	0.5158	Spinal muscular atrophy with congenital bone fractures 1	OMIM:616866
867	0.5158	Multiple benign circumferential skin creases on limbs	ORPHA:2505
906	0.5154	Cardiomyopathy, dilated, 1FF	OMIM:613286
907	0.5149	Multicentric osteolysis-nodulosis-arthropathy spectrum	ORPHA:371428
907	0.5149	Multicentric osteolysis-nodulosis-arthropathy spectrum	ORPHA:371428
909	0.5145	Werner syndrome	ORPHA:902
910	0.5135	PPARG-related familial partial lipodystrophy	ORPHA:79083
910	0.5135	Alstrom syndrome	OMIM:203800
910	0.5135	Seckel syndrome 10	OMIM:617253
913	0.5119	Autosomal dominant cutis laxa	ORPHA:90348
913	0.5119	Cutis laxa, autosomal dominant	OMIM:123700
913	0.5119	Autosomal dominant cutis laxa	ORPHA:90348
913	0.5119	Autosomal dominant cutis laxa	ORPHA:90348
917	0.5118	Familial atrial myxoma	ORPHA:615
918	0.5115	Cutis laxa, autosomal recessive, type IIC	OMIM:617402
919	0.511	Carnitine deficiency, systemic primary	OMIM:212140
920	0.5101	Cerebellar ataxia, brain abnormalities, and cardiac conduction defects	OMIM:619576
921	0.5099	Cardiomyopathy, hypertrophic, 15	OMIM:613255
922	0.5092	Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2	OMIM:616479
923	0.5085	Hyperoxaluria, primary, type 1	OMIM:259900
924	0.5082	Mucopolysaccharidosis II	OMIM:309900
924	0.5082	Marfan syndrome	OMIM:154700
924	0.5082	Cardiac valvular dysplasia, X-linked	OMIM:314400
927	0.5078	Diamond-Blackfan anemia 1	OMIM:105650
928	0.5075	Marbach-Rustad progeroid syndrome	OMIM:619322
929	0.5071	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
929	0.5071	Neutral lipid storage myopathy	ORPHA:98908
929	0.5071	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
929	0.5071	Inclusion body myopathy with Paget disease of bone and frontotemporal dementia	ORPHA:52430
929	0.5071	Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type	ORPHA:70472
929	0.5071	Hemolytic anemia due to triosephosphate isomerase deficiency	OMIM:615512
935	0.507	Singleton-Merten syndrome 1	OMIM:182250
936	0.5058	Polyglucosan body myopathy 1 with or without immunodeficiency	OMIM:615895
937	0.5049	Carney complex	ORPHA:1359
937	0.5049	Carney complex	ORPHA:1359
939	0.5047	Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency	ORPHA:1900
940	0.504	Capillary malformation-arteriovenous malformation	ORPHA:137667
940	0.504	Capillary malformation-arteriovenous malformation	ORPHA:137667
942	0.5039	?Combined oxidative phosphorylation deficiency 22	OMIM:616045
942	0.5039	Stuve-Wiedemann syndrome 2	OMIM:619751
942	0.5039	Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome	ORPHA:444077
942	0.5039	SADDAN	OMIM:616482
946	0.5035	Noonan syndrome-like disorder with loose anagen hair 2	OMIM:617506
947	0.5031	Congenital myopathy 24	OMIM:617336
947	0.5031	Kearns-Sayre syndrome	ORPHA:480
947	0.5031	Kearns-Sayre syndrome	ORPHA:480
947	0.5031	Acromesomelic dysplasia 4	OMIM:619636
951	0.5029	Cardiomyopathy-hypotonia-lactic acidosis syndrome	ORPHA:91130
952	0.4998	X-linked intellectual disability-psychosis-macroorchidism syndrome	ORPHA:3077
953	0.4992	Ehlers-Danlos syndrome, kyphoscoliotic type, 1	OMIM:225400
954	0.4974	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome	ORPHA:391487
954	0.4974	Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome	ORPHA:391487
956	0.4972	Weill-Marchesani syndrome 2, dominant	OMIM:608328
957	0.4962	Klippel-Trénaunay syndrome	ORPHA:90308
958	0.496	Developmental delay, impaired speech, and behavioral abnormalities	OMIM:619475
959	0.4959	3-methylglutaconic aciduria, type VIIB, autosomal recessive	OMIM:616271
960	0.4954	Pseudoxanthoma elasticum	OMIM:264800
960	0.4954	Pseudoxanthoma elasticum, modifier of severity of	OMIM:264800
960	0.4954	Pseudoxanthoma elasticum, modifier of severity of	OMIM:264800
963	0.4949	Geleophysic dysplasia 1	OMIM:231050
964	0.4941	Aceruloplasminemia	ORPHA:48818
965	0.4939	Familial dyskinesia and facial myokymia	ORPHA:324588
966	0.4925	Alström syndrome	ORPHA:64
967	0.4916	Beta-thalassemia intermedia	ORPHA:231222
968	0.4896	Hydrops, lactic acidosis, and sideroblastic anemia	OMIM:617021
968	0.4896	Immunodeficiency 87 and autoimmunity	OMIM:619573
970	0.4895	Primary sclerosing cholangitis	ORPHA:171
970	0.4895	Primary sclerosing cholangitis	ORPHA:171
970	0.4895	Primary sclerosing cholangitis	ORPHA:171
970	0.4895	Primary sclerosing cholangitis	ORPHA:171
974	0.488	Schimke immuno-osseous dysplasia	ORPHA:1830
975	0.4877	Parkes Weber syndrome	ORPHA:90307
976	0.4864	Incontinentia pigmenti	ORPHA:464
977	0.484	Primary aldosteronism, seizures, and neurologic abnormalities	OMIM:615474
978	0.4811	Waldenström macroglobulinemia	ORPHA:33226
979	0.4807	Dyskinesia with orofacial involvement, autosomal dominant	OMIM:606703
980	0.4744	Primary hyperaldosteronism-seizures-neurological abnormalities syndrome	ORPHA:369929
981	0.4699	Hereditary hemorrhagic telangiectasia	ORPHA:774
981	0.4699	Hereditary hemorrhagic telangiectasia	ORPHA:774
981	0.4699	Hereditary hemorrhagic telangiectasia	ORPHA:774
981	0.4699	Hereditary hemorrhagic telangiectasia	ORPHA:774
985	0.467	Pleural mesothelioma	ORPHA:50251
986	0.4663	Hereditary arterial and articular multiple calcification syndrome	ORPHA:289601
987	0.4589	H syndrome	ORPHA:168569
988	0.4442	Hurler syndrome	ORPHA:93473
989	0.4441	Cardiomyopathy, dilated, 2E	OMIM:619492
989	0.4441	Apolipoprotein A-I deficiency	ORPHA:425
989	0.4441	?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue	OMIM:616827
989	0.4441	Fish-eye disease	ORPHA:79292
989	0.4441	Triokinase and FMN cyclase deficiency syndrome	OMIM:618805
989	0.4441	Pyruvate dehydrogenase E3 deficiency	ORPHA:2394
989	0.4441	Dysbetalipoproteinemia	ORPHA:412
989	0.4441	Hepatic lipase deficiency	OMIM:614025
989	0.4441	Hyperlipidemia due to hepatic triacylglycerol lipase deficiency	ORPHA:140905
989	0.4441	Apolipoprotein A-I deficiency	ORPHA:425
989	0.4441	Familial cold autoinflammatory syndrome 3	OMIM:614468
1000	0.4416	Cerebrotendinous xanthomatosis	OMIM:213700
1001	0.44	Macrocephaly-intellectual disability-left ventricular non compaction syndrome	ORPHA:466791
1002	0.4387	Telangiectasia, hereditary hemorrhagic, type 1	OMIM:187300
1003	0.4375	PMM2-CDG	ORPHA:79318
1004	0.4357	Hutchinson-Gilford progeria syndrome	ORPHA:740
1004	0.4357	Hutchinson-Gilford progeria syndrome	ORPHA:740
1006	0.4346	Classical Ehlers-Danlos syndrome	ORPHA:287
1006	0.4346	Classical Ehlers-Danlos syndrome	ORPHA:287
1006	0.4346	Classical Ehlers-Danlos syndrome	ORPHA:287
1009	0.4333	Bannayan-Riley-Ruvalcaba syndrome	ORPHA:109
1010	0.4292	Lethal acantholytic erosive disorder	ORPHA:158687
1010	0.4292	Lethal acantholytic erosive disorder	ORPHA:158687
1012	0.4287	Polycythemia vera	ORPHA:729
1012	0.4287	Polycythemia vera	ORPHA:729
1012	0.4287	Polycythemia vera	ORPHA:729
1015	0.4282	Pseudoxanthoma elasticum, forme fruste	OMIM:177850
1016	0.428	Liver disease, severe congenital	OMIM:619991
1017	0.4261	Aortic aneurysm, familial thoracic 4	OMIM:132900
1017	0.4261	Familial aortic dissection	ORPHA:229
1017	0.4261	Paroxysmal nocturnal hemoglobinuria	ORPHA:447
1020	0.4253	Coronary artery disease, autosomal dominant, 1	OMIM:608320
1020	0.4253	Abdominal obesity-metabolic syndrome 4	OMIM:618620
1020	0.4253	Abdominal obesity-metabolic syndrome 3	OMIM:615812
1020	0.4253	Alkaptonuria	ORPHA:56
1024	0.4246	Peroxisome biogenesis disorder 5A (Zellweger)	OMIM:614866
1024	0.4246	Helsmoortel-van der Aa syndrome	OMIM:615873
1026	0.4244	Hypokalemic periodic paralysis	ORPHA:681
1026	0.4244	Idiopathic bronchiectasis	ORPHA:60033
1026	0.4244	Hypokalemic periodic paralysis	ORPHA:681
1026	0.4244	Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type) AR	OMIM:615418
1026	0.4244	Idiopathic bronchiectasis	ORPHA:60033
1026	0.4244	Idiopathic bronchiectasis	ORPHA:60033
1026	0.4244	Hypokalemic periodic paralysis	ORPHA:681
1026	0.4244	Intellectual developmental disorder with impaired language and dysmorphic facies	OMIM:618653
1026	0.4244	Idiopathic bronchiectasis	ORPHA:60033
1026	0.4244	Mucolipidosis type II	ORPHA:576
1026	0.4244	Tangier disease	OMIM:205400
1026	0.4244	HDL deficiency, familial, 1	OMIM:604091
1026	0.4244	Combined hyperlipidemia, familial	OMIM:144250
1026	0.4244	Seckel syndrome 2	OMIM:606744
1026	0.4244	Blepharophimosis-intellectual disability syndrome, Ohdo type	ORPHA:2728
1026	0.4244	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	OMIM:607155
1026	0.4244	Thrombosis, hyperhomocysteinemic	OMIM:236200
1026	0.4244	Brachydactyly-short stature-retinitis pigmentosa syndrome	ORPHA:166035
1026	0.4244	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 1	OMIM:613155
1045	0.4235	Familial bicuspid aortic valve	ORPHA:402075
1045	0.4235	Familial bicuspid aortic valve	ORPHA:402075
1045	0.4235	Familial bicuspid aortic valve	ORPHA:402075
1045	0.4235	Familial bicuspid aortic valve	ORPHA:402075
1049	0.4225	X-linked intellectual disability-short stature-overweight syndrome	ORPHA:457240
1050	0.422	Pulmonary hypertension, familial primary, 1, with or without HHT	OMIM:178600
1051	0.4215	Essential thrombocythemia	ORPHA:3318
1051	0.4215	Essential thrombocythemia	ORPHA:3318
1051	0.4215	Essential thrombocythemia	ORPHA:3318
1051	0.4215	Essential thrombocythemia	ORPHA:3318
1051	0.4215	Essential thrombocythemia	ORPHA:3318
1051	0.4215	Essential thrombocythemia	ORPHA:3318
1057	0.4208	Cardiomyopathy, dilated, 2D	OMIM:619371
1058	0.4207	Multiple congenital anomalies-neurodevelopmental syndrome, X-linked	OMIM:301056
1059	0.4201	Takayasu arteritis	ORPHA:3287
1059	0.4201	Takayasu arteritis	ORPHA:3287
1059	0.4201	Takayasu arteritis	ORPHA:3287
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1062	0.42	Behçet disease	ORPHA:117
1075	0.4198	Erythrocytosis, somatic	OMIM:133100
1075	0.4198	Erythrocytosis, somatic	OMIM:133100
1077	0.4192	Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss	OMIM:155100
1078	0.419	Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy	OMIM:619424
1079	0.4187	Thrombotic thrombocytopenic purpura, hereditary	OMIM:274150
1080	0.4166	Intellectual developmental disorder, autosomal dominant 45	OMIM:617600
1081	0.4165	Cushing disease	ORPHA:96253
1081	0.4165	Cushing disease	ORPHA:96253
1081	0.4165	Cushing disease	ORPHA:96253
1081	0.4165	Cushing disease	ORPHA:96253
1081	0.4165	Cushing disease	ORPHA:96253
1081	0.4165	Cushing disease	ORPHA:96253
1081	0.4165	Cushing disease	ORPHA:96253
1088	0.416	MYH9-related disease	ORPHA:182050
1089	0.4152	Coffin-Siris syndrome 12	OMIM:619325
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1090	0.4149	Familial thoracic aortic aneurysm and aortic dissection	ORPHA:91387
1109	0.4098	Yunis-Varon syndrome	OMIM:216340
1110	0.4097	Hypomagnesemia 7, renal, with or without dilated cardiomyopathy	OMIM:620152
1111	0.4082	Pulmonary alveolar microlithiasis	ORPHA:60025
1112	0.4079	Mitochondrial complex II deficiency, nuclear type 3	OMIM:619167
1113	0.4073	Intellectual disability and myopathy syndrome	OMIM:619719
1113	0.4073	Hypotaurinemic retinal degeneration and cardiomyopathy	OMIM:145350
1113	0.4073	Cutis laxa, autosomal recessive, type IA	OMIM:219100
1113	0.4073	Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 2	OMIM:613156
1113	0.4073	Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5	ORPHA:353
1113	0.4073	Robinow syndrome, autosomal dominant 1	OMIM:180700
1113	0.4073	Robinow syndrome, autosomal recessive	OMIM:268310
1120	0.4063	Developmental and epileptic encephalopathy 23	OMIM:615859
1121	0.4042	Supravalvar aortic stenosis	OMIM:185500
1121	0.4042	Craniosynostosis 1	OMIM:123100
1123	0.4025	Pulmonary venoocclusive disease 1	OMIM:265450
1123	0.4025	Pulmonary hypertension, primary, 2	OMIM:615342
1125	0.4003	Pulmonary capillary hemangiomatosis	ORPHA:199241
1126	0.3987	Noonan syndrome 12	OMIM:618624
1126	0.3987	Structural heart defects and renal anomalies syndrome	OMIM:617478
1128	0.3968	Generalized arterial calcification of infancy	ORPHA:51608
1128	0.3968	Generalized arterial calcification of infancy	ORPHA:51608
1130	0.3967	Congenital heart defects, multiple types, 4	OMIM:615779
1130	0.3967	Congenital heart defects, multiple types, 6	OMIM:613854
1132	0.3952	Cardiomyopathy, dilated, 1CC	OMIM:613122
1132	0.3952	Cardiomyopathy, dilated, 1W	OMIM:611407
1132	0.3952	Cardiomyopathy, dilated, 1X	OMIM:611615
1135	0.3922	Cardiomyopathy, dilated, 3B	OMIM:302045
1135	0.3922	Congenital analbuminemia	ORPHA:86816
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1137	0.3898	46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency	ORPHA:168558
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1137	0.3898	Periventricular nodular heterotopia	ORPHA:98892
1145	0.389	Ovarian hyperstimulation syndrome	ORPHA:64739
1145	0.389	Platelet glycoprotein IV deficiency	OMIM:608404
1145	0.389	Glycogen storage disease Ia	OMIM:232200
1148	0.3871	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
1148	0.3871	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
1148	0.3871	Sitosterolemia 1	OMIM:210250
1148	0.3871	Peroxisome biogenesis disorder 3B	OMIM:266510
1148	0.3871	Scott syndrome	OMIM:262890
1148	0.3871	THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome	ORPHA:363444
1148	0.3871	Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency	ORPHA:91135
1148	0.3871	Congenital erythropoietic porphyria	ORPHA:79277
1148	0.3871	Beta-thalassemia-X-linked thrombocytopenia syndrome	ORPHA:231393
1148	0.3871	Hepatoerythropoietic porphyria	ORPHA:95159
1148	0.3871	Congenital erythropoietic porphyria	ORPHA:79277
1148	0.3871	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
1148	0.3871	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
1148	0.3871	Nephrogenic diabetes insipidus	ORPHA:223
1148	0.3871	Congenital disorder of glycosylation, type Ib	OMIM:602579
1148	0.3871	Chronic visceral acid sphingomyelinase deficiency	ORPHA:77293
1148	0.3871	Microvillus inclusion disease	ORPHA:2290
1148	0.3871	Microvillus inclusion disease	ORPHA:2290
1148	0.3871	Fletcher factor (prekallikrein) deficiency	OMIM:612423
1148	0.3871	Congenital factor XII deficiency	ORPHA:330
1148	0.3871	Factor XI deficiency, autosomal dominant	OMIM:612416
1148	0.3871	Peripheral primitive neuroectodermal tumor	ORPHA:370348
1148	0.3871	Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality	ORPHA:86841
1148	0.3871	Arthrogryposis, renal dysfunction, and cholestasis 1	OMIM:208085
1148	0.3871	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
1148	0.3871	Vitamin K-dependent clotting factors, combined deficiency of, 2	OMIM:607473
1148	0.3871	RFT1-CDG	ORPHA:244310
1148	0.3871	Congenital disorder of glycosylation, type IIl	OMIM:614576
1148	0.3871	Lysinuric protein intolerance	ORPHA:470
1148	0.3871	Nephrogenic diabetes insipidus	ORPHA:223
1148	0.3871	Wolfram syndrome 2	OMIM:604928
1148	0.3871	Juvenile nephropathic cystinosis	ORPHA:411634
1148	0.3871	Developmental and epileptic encephalopathy 36	OMIM:300884
1148	0.3871	B4GALT1-CDG	ORPHA:79332
1148	0.3871	Combined factor V and VIII deficiency	OMIM:227300
1148	0.3871	Isolated permanent neonatal diabetes mellitus	ORPHA:99885
1184	0.3855	Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	OMIM:610842
1184	0.3855	Primary familial polycythemia	ORPHA:90042
1186	0.3851	Congenital bile acid synthesis defect type 1	ORPHA:79301
1186	0.3851	Neonatal intrahepatic cholestasis due to citrin deficiency	ORPHA:247598
1186	0.3851	?Thrombocytopenia 6	OMIM:616937
1189	0.385	FLNA-related X-linked myxomatous valvular dysplasia	ORPHA:555877
1190	0.3847	Hemophilia B	OMIM:306900
1190	0.3847	SLC35A1-CDG	ORPHA:238459
1192	0.3846	Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib	ORPHA:79259
1193	0.3841	Glanzmann thrombasthenia 2	OMIM:619267
1194	0.384	Factor XIIIB deficiency	OMIM:613235
1195	0.3837	Bleeding disorder, platelet-type, 24, autosomal dominant	OMIM:619271
1195	0.3837	Sea-blue histiocytosis	ORPHA:158029
1195	0.3837	Plasminogen activator inhibitor-1 deficiency	OMIM:613329
1195	0.3837	Bleeding disorder, platelet-type, 16, autosomal dominant	OMIM:187800
1195	0.3837	Bleeding disorder, platelet-type, 21	OMIM:617443
1195	0.3837	Mitochondrial complex IV deficiency, nuclear type 13	OMIM:616501
1201	0.3834	Autoimmune lymphoproliferative syndrome	ORPHA:3261
1201	0.3834	Autoimmune lymphoproliferative syndrome	ORPHA:3261
1201	0.3834	Autoimmune lymphoproliferative syndrome	ORPHA:3261
1201	0.3834	Autoimmune lymphoproliferative syndrome	ORPHA:3261
1201	0.3834	Autoimmune lymphoproliferative syndrome	ORPHA:3261
1201	0.3834	Alpha-thalassemia-myelodysplastic syndrome	ORPHA:231401
1207	0.3832	Congenital factor II deficiency	ORPHA:325
1208	0.3831	Generalized juvenile polyposis/juvenile polyposis coli	ORPHA:329971
1208	0.3831	Generalized juvenile polyposis/juvenile polyposis coli	ORPHA:329971
1208	0.3831	Generalized juvenile polyposis/juvenile polyposis coli	ORPHA:329971
1208	0.3831	Hereditary mixed polyposis syndrome	ORPHA:157794
1208	0.3831	Hereditary mixed polyposis syndrome	ORPHA:157794
1208	0.3831	von Willebrand disease, type 3	OMIM:277480
1208	0.3831	Bleeding disorder, platelet-type, 8	OMIM:609821
1215	0.3828	Megacystis-microcolon-intestinal hypoperistalsis syndrome 2	OMIM:619351
1216	0.3826	Leukocyte adhesion deficiency, type III	OMIM:612840
1217	0.3823	Cardiac-valvular Ehlers-Danlos syndrome	ORPHA:230851
1217	0.3823	Gray platelet syndrome	ORPHA:721
1217	0.3823	Bleeding disorder in hemophilia A carriers	ORPHA:177926
1220	0.3819	Factor V deficiency	OMIM:227400
1220	0.3819	Hermansky-Pudlak syndrome 6	OMIM:614075
1220	0.3819	Gray platelet syndrome	OMIM:139090
1223	0.3816	Musculocontractural Ehlers-Danlos syndrome	ORPHA:2953
1223	0.3816	Musculocontractural Ehlers-Danlos syndrome	ORPHA:2953
1225	0.3814	Beta-ketothiolase deficiency	ORPHA:134
1225	0.3814	Nephronophthisis 2, infantile	OMIM:602088
1225	0.3814	Tubulointerstitial kidney disease, autosomal dominant, 2	OMIM:174000
1225	0.3814	Corticosteroid-binding globulin deficiency	OMIM:611489
1225	0.3814	Grange syndrome	ORPHA:79094
1230	0.3812	Noonan syndrome 1	OMIM:163950
1230	0.3812	Noonan syndrome 4	OMIM:610733
1232	0.3811	Vascular Ehlers-Danlos syndrome	ORPHA:286
1233	0.381	Congenital factor XI deficiency	ORPHA:329
1234	0.3809	Fragile X-associated tremor/ataxia syndrome	ORPHA:93256
1235	0.3807	Mucopolysaccharidosis Ih	OMIM:607014
1235	0.3807	?Bleeding disorder, platelet-type, 19	OMIM:616176
1235	0.3807	Bernard-Soulier syndrome, type A1 (recessive)	OMIM:231200
1235	0.3807	Giant platelet disorder, isolated	OMIM:231200
1235	0.3807	Bernard-Soulier syndrome, type C	OMIM:231200
1235	0.3807	Bleeding disorder, platelet-type, 17	OMIM:187900
1235	0.3807	Alpha-mannosidosis, infantile form	ORPHA:309282
1242	0.3799	Hermansky-Pudlak syndrome 4	OMIM:614073
1243	0.3796	Familial dysfibrinogenemia	ORPHA:98881
1243	0.3796	Familial hypofibrinogenemia	ORPHA:101041
1243	0.3796	Familial dysfibrinogenemia	ORPHA:98881
1243	0.3796	Familial hypofibrinogenemia	ORPHA:101041
1243	0.3796	Familial dysfibrinogenemia	ORPHA:98881
1243	0.3796	Familial hypofibrinogenemia	ORPHA:101041
1249	0.3793	Perry syndrome	ORPHA:178509
1250	0.3788	Atrial septal defect 2	OMIM:607941
1250	0.3788	?Cardiomyopathy, familial restrictive, 6	OMIM:619433
1252	0.3787	Pseudohypoaldosteronism, type IB1, autosomal recessive	OMIM:264350
1252	0.3787	Bartter syndrome, type 3	OMIM:607364
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Renal tubular dysgenesis	OMIM:267430
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Renal tubular dysgenesis	OMIM:267430
1252	0.3787	Familial glucocorticoid deficiency	ORPHA:361
1252	0.3787	Renal tubular dysgenesis	OMIM:267430
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Pseudohypoaldosteronism, type IB2, autosomal recessive	OMIM:620125
1252	0.3787	Scheie syndrome	ORPHA:93474
1252	0.3787	Mosaic variegated aneuploidy syndrome	ORPHA:1052
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Cardiomyopathy, dilated, 1JJ	OMIM:615235
1252	0.3787	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
1252	0.3787	Mosaic variegated aneuploidy syndrome	ORPHA:1052
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	?Cardiomyopathy, dilated, 2H	OMIM:620203
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Mucolipidosis III alpha/beta	OMIM:252600
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Familial glucocorticoid deficiency	ORPHA:361
1252	0.3787	Cutis laxa, autosomal dominant 3	OMIM:616603
1252	0.3787	Non-acquired panhypopituitarism	ORPHA:90695
1252	0.3787	Mosaic variegated aneuploidy syndrome	ORPHA:1052
1252	0.3787	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
1252	0.3787	Familial glucocorticoid deficiency	ORPHA:361
1252	0.3787	Turnpenny-Fry syndrome	OMIM:618371
1252	0.3787	Syndactyly-telecanthus-anogenital and renal malformations syndrome	ORPHA:140952
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Pseudohypoaldosteronism type I, autosomal dominant	OMIM:177735
1252	0.3787	Hereditary angioedema type 1	ORPHA:100050
1252	0.3787	Severe combined immunodeficiency due to adenosine deaminase deficiency	ORPHA:277
1252	0.3787	Hypoaldosteronism, congenital, due to CMO I deficiency	OMIM:203400
1252	0.3787	Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency	ORPHA:90791
1252	0.3787	Distal 22q11.2 microdeletion syndrome	ORPHA:261330
1252	0.3787	Mosaic variegated aneuploidy syndrome 2	OMIM:614114
1252	0.3787	Mosaic variegated aneuploidy syndrome	ORPHA:1052
1252	0.3787	Familial glucocorticoid deficiency	ORPHA:361
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Congenital isolated ACTH deficiency	ORPHA:199296
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Non-acquired panhypopituitarism	ORPHA:90695
1252	0.3787	Combined pituitary hormone deficiencies, genetic forms	ORPHA:95494
1252	0.3787	Deficiency in anterior pituitary function-variable immunodeficiency syndrome	ORPHA:293978
1252	0.3787	Renin-angiotensin-aldosterone system-blocker-induced angioedema	ORPHA:100057
1252	0.3787	D-2-hydroxyglutaric aciduria	OMIM:600721
1252	0.3787	Alpha-mannosidosis, adult form	ORPHA:309288
1252	0.3787	Goldberg-Shprintzen megacolon syndrome	OMIM:609460
1252	0.3787	Ciliary dyskinesia, primary, 16	OMIM:614017
1252	0.3787	Familial glucocorticoid deficiency	ORPHA:361
1252	0.3787	Developmental and epileptic encephalopathy 18	OMIM:615476
1252	0.3787	Renal tubular dysgenesis	OMIM:267430
1252	0.3787	Mosaic variegated aneuploidy syndrome	ORPHA:1052
1252	0.3787	Aortic aneurysm, familial thoracic 12	OMIM:619825
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Analbuminemia	OMIM:616000
1252	0.3787	Temtamy syndrome	OMIM:218340
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Diamond-Blackfan anemia 21	OMIM:620072
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	Idiopathic pulmonary fibrosis	ORPHA:2032
1252	0.3787	ZTTK syndrome	OMIM:617140
1320	0.3786	Mitochondrial trifunctional protein deficiency 2	OMIM:620300
1321	0.3785	Congenital alpha2-antiplasmin deficiency	ORPHA:79
1322	0.3782	Afibrinogenemia, congenital	OMIM:202400
1322	0.3782	Hypofibrinogenemia, congenital	OMIM:202400
1322	0.3782	Hypofibrinogenemia, congenital	OMIM:202400
1325	0.378	Stormorken syndrome	OMIM:185070
1326	0.3779	Ehlers-Danlos syndrome, cardiac valvular type	OMIM:225320
1327	0.3778	Hermansky-Pudlak syndrome 3	OMIM:614072
1327	0.3778	Chédiak-Higashi syndrome	ORPHA:167
1329	0.3776	Alveolar capillary dysplasia with misalignment of pulmonary veins	OMIM:265380
1329	0.3776	Ehlers-Danlos syndrome, musculocontractural type 1	OMIM:601776
1331	0.3772	Aortic valve disease 2	OMIM:614823
1332	0.3771	Familial afibrinogenemia	ORPHA:98880
1332	0.3771	Factor VII deficiency	OMIM:227500
1332	0.3771	Familial afibrinogenemia	ORPHA:98880
1332	0.3771	Familial afibrinogenemia	ORPHA:98880
1336	0.3768	Juvenile polyposis of infancy	ORPHA:79076
1336	0.3768	Mucopolysaccharidosis Is	OMIM:607016
1336	0.3768	Mucopolysaccharidosis, type X	OMIM:619698
1336	0.3768	Juvenile polyposis of infancy	ORPHA:79076
1336	0.3768	Noonan syndrome-like with loose anagen hair 1	OMIM:607721
1336	0.3768	Mucolipidosis III gamma	OMIM:252605
1342	0.376	Mucopolysaccharidosis Ih/s	OMIM:607015
1342	0.376	Coenzyme Q10 deficiency, primary, 2	OMIM:614651
1344	0.3759	Congenital disorder of glycosylation, type IIf	OMIM:603585
1345	0.3757	Factor XIIIA deficiency	OMIM:613225
1346	0.3754	Vitamin K-dependent clotting factors, combined deficiency of, 1	OMIM:277450
1347	0.3752	Bernard-Soulier syndrome	ORPHA:274
1347	0.3752	Bernard-Soulier syndrome	ORPHA:274
1347	0.3752	Bernard-Soulier syndrome	ORPHA:274
1350	0.3751	Primary myelofibrosis	ORPHA:824
1350	0.3751	Primary myelofibrosis	ORPHA:824
1350	0.3751	Primary myelofibrosis	ORPHA:824
1350	0.3751	Primary myelofibrosis	ORPHA:824
1354	0.3747	Hermansky-Pudlak syndrome 2	OMIM:608233
1354	0.3747	Aplasia cutis congenita	ORPHA:1114
1354	0.3747	Dermatosparaxis Ehlers-Danlos syndrome	ORPHA:1901
1354	0.3747	Aplasia cutis congenita	ORPHA:1114
1354	0.3747	Aplasia cutis congenita	ORPHA:1114
1354	0.3747	von Willebrand disease, platelet-type	OMIM:177820
1354	0.3747	Aplasia cutis congenita	ORPHA:1114
1354	0.3747	Ichthyosis hystrix of Curth-Macklin	ORPHA:79503
1354	0.3747	Aplasia cutis congenita	ORPHA:1114
1354	0.3747	Dermatosparaxis Ehlers-Danlos syndrome	ORPHA:1901
1364	0.3746	Tuberous sclerosis complex	ORPHA:805
1364	0.3746	Tuberous sclerosis complex	ORPHA:805
1364	0.3746	Tuberous sclerosis complex	ORPHA:805
1367	0.3744	Noonan syndrome 14	OMIM:619745
1368	0.3743	Aromatic L-amino acid decarboxylase deficiency	OMIM:608643
1369	0.3741	Spondyloepiphyseal dysplasia with congenital joint dislocations	OMIM:143095
1370	0.3739	Hermansky-Pudlak syndrome 7	OMIM:614076
1371	0.3738	Arterial tortuosity syndrome	OMIM:208050
1372	0.3737	Cardiomyopathy, dilated, 2C	OMIM:618189
1373	0.3728	?Bleeding disorder, platelet-type, 22	OMIM:618462
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1374	0.3727	Acute promyelocytic leukemia	ORPHA:520
1387	0.3725	Hypertension, susceptibility to	OMIM:145500
1387	0.3725	Hypertension, essential, susceptibility to	OMIM:145500
1387	0.3725	Hypertension, essential	OMIM:145500
1387	0.3725	Neurofibromatosis-Noonan syndrome	ORPHA:638
1387	0.3725	Preeclampsia	ORPHA:275555
1387	0.3725	Neurofibromatosis-Noonan syndrome	ORPHA:638
1387	0.3725	Hypertension, essential, susceptibility to	OMIM:145500
1387	0.3725	Preeclampsia	ORPHA:275555
1387	0.3725	Hypertension, salt-sensitive essential, susceptibility to	OMIM:145500
1387	0.3725	Hypertension, essential, salt-sensitive	OMIM:145500
1387	0.3725	Hypertension, essential	OMIM:145500
1387	0.3725	Hypertension, essential, susceptibility to	OMIM:145500
1387	0.3725	Preeclampsia	ORPHA:275555
1400	0.3724	Moderate hemophilia A	ORPHA:169805
1401	0.3719	Systemic lupus erythematosus 17	OMIM:301080
1402	0.3718	Blue rubber bleb nevus	ORPHA:1059
1403	0.3715	Osteogenesis imperfecta, type XVI	OMIM:616229
1403	0.3715	Macrocephaly, alopecia, cutis laxa, and scoliosis	OMIM:613075
1403	0.3715	?Cholestasis, progressive familial intrahepatic, 6	OMIM:619484
1406	0.3713	Syndromic diarrhea	ORPHA:84064
1406	0.3713	Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome	ORPHA:508498
1406	0.3713	Syndromic diarrhea	ORPHA:84064
1409	0.3711	Factor V and factor VIII, combined deficiency of	OMIM:613625
1410	0.3709	Platelet disorder, familial, with associated myeloid malignancy	OMIM:601399
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Spondyloenchondrodysplasia	ORPHA:1855
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1411	0.3707	Systemic lupus erythematosus	ORPHA:536
1442	0.3706	?Bleeding disorder, platelet-type, 18	OMIM:615888
1443	0.3704	Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations	ORPHA:247691
1444	0.3702	Trichohepatoenteric syndrome 1	OMIM:222470
1444	0.3702	Kleefstra syndrome due to 9q34 microdeletion	ORPHA:96147
1446	0.3701	Erythrocytosis, familial, 2	OMIM:263400
1446	0.3701	Mitochondrial complex IV deficiency, nuclear type 5, (French-Canadian)	OMIM:220111
1448	0.3699	Cockayne syndrome type 3	ORPHA:90324
1448	0.3699	Cockayne syndrome type 3	ORPHA:90324
1448	0.3699	Cockayne syndrome type 3	ORPHA:90324
1451	0.3698	Alpha-2-plasmin inhibitor deficiency	OMIM:262850
1451	0.3698	Moyamoya disease with early-onset achalasia	ORPHA:401945
1453	0.3696	Congenital factor XIII deficiency	ORPHA:331
1453	0.3696	Congenital factor XIII deficiency	ORPHA:331
1455	0.3693	Moyamoya 6 with achalasia	OMIM:615750
1456	0.3691	Polycystic kidney disease 1	OMIM:173900
1456	0.3691	Acromegaly	ORPHA:963
1456	0.3691	Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy	OMIM:226300
1456	0.3691	Acromegaly	ORPHA:963
1456	0.3691	Thrombophilia 7 due to antithrombin III deficiency	OMIM:613118
1461	0.3688	Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	OMIM:300367
1461	0.3688	Thrombocytopenia with beta-thalassemia, X-linked	OMIM:314050
1461	0.3688	Hermansky-Pudlak syndrome 5	OMIM:614074
1464	0.3686	von Willebrand disease, type 1	OMIM:193400
1465	0.3685	STING-associated vasculopathy, infantile-onset	OMIM:615934
1466	0.3679	Cockayne syndrome type 1	ORPHA:90321
1466	0.3679	Cockayne syndrome type 1	ORPHA:90321
1466	0.3679	Cockayne syndrome type 1	ORPHA:90321
1466	0.3679	Cockayne syndrome type 1	ORPHA:90321
1466	0.3679	Neuroblastoma, susceptibility to, 1	OMIM:256700
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Deafness-lymphedema-leukemia syndrome	ORPHA:3226
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Orofaciodigital syndrome type 1	ORPHA:2750
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1466	0.3679	Aicardi-Goutières syndrome	ORPHA:51
1481	0.3678	Hermansky-Pudlak syndrome 8	OMIM:614077
1481	0.3678	Hemophilia A	OMIM:306700
1483	0.3675	Congenital factor V deficiency	ORPHA:326
1484	0.3673	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1484	0.3673	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1484	0.3673	Birk-Landau-Perez syndrome	OMIM:617595
1484	0.3673	Autosomal dominant dopa-responsive dystonia	ORPHA:98808
1484	0.3673	Nephronophthisis-like nephropathy 1	OMIM:613159
1489	0.367	Congenital disorder of glycosylation, type IIw	OMIM:619525
1489	0.367	Bleeding disorder, platelet-type, 11	OMIM:614201
1491	0.3669	SESAME syndrome	OMIM:612780
1491	0.3669	Combined deficiency of factor V and factor VIII	ORPHA:35909
1491	0.3669	Combined deficiency of factor V and factor VIII	ORPHA:35909
1494	0.3666	?Liddle syndrome 3	OMIM:618126
1494	0.3666	Hyperaldosteronism, familial, type III	OMIM:613677
1494	0.3666	Bartter syndrome type 4	ORPHA:89938
1494	0.3666	Familial partial lipodystrophy, Köbberling type	ORPHA:79084
1494	0.3666	Lipodystrophy, familial partial, type 2	OMIM:151660
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Bartter syndrome type 4	ORPHA:89938
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome 1	OMIM:209900
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome 1	OMIM:209900
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome 1, modifier of	OMIM:209900
1494	0.3666	Hyperaldosteronism, familial, type II	OMIM:605635
1494	0.3666	?Inflammatory skin and bowel disease, neonatal, 2	OMIM:616069
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Hypertension, pregnancy-induced	OMIM:189800
1494	0.3666	Scalp-ear-nipple syndrome	ORPHA:2036
1494	0.3666	XFE progeroid syndrome	OMIM:610965
1494	0.3666	von Hippel-Lindau syndrome	OMIM:193300
1494	0.3666	Budd-Chiari syndrome, somatic	OMIM:600880
1494	0.3666	Liddle syndrome 1	OMIM:177200
1494	0.3666	Liddle syndrome 2	OMIM:618114
1494	0.3666	Sickle cell disease	OMIM:603903
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	von Hippel-Lindau syndrome, modifier of	OMIM:193300
1494	0.3666	Hemolytic uremic syndrome, atypical, susceptibility to, 5	OMIM:612925
1494	0.3666	Neurofibromatosis, type 1	OMIM:162200
1494	0.3666	Paragangliomas 6	OMIM:618464
1494	0.3666	Multisystemic smooth muscle dysfunction syndrome	OMIM:613834
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Polycystic kidney disease 2	OMIM:613095
1494	0.3666	Bartter syndrome type 4	ORPHA:89938
1494	0.3666	Chilblain lupus	OMIM:610448
1494	0.3666	Bartter syndrome, type 2	OMIM:241200
1494	0.3666	Bartter syndrome, type 1	OMIM:601678
1494	0.3666	Amyloidosis, 3 or more types	OMIM:105200
1494	0.3666	Symptomatic form of fragile X syndrome in female carriers	ORPHA:449291
1494	0.3666	Pseudohypoaldosteronism, type IIB	OMIM:614491
1494	0.3666	Insulin resistance, severe, digenic	OMIM:604367
1494	0.3666	Pseudohypoaldosteronism, type IIC	OMIM:614492
1494	0.3666	Glomerulosclerosis, focal segmental, 1	OMIM:603278
1494	0.3666	Isolated ectopia lentis	ORPHA:1885
1494	0.3666	Stiff skin syndrome	ORPHA:2833
1494	0.3666	Obesity due to melanocortin 4 receptor deficiency	ORPHA:71529
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Short-rib thoracic dysplasia 9 with or without polydactyly	OMIM:266920
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Coenzyme Q10 deficiency, primary, 8	OMIM:616733
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Polycystic kidney disease 7	OMIM:620056
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Low phospholipid-associated cholelithiasis	ORPHA:69663
1494	0.3666	Methylcobalamin deficiency type cblE	ORPHA:2169
1494	0.3666	Glomerulopathy with fibronectin deposits 2	OMIM:601894
1494	0.3666	Myhre syndrome	ORPHA:2588
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Calcification of joints and arteries	OMIM:211800
1494	0.3666	Glomerulosclerosis, focal segmental, 2	OMIM:603965
1494	0.3666	Blau syndrome	OMIM:186580
1494	0.3666	Congenital plasminogen activator inhibitor type 1 deficiency	ORPHA:465
1494	0.3666	Amyloidosis, renal	OMIM:105200
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Short stature, hearing loss, retinitis pigmentosa, and distinctive facies	OMIM:617763
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Au-Kline syndrome	OMIM:616580
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Bardet-Biedl syndrome 1, modifier of	OMIM:209900
1494	0.3666	Papillorenal syndrome	OMIM:120330
1494	0.3666	Alport syndrome 1, X-linked	OMIM:301050
1494	0.3666	Alport syndrome 2, autosomal recessive	OMIM:203780
1494	0.3666	Generalized glucocorticoid resistance syndrome	ORPHA:786
1494	0.3666	Glucocorticoid resistance	OMIM:615962
1494	0.3666	?Amyloidosis, familial visceral	OMIM:105200
1494	0.3666	Amyloidosis, familial visceral	OMIM:105200
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Frasier syndrome	ORPHA:347
1494	0.3666	Denys-Drash syndrome	OMIM:194080
1494	0.3666	Denys-Drash syndrome	ORPHA:220
1494	0.3666	Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities	OMIM:617913
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Familial pseudohyperkalemia	ORPHA:90044
1494	0.3666	Apert syndrome	ORPHA:87
1494	0.3666	Beare-Stevenson cutis gyrata syndrome	OMIM:123790
1494	0.3666	Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome	ORPHA:1555
1494	0.3666	Hyperaldosteronism, familial, type IV	OMIM:617027
1494	0.3666	Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	OMIM:605115
1494	0.3666	Glomerulosclerosis, focal segmental, 3	OMIM:607832
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Renal hypodysplasia/aplasia 1	OMIM:191830
1494	0.3666	17,20-lyase deficiency, isolated	OMIM:202110
1494	0.3666	Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency	ORPHA:90793
1494	0.3666	Lipodystrophy, familial partial, type 6	OMIM:615980
1494	0.3666	Brachydactyly-arterial hypertension syndrome	ORPHA:1276
1494	0.3666	Hypertension and brachydactyly syndrome	OMIM:112410
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Lipodystrophy, familial partial, type 4	OMIM:613877
1494	0.3666	PLIN1-related familial partial lipodystrophy	ORPHA:280356
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	OMIM:202010
1494	0.3666	Aldosteronism, glucocorticoid-remediable	OMIM:103900
1494	0.3666	Budd-Chiari syndrome	OMIM:600880
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Potocki-Shaffer syndrome	ORPHA:52022
1494	0.3666	Orofaciodigital syndrome I	OMIM:311200
1494	0.3666	?IgA nephropathy, susceptibility to, 3	OMIM:616818
1494	0.3666	Fanconi renotubular syndrome 5	OMIM:618913
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Ochoa syndrome	ORPHA:2704
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Cranioectodermal dysplasia 2	OMIM:613610
1494	0.3666	Caudal regression syndrome	ORPHA:3027
1494	0.3666	Pseudohypoaldosteronism, type IIE	OMIM:614496
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Potocki-Shaffer syndrome	ORPHA:52022
1494	0.3666	Nail-patella-like renal disease	ORPHA:2613
1494	0.3666	Juvenile Paget disease	ORPHA:2801
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Isolated ectopia lentis	ORPHA:1885
1494	0.3666	Pseudohypoaldosteronism, type IID	OMIM:614495
1494	0.3666	Pituitary adenoma 1, multiple types	OMIM:102200
1494	0.3666	Galloway-Mowat syndrome 3	OMIM:617729
1494	0.3666	Potocki-Shaffer syndrome	ORPHA:52022
1494	0.3666	Nephronophthisis 18	OMIM:615862
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Polycystic kidney disease 6 with or without polycystic liver disease	OMIM:618061
1494	0.3666	IFAP syndrome with or without BRESHECK syndrome	OMIM:308205
1494	0.3666	Polycystic kidney disease 3	OMIM:600666
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Congenital factor X deficiency	ORPHA:328
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Juvenile Paget disease	ORPHA:2801
1494	0.3666	Tessadori-Bicknell-van Haaften neurodevelopmental syndrome 1	OMIM:619758
1494	0.3666	Congenital disorder of glycosylation, type IIm	OMIM:300896
1494	0.3666	Hemolytic uremic syndrome, atypical, susceptibility to, 3	OMIM:612923
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	OMIM:201750
1494	0.3666	Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency	ORPHA:95699
1494	0.3666	Multicentric carpotarsal osteolysis syndrome	OMIM:166300
1494	0.3666	COACH syndrome 2	OMIM:619111
1494	0.3666	Hemolytic uremic syndrome, atypical, susceptibility to, 6	OMIM:612926
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	X-linked hypohidrotic ectodermal dysplasia	ORPHA:181
1494	0.3666	Ochoa syndrome	ORPHA:2704
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Nephronophthisis 1, juvenile	OMIM:256100
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Glutaric aciduria III	OMIM:231690
1494	0.3666	Autosomal dominant polycystic kidney disease	ORPHA:730
1494	0.3666	Glomerulosclerosis, focal segmental, 5	OMIM:613237
1494	0.3666	Nephrogenic syndrome of inappropriate antidiuresis	OMIM:300539
1494	0.3666	Caudal regression syndrome	ORPHA:3027
1494	0.3666	?Lipodystrophy, familial partial, type 5	OMIM:615238
1494	0.3666	Posterior urethral valve	ORPHA:93110
1494	0.3666	Polycystic kidney disease 5	OMIM:617610
1494	0.3666	Apparent mineralocorticoid excess	OMIM:218030
1494	0.3666	Apparent mineralocorticoid excess	ORPHA:320
1494	0.3666	Glycogen storage disease Ib	OMIM:232220
1494	0.3666	ACTH-independent macronodular adrenal hyperplasia 2	OMIM:615954
1494	0.3666	Hemolytic uremic syndrome, atypical, susceptibility to, 2	OMIM:612922
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1494	0.3666	Hemolytic uremic syndrome, atypical, susceptibility to, 4	OMIM:612924
1494	0.3666	Alport syndrome 2, autosomal recessive	OMIM:203780
1494	0.3666	Alport syndrome 3, autosomal dominant	OMIM:104200
1494	0.3666	Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	OMIM:201910
1494	0.3666	X-linked hypohidrotic ectodermal dysplasia	ORPHA:181
1494	0.3666	?Immunodeficiency 22	OMIM:615758
1494	0.3666	?Lessel-Kubisch syndrome	OMIM:618681
1494	0.3666	Senior-Loken syndrome	ORPHA:3156
1494	0.3666	Nephroblastoma	ORPHA:654
1494	0.3666	Bardet-Biedl syndrome	ORPHA:110
1681	0.3665	Severe neurodegenerative syndrome with lipodystrophy	ORPHA:363400
1681	0.3665	Classic homocystinuria	ORPHA:394
1683	0.3654	Glanzmann thrombasthenia	ORPHA:849
1683	0.3654	Glanzmann thrombasthenia	ORPHA:849
1685	0.3652	Hemolytic uremic syndrome, atypical, susceptibility to	OMIM:235400
1685	0.3652	Keutel syndrome	OMIM:245150
1685	0.3652	Myhre syndrome	OMIM:139210
1685	0.3652	Spondyloenchondrodysplasia with immune dysregulation	OMIM:607944
1685	0.3652	Hemolytic uremic syndrome, atypical, susceptibility to, 1	OMIM:235400
1685	0.3652	Hemolytic uremic syndrome, atypical, susceptibility to	OMIM:235400
1691	0.3651	Polycythemia vera, somatic	OMIM:263300
1691	0.3651	Heme oxygenase-1 deficiency	OMIM:614034
1693	0.3642	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
1693	0.3642	ACTH-independent macronodular adrenal hyperplasia	OMIM:219080
1693	0.3642	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1	OMIM:619115
1693	0.3642	Pigmented nodular adrenocortical disease, primary, 1	OMIM:610489
1693	0.3642	Marfan lipodystrophy syndrome	OMIM:616914
1693	0.3642	Cushing syndrome, ACTH-independent adrenal, somatic	OMIM:615830
1693	0.3642	Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2	OMIM:619120
1693	0.3642	Pigmented nodular adrenocortical disease, primary, 2	OMIM:610475
1693	0.3642	Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	OMIM:615688
1693	0.3642	Lysyl hydroxylase 3 deficiency	OMIM:612394
1693	0.3642	Cushing syndrome due to bilateral macronodular adrenocortical disease	ORPHA:189427
1693	0.3642	Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency	ORPHA:300179
1705	0.3638	Gaucher disease, type I	OMIM:230800
1706	0.3637	Sneddon syndrome	ORPHA:820
1707	0.3636	Hermansky-Pudlak syndrome 1	OMIM:203300
1708	0.3635	Glycogen storage disease Ic	OMIM:232240
1709	0.3634	Thrombocytopenia, autosomal dominant, 7	OMIM:619130
1710	0.3633	Familial hyperaldosteronism type II	ORPHA:404
1710	0.3633	Wiskott-Aldrich syndrome	OMIM:301000
1710	0.3633	Xq21 microdeletion syndrome	ORPHA:1435
1710	0.3633	Familial hyperaldosteronism type I	ORPHA:403
1710	0.3633	Familial hyperaldosteronism type I	ORPHA:403
1715	0.3632	Aicardi-Goutieres syndrome 7	OMIM:615846
1715	0.3632	Schimke immunoosseous dysplasia	OMIM:242900
1717	0.3631	Vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations	OMIM:192315
1717	0.3631	Hypoprothrombinemia	OMIM:613679
1717	0.3631	Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency	ORPHA:90795
1717	0.3631	Severe hemophilia A	ORPHA:169802
1717	0.3631	Joubert syndrome 14	OMIM:614424
1722	0.3629	Fibronectin glomerulopathy	ORPHA:84090
1722	0.3629	Pseudo-TORCH syndrome 3	OMIM:618886
1724	0.3624	17q11 microdeletion syndrome	ORPHA:97685
1725	0.3621	Blau syndrome	ORPHA:90340
1725	0.3621	Cirrhosis, noncryptogenic, susceptibility to	OMIM:215600
1725	0.3621	Cirrhosis, cryptogenic	OMIM:215600
1725	0.3621	Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type	OMIM:613320
1729	0.362	Lipodystrophy, familial partial, type 7	OMIM:606721
1729	0.362	Sneddon syndrome	OMIM:182410
1731	0.3619	Senior-Boichis syndrome	ORPHA:84081
1731	0.3619	COACH syndrome 1	OMIM:216360
1731	0.3619	Senior-Boichis syndrome	ORPHA:84081
1734	0.3617	Pituitary adenoma 4, ACTH-secreting, somatic	OMIM:219090
1734	0.3617	Autosomal recessive polycystic kidney disease	ORPHA:731
1734	0.3617	Autosomal recessive polycystic kidney disease	ORPHA:731
1737	0.3616	Glanzmann thrombasthenia 1	OMIM:273800
1737	0.3616	Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2	OMIM:616779
1739	0.3614	Hardikar syndrome	OMIM:301068
1739	0.3614	Polycystic kidney disease 4, with or without hepatic disease	OMIM:263200
1741	0.3611	Deafness, autosomal dominant 1, with or without thrombocytopenia	OMIM:124900
1742	0.361	Pierson syndrome	OMIM:609049
1742	0.361	Ehlers-Danlos syndrome, vascular type	OMIM:130050
1744	0.3603	Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome	ORPHA:280679
1745	0.3602	?Reynolds syndrome	OMIM:613471
1746	0.3593	?Mungan syndrome	OMIM:611376
1747	0.359	Alagille syndrome 2	OMIM:610205
1748	0.3586	Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	OMIM:607459
1748	0.3586	Tatton-Brown-Rahman syndrome	OMIM:615879
1748	0.3586	Mandibuloacral dysplasia progeroid syndrome	OMIM:619127
1748	0.3586	Meckel syndrome 14	OMIM:619879
1752	0.3584	Familial cerebral saccular aneurysm	ORPHA:231160
1752	0.3584	Familial cerebral saccular aneurysm	ORPHA:231160
1752	0.3584	Familial cerebral saccular aneurysm	ORPHA:231160
1752	0.3584	Familial cerebral saccular aneurysm	ORPHA:231160
1752	0.3584	Familial cerebral saccular aneurysm	ORPHA:231160
1757	0.3577	Malouf syndrome	OMIM:212112
1757	0.3577	Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy	ORPHA:136
1757	0.3577	Telangiectasia, hereditary hemorrhagic, type 2	OMIM:600376
1760	0.3576	Autosomal dominant spastic paraplegia type 9A	ORPHA:447753
1760	0.3576	Sandhoff disease, infantile form	ORPHA:309155
1760	0.3576	Autosomal dominant spastic paraplegia type 9A	ORPHA:447753
1763	0.3568	Congenital dyserythropoietic anemia type III	ORPHA:98870
1763	0.3568	Congenital dyserythropoietic anemia type III	ORPHA:98870
1765	0.3566	Progressive external ophthalmoplegia, autosomal recessive 1	OMIM:258450
1765	0.3566	Ehlers-Danlos syndrome, kyphoscoliotic type, 2	OMIM:614557
1767	0.3562	Yunis-Varon syndrome	ORPHA:3472
1767	0.3562	Yunis-Varon syndrome	ORPHA:3472
1767	0.3562	Thrombocytopenia-absent radius syndrome	OMIM:274000
1770	0.3561	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	OMIM:175050
1771	0.3557	Adams-Oliver syndrome 1	OMIM:100300
1772	0.3556	Hypothyroidism, congenital nongoitrous, 5	OMIM:225250
1772	0.3556	?Uruguay faciocardiomusculoskeletal syndrome	OMIM:300280
1772	0.3556	Dehydrated hereditary stomatocytosis	ORPHA:3202
1772	0.3556	Bardet-Biedl syndrome 3	OMIM:600151
1772	0.3556	Agenesis of corpus callosum, cardiac, ocular, and genital syndrome	OMIM:618929
1772	0.3556	Overhydrated hereditary stomatocytosis	OMIM:185000
1772	0.3556	Contractural arachnodactyly, congenital	OMIM:121050
1772	0.3556	?Cutis laxa, autosomal dominant 2	OMIM:614434
1772	0.3556	Shprintzen-Goldberg syndrome	ORPHA:2462
1772	0.3556	Aortic aneurysm, familial thoracic 10	OMIM:617168
1772	0.3556	Myopathy, myofibrillar, 6	OMIM:612954
1772	0.3556	Centronuclear myopathy 5	OMIM:615959
1772	0.3556	Dehydrated hereditary stomatocytosis	ORPHA:3202
1772	0.3556	Coffin-Lowry syndrome	OMIM:303600
1772	0.3556	Dehydrated hereditary stomatocytosis	ORPHA:3202
1772	0.3556	Thromboembolism, susceptibility to	OMIM:188050
1772	0.3556	Aspartylglucosaminuria	OMIM:208400
1772	0.3556	Congenital myopathy 15	OMIM:620161
1772	0.3556	Terminal osseous dysplasia-pigmentary defects syndrome	ORPHA:88630
1772	0.3556	Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome	ORPHA:83473
1772	0.3556	Khan-Khan-Katsanis syndrome	OMIM:618460
1772	0.3556	Robinow syndrome, autosomal dominant 3	OMIM:616894
1772	0.3556	Luo-Schoch-Yamamoto syndrome	OMIM:619460
1772	0.3556	Mucopolysaccharidosis type IIID	OMIM:252940
1772	0.3556	?Central hypoventilation syndrome, congenital, 3	OMIM:619483
1772	0.3556	Thrombophilia 1 due to thrombin defect	OMIM:188050
1772	0.3556	?Immunodeficiency 94 with autoinflammation and dysmorphic facies	OMIM:619750
1772	0.3556	Thrombophilia 3 due to protein C deficiency, autosomal dominant	OMIM:176860
1772	0.3556	Spastic paraplegia type 2	ORPHA:99015
1772	0.3556	Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome	ORPHA:83473
1772	0.3556	Mitral valve prolapse 2	OMIM:607829
1772	0.3556	Intellectual developmental disorder, X-linked syndromic, Hackman-Di Donato type	OMIM:301039
1772	0.3556	Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	OMIM:271640
1772	0.3556	Venous thrombosis, protection against	OMIM:188050
1772	0.3556	Short-rib thoracic dysplasia 6 with or without polydactyly	OMIM:263520
1772	0.3556	Hyperammonemia due to N-acetylglutamate synthase deficiency	ORPHA:927
1772	0.3556	Shprintzen-Goldberg syndrome	ORPHA:2462
1772	0.3556	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	OMIM:603387
1772	0.3556	Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome	ORPHA:83473
1772	0.3556	ALG9-CDG	ORPHA:79328
1772	0.3556	Ehlers-Danlos syndrome, musculocontractural type 2	OMIM:615539
1772	0.3556	Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome	ORPHA:2848
1772	0.3556	Geleophysic dysplasia 3	OMIM:617809
1772	0.3556	Skeletal dysplasia, mild, with joint laxity and advanced bone age	OMIM:618870
1772	0.3556	Neurodegeneration and seizures due to copper transport defect	OMIM:620306
1772	0.3556	Thrombophilia 12 due to thrombomodulin defect	OMIM:614486
1772	0.3556	Immunodeficiency 47	OMIM:300972
1772	0.3556	?Mitral valve prolapse 3	OMIM:610840
1772	0.3556	Myopathy, myofibrillar, 8	OMIM:617258
1772	0.3556	Venous thromboembolism, susceptibility to	OMIM:188050
1772	0.3556	Carpenter syndrome 2	OMIM:614976
1772	0.3556	Thrombophilia 13, X-linked, due to factor VIII defect	OMIM:301071
1772	0.3556	Hereditary thrombophilia due to congenital antithrombin deficiency	ORPHA:82
1772	0.3556	Cardiospondylocarpofacial syndrome	ORPHA:3238
1772	0.3556	Cardiospondylocarpofacial syndrome	OMIM:157800
1772	0.3556	Carey-Fineman-Ziter syndrome	ORPHA:1358
1772	0.3556	Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome	ORPHA:457395
1772	0.3556	Developmental and speech delay due to SOX5 deficiency	ORPHA:313892
1772	0.3556	Neurooculocardiogenitourinary syndrome	OMIM:618652
1831	0.355	Severe hereditary thrombophilia due to congenital protein C deficiency	ORPHA:745
1831	0.355	Congenital factor VII deficiency	ORPHA:327
1833	0.3548	Cardiac valvular dysplasia 1	OMIM:212093
1834	0.3546	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	OMIM:613563
1834	0.3546	Noonan syndrome 8	OMIM:615355
1834	0.3546	Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion	ORPHA:363700
1834	0.3546	Mucopolysaccharidosis type IVB (Morquio)	OMIM:253010
1834	0.3546	Thrombophilia 5 due to protein S deficiency, autosomal dominant	OMIM:612336
1839	0.3545	Severe hereditary thrombophilia due to congenital protein S deficiency	ORPHA:743
1840	0.3543	Factor X deficiency	OMIM:227600
1841	0.3542	Noonan syndrome 10	OMIM:616564
1842	0.3539	Weill-Marchesani syndrome	ORPHA:3449
1842	0.3539	Weill-Marchesani syndrome	ORPHA:3449
1842	0.3539	Weill-Marchesani syndrome 1, recessive	OMIM:277600
1842	0.3539	Weill-Marchesani syndrome	ORPHA:3449
1846	0.3537	Loeys-Dietz syndrome 5	OMIM:615582
1846	0.3537	Noonan syndrome 13	OMIM:619087
1848	0.3536	Bernard-Soulier syndrome, type A2 (dominant)	OMIM:153670
1849	0.3518	Thrombophilia 5 due to protein S deficiency, autosomal recessive	OMIM:614514
1850	0.3515	Mitochondrial complex IV deficiency, nuclear type 7	OMIM:619051
1850	0.3515	Fontaine progeroid syndrome	OMIM:612289
1850	0.3515	Respiratory infections, recurrent, and failure to thrive with or without diarrhea	OMIM:620233
1850	0.3515	Lymphatic malformation 13	OMIM:620244
1854	0.3514	CTCF-related neurodevelopmental disorder	ORPHA:363611
1855	0.3513	Adams-Oliver syndrome 6	OMIM:616589
1855	0.3513	Dursun syndrome	OMIM:612541
1857	0.3512	Geleophysic dysplasia 2	OMIM:614185
1858	0.3508	Sturge-Weber syndrome	ORPHA:3205
1859	0.3504	Thrombophilia 3 due to protein C deficiency, autosomal recessive	OMIM:612304
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	Pulmonary hypertension, primary, 3	OMIM:615343
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1860	0.3497	22q11.2 deletion syndrome	ORPHA:567
1870	0.3491	Diamond-Blackfan anemia 6	OMIM:612561
1871	0.349	Methylmalonic acidemia with homocystinuria, type cblC	ORPHA:79282
1872	0.3468	Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	OMIM:605714
1873	0.3214	Chilton-Okur-Chung neurodevelopmental syndrome	OMIM:619841
1874	0.3206	Menkes disease	ORPHA:565
1875	0.3196	Cholestasis, progressive familial intrahepatic 1	OMIM:211600
1875	0.3196	Bleeding disorder, platelet-type, 15	OMIM:615193
1875	0.3196	?Immunodeficiency 108 with autoinflammation	OMIM:260570
1878	0.3194	Alacrima, achalasia, and impaired intellectual development syndrome	OMIM:615510
1878	0.3194	Achalasia-addisonianism-alacrimia syndrome	OMIM:231550
1880	0.3192	Thrombocytopenia, X-linked, intermittent	OMIM:313900
1880	0.3192	Thrombocytopenia 3	OMIM:273900
1880	0.3192	Quebec platelet disorder	OMIM:601709
1883	0.3185	Bleeding disorder, platelet-type, 13, susceptibility to	OMIM:614009
1883	0.3185	von Willebrand disease, types 2A, 2B, 2M, and 2N	OMIM:613554
1883	0.3185	Thrombocytopenia 5	OMIM:616216
1883	0.3185	Bleeding disorder, platelet-type, 20	OMIM:616913
1887	0.3175	Multiple system atrophy, susceptibility to	OMIM:146500
1887	0.3175	Sandhoff disease, infantile, juvenile, and adult forms	OMIM:268800
1889	0.3173	Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome	ORPHA:500150
1890	0.3172	Parkinson disease 22, autosomal dominant	OMIM:616710
1891	0.3167	Adult-onset autosomal dominant leukodystrophy	ORPHA:99027
1892	0.3166	Hermansky-Pudlak syndrome 11	OMIM:619172
1892	0.3166	Immune thrombocytopenia	ORPHA:3002
1894	0.3163	Portal hypertension, noncirrhotic, 2	OMIM:619463
1895	0.3158	Tyrosinemia, type I	OMIM:276700
1896	0.3155	Chediak-Higashi syndrome	OMIM:214500
1897	0.3153	Norrie disease	ORPHA:649
1898	0.3139	Idiopathic aplastic anemia	ORPHA:88
1898	0.3139	Idiopathic aplastic anemia	ORPHA:88
1898	0.3139	Idiopathic aplastic anemia	ORPHA:88
1898	0.3139	Idiopathic aplastic anemia	ORPHA:88
1898	0.3139	Telangiectasia, hereditary hemorrhagic, type 5	OMIM:615506
1903	0.3132	Hyperimmunoglobulinemia D with periodic fever	ORPHA:343
1904	0.3128	Occipital horn syndrome	ORPHA:198
1904	0.3128	Occipital horn syndrome	OMIM:304150
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Gastrointestinal stromal tumor	ORPHA:44890
1906	0.3127	Carney-Stratakis syndrome	ORPHA:97286
1906	0.3127	Gastrointestinal stromal tumor	ORPHA:44890
1906	0.3127	Carney-Stratakis syndrome	ORPHA:97286
1906	0.3127	Carney-Stratakis syndrome	ORPHA:97286
1906	0.3127	Autosomal recessive spastic paraplegia type 11	ORPHA:2822
1906	0.3127	Proteus-like syndrome	ORPHA:2969
1906	0.3127	Lymphangioleiomyomatosis	ORPHA:538
1906	0.3127	Lymphangioleiomyomatosis	ORPHA:538
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Polyglucosan body disease, adult form	OMIM:263570
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Desmoid tumor	ORPHA:873
1906	0.3127	Gastrointestinal stromal tumor	ORPHA:44890
1906	0.3127	Pachydermoperiostosis	ORPHA:2796
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Parkinson disease 4	OMIM:605543
1906	0.3127	Gastrointestinal stromal tumor	ORPHA:44890
1906	0.3127	Isolated polycystic liver disease	ORPHA:2924
1906	0.3127	Isolated polycystic liver disease	ORPHA:2924
1906	0.3127	Pachydermoperiostosis	ORPHA:2796
1906	0.3127	Fructose intolerance, hereditary	OMIM:229600
1906	0.3127	?Cerebroretinal microangiopathy with calcifications and cysts 3	OMIM:620368
1906	0.3127	Periodic fever, familial	OMIM:142680
1906	0.3127	Gastrointestinal stromal tumor	ORPHA:44890
1906	0.3127	Peutz-Jeghers syndrome	ORPHA:2869
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Desmoid tumor	ORPHA:873
1906	0.3127	Hypoaldosteronism, congenital, due to CMO II deficiency	OMIM:610600
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Microphthalmia with limb anomalies	ORPHA:1106
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Lynch syndrome	ORPHA:144
1906	0.3127	Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary CAKUT	OMIM:191800
1906	0.3127	Wolfram syndrome	ORPHA:3463
1906	0.3127	Isolated polycystic liver disease	ORPHA:2924
1906	0.3127	8q24.3 microdeletion syndrome	ORPHA:508488
1906	0.3127	Wolfram syndrome	ORPHA:3463
1906	0.3127	Palmoplantar keratoderma-esophageal carcinoma syndrome	ORPHA:2198
1906	0.3127	Orthostatic hypotension 2	OMIM:618182
1906	0.3127	Burkitt lymphoma	ORPHA:543
1951	0.3125	Autoimmune lymphoproliferative syndrome, type II	OMIM:603909
1952	0.3114	Amyloidosis, hereditary, transthyretin-related	OMIM:105210
1953	0.3112	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	OMIM:616007
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1954	0.3108	Hereditary late-onset Parkinson disease	ORPHA:411602
1961	0.3107	Cutis marmorata telangiectatica congenita	ORPHA:1556
1961	0.3107	Cutis marmorata telangiectatica congenita	ORPHA:1556
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1963	0.3104	Primary biliary cholangitis	ORPHA:186
1971	0.3101	Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome	ORPHA:2072
1972	0.3099	Budd-Chiari syndrome	ORPHA:131
1972	0.3099	Budd-Chiari syndrome	ORPHA:131
1972	0.3099	MPI-CDG	ORPHA:79319
1972	0.3099	Budd-Chiari syndrome	ORPHA:131
1976	0.3097	Histiocytosis-lymphadenopathy plus syndrome	OMIM:602782
1977	0.3094	MIRAGE syndrome	OMIM:617053
1978	0.3077	Polymicrogyria with or without vascular-type EDS	OMIM:618343
1979	0.3076	Cerebroretinal microangiopathy with calcifications and cysts 2	OMIM:617341
1980	0.3067	Alpha-N-acetylgalactosaminidase deficiency type 1	ORPHA:79279
1981	0.3066	Classical-like Ehlers-Danlos syndrome type 2	ORPHA:536532
1982	0.3065	Autosomal dominant spastic paraplegia type 10	ORPHA:100991
1983	0.3063	Ataxia-telangiectasia-like disorder 1	OMIM:604391
1984	0.3061	Bilateral striopallidodentate calcinosis	ORPHA:1980
1984	0.3061	Bilateral striopallidodentate calcinosis	ORPHA:1980
1984	0.3061	Autoimmune interstitial lung, joint, and kidney disease	OMIM:616414
1984	0.3061	Bilateral striopallidodentate calcinosis	ORPHA:1980
1984	0.3061	Bilateral striopallidodentate calcinosis	ORPHA:1980
1984	0.3061	Bilateral striopallidodentate calcinosis	ORPHA:1980
1984	0.3061	Lysinuric protein intolerance	OMIM:222700
1984	0.3061	Bilateral striopallidodentate calcinosis	ORPHA:1980
1984	0.3061	Immunodeficiency 91 and hyperinflammation	OMIM:619644
1993	0.3059	Obesity due to congenital leptin deficiency	ORPHA:66628
1993	0.3059	Obesity due to leptin receptor gene deficiency	ORPHA:179494
1993	0.3059	Insensitivity to pain, congenital, with anhidrosis	OMIM:256800
1993	0.3059	CLAPO syndrome, somatic	OMIM:613089
1993	0.3059	Feingold syndrome type 1	ORPHA:391641
1993	0.3059	Feingold syndrome 1	OMIM:164280
1993	0.3059	Congenital disorder of glycosylation, type Ie	OMIM:608799
1993	0.3059	Lymphatic malformation 6	OMIM:616843
1993	0.3059	Milroy disease	ORPHA:79452
1993	0.3059	Loeys-Dietz syndrome 6	OMIM:619656
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1993	0.3059	Milroy disease	ORPHA:79452
1993	0.3059	Milroy disease	ORPHA:79452
1993	0.3059	Lymphatic malformation 7	OMIM:617300
1993	0.3059	Meige disease	ORPHA:90186
1993	0.3059	Leukodystrophy, adult-onset, autosomal dominant	OMIM:169500
1993	0.3059	Milroy disease	ORPHA:79452
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1993	0.3059	Thauvin-Robinet-Faivre syndrome	OMIM:617107
1993	0.3059	Tall stature-intellectual disability-renal anomalies syndrome	ORPHA:500095
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
1993	0.3059	Hyperphosphatasia-intellectual disability syndrome	ORPHA:247262
2018	0.3058	?Cutaneous telangiectasia and cancer syndrome, familial	OMIM:614564
2019	0.3056	?De Sanctis-Cacchione syndrome	OMIM:278800
2019	0.3056	?De Sanctis-Cacchione syndrome	OMIM:278800
2019	0.3056	Xeroderma pigmentosum, group D	OMIM:278730
2019	0.3056	Xeroderma pigmentosum, group A	OMIM:278700
2023	0.3051	Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1	OMIM:125310
2024	0.305	UV-sensitive syndrome 1	OMIM:600630
2024	0.305	UV-sensitive syndrome 1	OMIM:600630
2024	0.305	Moyamoya disease	ORPHA:2573
2024	0.305	Focal dermal hypoplasia	OMIM:305600
2024	0.305	Trichothiodystrophy 1, photosensitive	OMIM:601675
2024	0.305	Xeroderma pigmentosum, group E, DDB-negative subtype	OMIM:278740
2024	0.305	Capillary malformation-arteriovenous malformation 2	OMIM:618196
2024	0.305	Transaldolase deficiency	ORPHA:101028
2024	0.305	Transaldolase deficiency	OMIM:606003
2024	0.305	Bloom syndrome	ORPHA:125
2024	0.305	Moyamoya disease	ORPHA:2573
2024	0.305	Xeroderma pigmentosum variant	ORPHA:90342
2024	0.305	Xeroderma pigmentosum, group C	OMIM:278720
2024	0.305	LIG4 syndrome	OMIM:606593
2024	0.305	Rothmund-Thomson syndrome type 1	ORPHA:221008
2024	0.305	UV-sensitive syndrome 3	OMIM:614640
2024	0.305	Ataxia-oculomotor apraxia type 4	ORPHA:459033
2024	0.305	Poikiloderma with neutropenia	OMIM:604173
2024	0.305	Rothmund-Thomson syndrome, type 2	OMIM:268400
2024	0.305	Moyamoya disease	ORPHA:2573
2044	0.3046	COG8-CDG	ORPHA:95428
2045	0.3041	Adams-Oliver syndrome	ORPHA:974
2045	0.3041	Adams-Oliver syndrome	ORPHA:974
2045	0.3041	Adams-Oliver syndrome	ORPHA:974
2045	0.3041	Adams-Oliver syndrome	ORPHA:974
2045	0.3041	Adams-Oliver syndrome	ORPHA:974
2045	0.3041	Adams-Oliver syndrome	ORPHA:974
2051	0.3037	Hepatic veno-occlusive disease-immunodeficiency syndrome	ORPHA:79124
2052	0.3036	Cerebral cavernous malformations-2	OMIM:603284
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2053	0.3032	Xeroderma pigmentosum	ORPHA:910
2060	0.3028	Ataxia-telangiectasia	ORPHA:100
2061	0.3018	Reynolds syndrome	ORPHA:779
2062	0.3015	Developmental delay, language impairment, and ocular abnormalities	OMIM:620141
2063	0.3011	Noonan syndrome 2	OMIM:605275
2063	0.3011	Hajdu-Cheney syndrome	ORPHA:955
2063	0.3011	Congenital heart defects, nonsyndromic, 1, X-linked	OMIM:306955
2063	0.3011	Vertebral, cardiac, renal, and limb defects syndrome 1	OMIM:617660
2063	0.3011	RIDDLE syndrome	ORPHA:420741
2068	0.301	Prolidase deficiency	OMIM:170100
2069	0.3009	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2069	0.3009	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2069	0.3009	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2069	0.3009	Familial hemophagocytic lymphohistiocytosis	ORPHA:540
2073	0.3007	Wiedemann-Rautenstrauch syndrome	ORPHA:3455
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Focal dermal hypoplasia	ORPHA:2092
2074	0.3006	Mastocytosis, cutaneous	OMIM:154800
2074	0.3006	Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	OMIM:615381
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Familial multiple trichoepithelioma	ORPHA:867
2074	0.3006	Familial cylindromatosis	ORPHA:211
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Ramon syndrome	ORPHA:3019
2074	0.3006	Xeroderma pigmentosum, variant type	OMIM:278750
2074	0.3006	Epidermodysplasia verruciformis	ORPHA:302
2074	0.3006	LIG4 syndrome	ORPHA:99812
2074	0.3006	LIG4 syndrome	ORPHA:99812
2074	0.3006	Epidermodysplasia verruciformis	ORPHA:302
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Infantile systemic hyalinosis	ORPHA:2176
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Kindler syndrome	OMIM:173650
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Epidermodysplasia verruciformis	ORPHA:302
2074	0.3006	Epidermodysplasia verruciformis	ORPHA:302
2074	0.3006	Acrogeria	ORPHA:2500
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Dyskeratosis congenita	ORPHA:1775
2074	0.3006	Cowden syndrome	ORPHA:201
2074	0.3006	Cowden syndrome	ORPHA:201
2111	0.3005	Gaucher disease, perinatal lethal	OMIM:608013
2111	0.3005	Aicardi-Goutieres syndrome 1, dominant and recessive	OMIM:225750
2111	0.3005	Autoinflammation with pulmonary and cutaneous vasculitis	OMIM:620296
2111	0.3005	Tufted angioma	ORPHA:1063
2111	0.3005	Radioulnar synostosis with amegakaryocytic thrombocytopenia 1	OMIM:605432
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive	OMIM:619461
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2116	0.3004	1p36 deletion syndrome	ORPHA:1606
2130	0.3	Myelofibrosis, somatic	OMIM:254450
2130	0.3	Myelofibrosis with myeloid metaplasia, somatic	OMIM:254450
2130	0.3	Myelofibrosis, somatic	OMIM:254450
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Hemochromatosis, type 3	OMIM:604250
2130	0.3	Stormorken-Sjaastad-Langslet syndrome	ORPHA:3204
2130	0.3	Persistent hyperplastic primary vitreous	ORPHA:91495
2130	0.3	Stormorken-Sjaastad-Langslet syndrome	ORPHA:3204
2130	0.3	Immunodeficiency, common variable, 6	OMIM:613496
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	CINCA syndrome	ORPHA:1451
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Persistent hyperplastic primary vitreous	ORPHA:91495
2130	0.3	Myelofibrosis, somatic	OMIM:254450
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Autoinflammation with infantile enterocolitis	OMIM:616050
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	Persistent hyperplastic primary vitreous	ORPHA:91495
2130	0.3	Common variable immunodeficiency	ORPHA:1572
2130	0.3	C4a deficiency	OMIM:614380
2130	0.3	C2 deficiency	OMIM:217000
2157	0.2999	Limited cutaneous systemic sclerosis	ORPHA:220402
2157	0.2999	Limited cutaneous systemic sclerosis	ORPHA:220402
2157	0.2999	Limited cutaneous systemic sclerosis	ORPHA:220402
2157	0.2999	Limited cutaneous systemic sclerosis	ORPHA:220402
2157	0.2999	Limited cutaneous systemic sclerosis	ORPHA:220402
2157	0.2999	Limited cutaneous systemic sclerosis	ORPHA:220402
2163	0.2996	Hypoplastic left heart syndrome	ORPHA:2248
2163	0.2996	Hypoplastic left heart syndrome	ORPHA:2248
2163	0.2996	Gaucher disease, type IIIC	OMIM:231005
2163	0.2996	Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies	OMIM:617260
2163	0.2996	Grange syndrome	OMIM:602531
2163	0.2996	Distal deletion 15q	ORPHA:1596
2169	0.2991	Pontocerebellar hypoplasia, type 2E	OMIM:615851
2170	0.2984	PCNA-related progressive neurodegenerative photosensitivity syndrome	ORPHA:438134
2171	0.298	Cerebroretinal microangiopathy with calcifications and cysts	OMIM:612199
2172	0.2979	?Ataxia-telangiectasia-like disorder 2	OMIM:615919
2173	0.2974	Alpha-N-acetylgalactosaminidase deficiency type 2	ORPHA:79280
2173	0.2974	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	OMIM:137940
2175	0.2973	Aortic valve disease 1	OMIM:109730
2176	0.297	Noonan syndrome 3	OMIM:609942
2176	0.297	Mowat-Wilson syndrome due to a ZEB2 point mutation	ORPHA:261552
2176	0.297	Brittle cornea syndrome	ORPHA:90354
2176	0.297	Brittle cornea syndrome	ORPHA:90354
2180	0.2966	Autosomal recessive malignant osteopetrosis	ORPHA:667
2180	0.2966	Autosomal recessive malignant osteopetrosis	ORPHA:667
2180	0.2966	Autosomal recessive malignant osteopetrosis	ORPHA:667
2180	0.2966	Autosomal recessive malignant osteopetrosis	ORPHA:667
2184	0.2963	Schöpf-Schulz-Passarge syndrome	ORPHA:50944
2184	0.2963	Partington syndrome	ORPHA:94083
2184	0.2963	Congenital bile acid synthesis defect type 4	ORPHA:79095
2187	0.2953	Renal-hepatic-pancreatic dysplasia 2	OMIM:615415
2187	0.2953	Nephronophthisis 16	OMIM:615382
2187	0.2953	Microphthalmia, syndromic 2	OMIM:300166
2187	0.2953	?Weill-Marchesani syndrome 3, recessive	OMIM:614819
2191	0.295	Cardiac, facial, and digital anomalies with developmental delay	OMIM:618164
2192	0.2945	X-linked intellectual disability, Nascimento type	ORPHA:163956
2193	0.2944	Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia	OMIM:617718
2194	0.2943	Persistent hyperplastic primary vitreous, autosomal recessive	OMIM:221900
2195	0.2938	17q21.31 microdeletion syndrome	ORPHA:363958
2196	0.2936	Noonan syndrome 7	OMIM:613706
2196	0.2936	Cardiofaciocutaneous syndrome	ORPHA:1340
2196	0.2936	Cardiofaciocutaneous syndrome	OMIM:115150
2196	0.2936	Hypophosphatemic rickets, autosomal recessive, 2	OMIM:613312
2196	0.2936	Cardiofaciocutaneous syndrome	ORPHA:1340
2196	0.2936	Noonan syndrome 11	OMIM:618499
2196	0.2936	Noonan syndrome 6	OMIM:613224
2196	0.2936	Noonan syndrome 9	OMIM:616559
2196	0.2936	Costello syndrome	ORPHA:3071
2196	0.2936	Neurofibromatosis-Noonan syndrome	OMIM:601321
2196	0.2936	Watson syndrome	OMIM:193520
2196	0.2936	Vertebral anomalies and variable endocrine and T-cell dysfunction	OMIM:618223
2196	0.2936	Neurodevelopmental, jaw, eye, and digital syndrome	OMIM:618914
2196	0.2936	Noonan syndrome-like disorder with loose anagen hair	ORPHA:2701
2196	0.2936	Baraitser-Winter syndrome 1	OMIM:243310
2196	0.2936	Coffin-Siris syndrome 4	OMIM:614609
2196	0.2936	Takenouchi-Kosaki syndrome	OMIM:616737
2196	0.2936	Congenital heart defects, multiple types, 8, with or without heterotaxy	OMIM:619657
2196	0.2936	Sarcosinemia	ORPHA:3129
2196	0.2936	Cardiofaciocutaneous syndrome 3	OMIM:615279
2196	0.2936	Cardiofaciocutaneous syndrome	ORPHA:1340
2196	0.2936	Cardiofaciocutaneous syndrome	ORPHA:1340
2196	0.2936	Cardiofaciocutaneous syndrome 4	OMIM:615280
2196	0.2936	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	OMIM:615508
2196	0.2936	Lessel-Kreienkamp syndrome	OMIM:619149
2196	0.2936	Cornelia de Lange syndrome 3	OMIM:610759
2196	0.2936	Isobutyryl-CoA dehydrogenase deficiency	ORPHA:79159
2196	0.2936	SERKAL syndrome	ORPHA:139466
2196	0.2936	Temple-Baraitser syndrome	OMIM:611816
2196	0.2936	Intellectual developmental disorder, autosomal recessive 40	OMIM:615599
2196	0.2936	Jacobsen syndrome	ORPHA:2308
2196	0.2936	Hypermethioninemia due to adenosine kinase deficiency	OMIM:614300
2196	0.2936	Arboleda-Tham syndrome	OMIM:616268
2196	0.2936	Noonan syndrome-like disorder with loose anagen hair	ORPHA:2701
2196	0.2936	Cerebrofacioarticular syndrome	ORPHA:314679
2196	0.2936	Snijders Blok-Campeau syndrome	OMIM:618205
2196	0.2936	Kabuki syndrome 2	OMIM:300867
2196	0.2936	?Arthrogryposis, Perthes disease, and upward gaze palsy	OMIM:614262
2196	0.2936	?Diamond-Blackfan anemia 16	OMIM:617408
2196	0.2936	Neurodevelopmental disorder with or without autism or seizures	OMIM:619239
2196	0.2936	Cerebrofacioarticular syndrome	ORPHA:314679
2196	0.2936	Peters-plus syndrome	OMIM:261540
2196	0.2936	Peters plus syndrome	ORPHA:709
2196	0.2936	Mowat-Wilson syndrome	OMIM:235730
2196	0.2936	Koolen-De Vries syndrome	OMIM:610443
2196	0.2936	Osteopathia striata-cranial sclerosis syndrome	ORPHA:2780
2196	0.2936	Neurodevelopmental disorder with hypotonia, craniofacial abnormalities, and seizures	OMIM:614501
2196	0.2936	Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	OMIM:614224
2196	0.2936	Aortic valve disease 3	OMIM:618496
2196	0.2936	Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome	ORPHA:459061
2196	0.2936	Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome	ORPHA:459061
2196	0.2936	Cenani-Lenz syndactyly syndrome	OMIM:212780
2196	0.2936	Intellectual developmental disorder, autosomal dominant 43	OMIM:616977
2196	0.2936	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	OMIM:253800
2196	0.2936	Pitt-Hopkins-like syndrome 2	OMIM:614325
2196	0.2936	Neurodevelopmental disorder with dysmorphic features, spasticity, and brain abnormalities	OMIM:615802
2196	0.2936	MEND syndrome	OMIM:300960
2196	0.2936	MEND syndrome	ORPHA:401973
2196	0.2936	Frontometaphyseal dysplasia 2	OMIM:617137
2196	0.2936	Mosaic variegated aneuploidy syndrome 1	OMIM:257300
2196	0.2936	Cardiofacioneurodevelopmental syndrome	OMIM:619123
2196	0.2936	TBCK-related intellectual disability syndrome	ORPHA:488632
2196	0.2936	Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion	ORPHA:284169
2196	0.2936	Hyper-IgE recurrent infection syndrome 3, autosomal recessive	OMIM:618282
2260	0.293	Atelis syndrome 2	OMIM:620185
2261	0.2923	Bloom syndrome	OMIM:210900
2262	0.2922	Encephalocraniocutaneous lipomatosis	ORPHA:2396
2262	0.2922	Encephalocraniocutaneous lipomatosis	ORPHA:2396
2262	0.2922	Adams-Oliver syndrome 5	OMIM:616028
2262	0.2922	Ciliary dyskinesia, primary, 20	OMIM:615067
2266	0.292	Meckel syndrome 7	OMIM:267010
2266	0.292	Renal-hepatic-pancreatic dysplasia 1	OMIM:208540
2268	0.2918	3C syndrome	ORPHA:7
2268	0.2918	Mowat-Wilson syndrome due to monosomy 2q22	ORPHA:261537
2268	0.2918	Ritscher-Schinzel syndrome 1	OMIM:220210
2268	0.2918	3C syndrome	ORPHA:7
2268	0.2918	3C syndrome	ORPHA:7
2268	0.2918	3C syndrome	ORPHA:7
2274	0.2914	Glutaryl-CoA dehydrogenase deficiency	ORPHA:25
2275	0.2905	Mitochondrial complex IV deficiency, nuclear type 12	OMIM:619055
2276	0.2901	Brain-lung-thyroid syndrome	ORPHA:209905
2277	0.2898	Ventricular septal defect 1	OMIM:614429
2277	0.2898	Pancreatic hypoplasia-diabetes-congenital heart disease syndrome	ORPHA:2255
2277	0.2898	Pancreatic agenesis and congenital heart defects	OMIM:600001
2277	0.2898	Microphthalmia, syndromic 9	OMIM:601186
2277	0.2898	Meacham syndrome	ORPHA:3097
2277	0.2898	CHARGE syndrome	OMIM:214800
2277	0.2898	Carpenter syndrome	OMIM:201000
2277	0.2898	Congenital heart defects, multiple types, 7	OMIM:618780
2277	0.2898	Toriello-Carey syndrome	ORPHA:3338
2277	0.2898	Right atrial isomerism (Ivemark)	OMIM:208530
2287	0.2895	Fucosidosis	OMIM:230000
2287	0.2895	ABeta amyloidosis, Iowa type	ORPHA:324708
2289	0.289	Congenital alveolar capillary dysplasia	ORPHA:210122
2290	0.2888	Peutz-Jeghers syndrome	OMIM:175200
2290	0.2888	Venous malformations, multiple cutaneous and mucosal	OMIM:600195
2290	0.2888	Pseudo-TORCH syndrome 1	OMIM:251290
2290	0.2888	?Immunodeficiency 81	OMIM:619374
2290	0.2888	Griscelli syndrome type 2	ORPHA:79477
2290	0.2888	Ethylmalonic encephalopathy	OMIM:602473
2290	0.2888	Ethylmalonic encephalopathy	ORPHA:51188
2290	0.2888	Dyskeratosis congenita, autosomal recessive 8	OMIM:620133
2290	0.2888	Osteopetrosis, autosomal recessive 4	OMIM:611490
2290	0.2888	Hatipoglu immunodeficiency syndrome	OMIM:620331
2290	0.2888	Familial hyperprolactinemia	ORPHA:397685
2290	0.2888	Hyperprolactinemia	OMIM:615555
2302	0.288	Legius syndrome	OMIM:611431
2302	0.288	STAR syndrome	OMIM:300707
2304	0.2874	PCWH syndrome	OMIM:609136
2305	0.2872	Neuronopathy, distal hereditary motor, type X	OMIM:620080
2306	0.2871	Kanzaki disease	OMIM:609242
2307	0.2865	TARP syndrome	OMIM:311900
2308	0.2837	Marshall-Smith syndrome	ORPHA:561
2308	0.2837	Osteogenesis imperfecta, type I	OMIM:166200
2308	0.2837	Ehlers-Danlos syndrome, arthrochalasia type, 1	OMIM:130060
2308	0.2837	Ehlers-Danlos syndrome, classic-like, 1	OMIM:606408
2308	0.2837	Cutis laxa, autosomal recessive, type IIB	OMIM:612940
2308	0.2837	Ehlers-Danlos syndrome, classic type, 2	OMIM:130010
2308	0.2837	Epidermolysis bullosa simplex 5A, Ogna type	OMIM:131950
2308	0.2837	Ehlers-Danlos syndrome, arthrochalasia type, 2	OMIM:617821
2308	0.2837	Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16	ORPHA:98791
2308	0.2837	Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16	ORPHA:98791
2308	0.2837	SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome	ORPHA:157965
2308	0.2837	Ehlers-Danlos syndrome, spondylodysplastic type, 3	OMIM:612350
2308	0.2837	X-linked Ehlers-Danlos syndrome	ORPHA:75497
2308	0.2837	Ehlers-Danlos syndrome, classic type, 1	OMIM:130000
2308	0.2837	Tumor necrosis factor receptor 1 associated periodic syndrome	ORPHA:32960
2308	0.2837	Fanconi anemia, complementation group D2	OMIM:227646
2308	0.2837	Loeys-Dietz syndrome 4	OMIM:614816
2308	0.2837	Fanconi anemia, complementation group A	OMIM:227650
2308	0.2837	Fanconi anemia, complementation group C	OMIM:227645
2308	0.2837	Fanconi anemia, complementation group E	OMIM:600901
2308	0.2837	B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome	ORPHA:536467
2308	0.2837	?Spondyloepimetaphyseal dysplasia, Krakow type	OMIM:618162
2308	0.2837	Brittle cornea syndrome 2	OMIM:614170
2308	0.2837	Ehlers-Danlos syndrome, classic-like, 2	OMIM:618000
2308	0.2837	Meester-Loeys syndrome	OMIM:300989
2308	0.2837	RIN2 syndrome	ORPHA:217335
2308	0.2837	Wilson disease	ORPHA:905
2308	0.2837	Osteogenesis imperfecta, type XI	OMIM:610968
2308	0.2837	Diaphyseal medullary stenosis with malignant fibrous histiocytoma	OMIM:112250
2308	0.2837	Thrombocytopenia 2	OMIM:188000
2338	0.2829	Ehlers-Danlos syndrome, dermatosparaxis type	OMIM:225410
2338	0.2829	CARASIL syndrome	OMIM:600142
2338	0.2829	Ehlers-Danlos syndrome, periodontal type, 1	OMIM:130080
2338	0.2829	Ehlers-Danlos syndrome, periodontal type, 2	OMIM:617174
2342	0.2828	Multiple congenital anomalies-hypotonia-seizures syndrome	ORPHA:280633
2343	0.2826	Oculoectodermal syndrome, somatic	OMIM:600268
2343	0.2826	Baraitser-Winter cerebrofrontofacial syndrome	ORPHA:2995
2343	0.2826	Baraitser-Winter cerebrofrontofacial syndrome	ORPHA:2995
2343	0.2826	Moyamoya disease 2, susceptibility to	OMIM:607151
2347	0.2824	VISS syndrome	OMIM:619472
2348	0.2818	Gaucher disease type 1	ORPHA:77259
2348	0.2818	Gaucher disease type 1	ORPHA:77259
2350	0.2811	FILS syndrome	OMIM:615139
2350	0.2811	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	OMIM:616295
2352	0.2799	Multiple mitochondrial dysfunctions syndrome 1	OMIM:605711
2353	0.2797	Turcot syndrome with polyposis	ORPHA:99818
2354	0.2788	Developmental delay with or without intellectual impairment or behavioral abnormalities	OMIM:619575
2354	0.2788	Polyposis, juvenile intestinal	OMIM:174900
2354	0.2788	Mucoepithelial dysplasia, hereditary	OMIM:158310
2354	0.2788	Polyposis, juvenile intestinal	OMIM:174900
2354	0.2788	Bile acid synthesis defect, congenital, 3	OMIM:613812
2354	0.2788	Inflammatory bowel disease 28, early onset, autosomal recessive	OMIM:613148
2354	0.2788	Gastric adenocarcinoma and proximal polyposis of the stomach	OMIM:619182
2354	0.2788	Diarrhea 10, protein-losing enteropathy type	OMIM:618183
2354	0.2788	Bile acid synthesis defect, congenital, 4	OMIM:214950
2354	0.2788	Gastrointestinal defects and immunodeficiency syndrome	OMIM:243150
2364	0.2786	Joubert syndrome with hepatic defect	ORPHA:1454
2364	0.2786	Joubert syndrome with hepatic defect	ORPHA:1454
2364	0.2786	Joubert syndrome with hepatic defect	ORPHA:1454
2364	0.2786	Joubert syndrome with hepatic defect	ORPHA:1454
2368	0.2772	Ataxia-telangiectasia	OMIM:208900
2369	0.2768	Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome	ORPHA:309854
2370	0.2747	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	OMIM:606002
2371	0.2678	Brain small vessel disease with or without ocular anomalies	OMIM:175780
2372	0.267	Cerebral amyloid angiopathy	OMIM:105150
2372	0.267	3-hydroxyisobutryl-CoA hydrolase deficiency	OMIM:250620
2374	0.2666	Fetal Gaucher disease	ORPHA:85212
2374	0.2666	Witteveen-Kolk syndrome	OMIM:613406
2374	0.2666	Brain small vessel disease 2	OMIM:614483
2374	0.2666	Menkes disease	OMIM:309400
2374	0.2666	Focal facial dermal dysplasia type IV	ORPHA:398189
2374	0.2666	Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	OMIM:116860
2374	0.2666	Hypophosphatasia, infantile	OMIM:241500
2381	0.2662	Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome	ORPHA:69735
2382	0.2641	Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome	ORPHA:95433
2382	0.2641	Thrombocythemia 3	OMIM:614521
2384	0.2639	Neurodevelopmental disorder with hypotonia and dysmorphic facies	OMIM:619503
2385	0.2631	Congenital myopathy 2C, severe infantile, autosomal dominant	OMIM:620278
2386	0.2626	Familial cerebral cavernous malformation	ORPHA:221061
2386	0.2626	Propionicacidemia	OMIM:606054
2386	0.2626	Propionicacidemia	OMIM:606054
2386	0.2626	Osteogenesis imperfecta, type XVII	OMIM:616507
2386	0.2626	Methylmalonic aciduria, mut(0) type	OMIM:251000
2386	0.2626	Methylmalonic acidemia with homocystinuria type cblF	ORPHA:79284
2386	0.2626	ACys amyloidosis	ORPHA:100008
2386	0.2626	Congenital disorder of glycosylation, type Iw, autosomal dominant	OMIM:619714
2386	0.2626	Autoinflammatory disease, systemic, X-linked	OMIM:301081
2386	0.2626	?Combined oxidative phosphorylation deficiency 25	OMIM:616430
2386	0.2626	Heterotopia, periventricular, 1	OMIM:300049
2386	0.2626	Isovaleric acidemia	OMIM:243500
2386	0.2626	Seizures, scoliosis, and macrocephaly syndrome	OMIM:616682
2386	0.2626	Cerebral cavernous malformations-3	OMIM:603285
2386	0.2626	Familial cerebral cavernous malformation	ORPHA:221061
2386	0.2626	1p31p32 microdeletion syndrome	ORPHA:401986
2386	0.2626	Spinal muscular atrophy, lower extremity-predominant, 2B, autosomal dominant	OMIM:618291
2386	0.2626	Familial cerebral cavernous malformation	ORPHA:221061
2386	0.2626	Familial cerebral cavernous malformation	ORPHA:221061
2386	0.2626	ABeta amyloidosis, Dutch type	ORPHA:100006
2386	0.2626	ABetaL34V amyloidosis	ORPHA:324703
2386	0.2626	ABeta amyloidosis, Italian type	ORPHA:324713
2408	0.2613	Lethal congenital contracture syndrome 5	OMIM:615368
2409	0.26	Oculoskeletodental syndrome	OMIM:618440
2409	0.26	Brain small vessel disease 3	OMIM:618360
2411	0.2594	Hypotrichosis-lymphedema-telangiectasia syndrome	OMIM:607823
2412	0.2578	Myxoma, intracardiac	OMIM:255960
2413	0.2541	Acatalasemia	ORPHA:926
2413	0.2541	Familial acute necrotizing encephalopathy	ORPHA:88619
2413	0.2541	Vascular malformation, primary intraosseous	OMIM:606893
2413	0.2541	?Hepatitis, fulminant viral, susceptibility to	OMIM:618549
2417	0.2532	Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency	ORPHA:88639
2418	0.2516	Hyper-IgE recurrent infection syndrome, autosomal recessive	OMIM:243700
2418	0.2516	?Aneurysm, intracranial berry, 12	OMIM:618734
2420	0.245	Neurodevelopmental disorder with seizures and speech and walking impairment	OMIM:618480
2421	0.2429	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	OMIM:620005
2422	0.242	Atrial septal defect 9	OMIM:614475
2422	0.242	Neonatal acute respiratory distress due to SP-B deficiency	ORPHA:217563
2422	0.242	Surfactant metabolism dysfunction, pulmonary, 1	OMIM:265120
2422	0.242	Surfactant metabolism dysfunction, pulmonary, 2	OMIM:610913
2422	0.242	Gaucher disease type 3	ORPHA:77261
2422	0.242	Keutel syndrome	ORPHA:85202
2422	0.242	Intellectual disability-severe speech delay-mild dysmorphism syndrome	ORPHA:391372
2422	0.242	Sarcoidosis, susceptibility to, 1	OMIM:181000
2422	0.242	Sarcoidosis, susceptibility to, 2	OMIM:612387
2422	0.242	Osteogenesis imperfecta, type III	OMIM:259420
2422	0.242	17q23.1q23.2 microdeletion syndrome	ORPHA:261279
2422	0.242	?Mitochondrial complex IV deficiency, nuclear type 20	OMIM:619064
2422	0.242	Osteopetrosis with renal tubular acidosis	ORPHA:2785
2422	0.242	Osteogenesis imperfecta, type III	OMIM:259420
2422	0.242	?Mitochondrial complex I deficiency, nuclear type 35	OMIM:619003
2422	0.242	Melnick-Needles syndrome	OMIM:309350
2422	0.242	?Mitochondrial complex IV deficiency, nuclear type 15	OMIM:619059
2422	0.242	Methylmalonic aciduria and homocystinuria, cblJ type	OMIM:614857
2422	0.242	Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	OMIM:601559
2422	0.242	Developmental delay with or without dysmorphic facies and autism	OMIM:618454
2422	0.242	Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome	OMIM:620186
2422	0.242	FG syndrome type 1	ORPHA:93932
2422	0.242	Synaptic congenital myasthenic syndromes	ORPHA:98915
2422	0.242	Diaphragmatic hernia 4, with cardiovascular defects	OMIM:620025
2422	0.242	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	OMIM:613845
2422	0.242	Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14	ORPHA:96334
2422	0.242	Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14	ORPHA:96334
2422	0.242	COG1-CDG	ORPHA:263508
2422	0.242	Pulmonary venoocclusive disease 2	OMIM:234810
2422	0.242	Pulmonary fibrosis, idiopathic, susceptibility to	OMIM:178500
2422	0.242	Interstitial lung disease 2	OMIM:178500
2422	0.242	Carey-Fineman-Ziter syndrome	OMIM:254940
2422	0.242	Synaptic congenital myasthenic syndromes	ORPHA:98915
2422	0.242	Basel-Vanagaite-Smirin-Yosef syndrome	ORPHA:464738
2422	0.242	Basel-Vanagait-Smirin-Yosef syndrome	OMIM:616449
2457	0.2407	Linear skin defects with multiple congenital anomalies 2	OMIM:300887
2458	0.2389	Glycogen storage disease IV	OMIM:232500
2458	0.2389	Familial exudative vitreoretinopathy	ORPHA:891
2458	0.2389	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	OMIM:251880
2458	0.2389	Portal hypertension, noncirrhotic, 1	OMIM:617068
2458	0.2389	?Bile acid synthesis defect, congenital, 5	OMIM:616278
2458	0.2389	Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7	OMIM:620365
2458	0.2389	Familial exudative vitreoretinopathy	ORPHA:891
2458	0.2389	Familial exudative vitreoretinopathy	ORPHA:891
2458	0.2389	Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	OMIM:607626
2458	0.2389	Neonatal ichthyosis-sclerosing cholangitis syndrome	ORPHA:59303
2458	0.2389	Cholesteryl ester storage disease	OMIM:278000
2458	0.2389	Johanson-Blizzard syndrome	OMIM:243800
2458	0.2389	Cholestasis, progressive familial intrahepatic 4	OMIM:615878
2458	0.2389	Rajab interstitial lung disease with brain calcifications 1	OMIM:613658
2458	0.2389	Megacystis-microcolon-intestinal hypoperistalsis syndrome 5	OMIM:619431
2458	0.2389	Diabetes mellitus, neonatal, with congenital hypothyroidism	OMIM:610199
2458	0.2389	Caroli disease	ORPHA:53035
2458	0.2389	Enteric anendocrinosis	ORPHA:83620
2458	0.2389	Cholestasis, progressive familial intrahepatic, 9	OMIM:619849
2458	0.2389	Glycosylphosphatidylinositol deficiency	OMIM:610293
2458	0.2389	Sclerosing cholangitis, neonatal	OMIM:617394
2458	0.2389	Isolated sedoheptulokinase deficiency	ORPHA:440713
2458	0.2389	Hepatorenocardiac degenerative fibrosis	OMIM:619902
2458	0.2389	Familial exudative vitreoretinopathy	ORPHA:891
2458	0.2389	Familial exudative vitreoretinopathy	ORPHA:891
2458	0.2389	Familial exudative vitreoretinopathy	ORPHA:891
2458	0.2389	Autoimmune disease, multisystem, with facial dysmorphism	OMIM:613385
2458	0.2389	Syndromic multisystem autoimmune disease due to Itch deficiency	ORPHA:228426
2458	0.2389	Cholestasis, progressive familial intrahepatic, 8	OMIM:619662
2487	0.236	Uveal melanoma	ORPHA:39044
2487	0.236	Uveal melanoma	ORPHA:39044
2487	0.236	Uveal melanoma	ORPHA:39044
2487	0.236	Retinoblastoma, trilateral	OMIM:180200
2487	0.236	?Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma 2	OMIM:193220
2487	0.236	Vitreoretinochoroidopathy	OMIM:193220
2487	0.236	Retinopathy of prematurity	ORPHA:90050
2487	0.236	Retinopathy of prematurity	OMIM:133780
2487	0.236	Retinopathy of prematurity	ORPHA:90050
2487	0.236	Exudative vitreoretinopathy 4	OMIM:601813
2487	0.236	Uveal melanoma	ORPHA:39044
2487	0.236	Retinoschisis	OMIM:312700
2487	0.236	Uveal melanoma	ORPHA:39044
2487	0.236	Retinopathy of prematurity	ORPHA:90050
2487	0.236	Vitreoretinopathy, neovascular inflammatory	OMIM:193235
2502	0.2336	Leber hereditary optic neuropathy, autosomal recessive	OMIM:619382
2502	0.2336	Rabin-Pappas syndrome	OMIM:620155
2502	0.2336	Intellectual developmental disorder, autosomal dominant 70	OMIM:620157
2505	0.2334	Autosomal spastic paraplegia type 58	ORPHA:397946
2506	0.232	Parkinson disease 14, autosomal recessive	OMIM:612953
2507	0.2296	?Retinal arteries, tortuosity of	OMIM:180000
2507	0.2296	Incontinentia pigmenti	OMIM:308300
2509	0.2271	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
2509	0.2271	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
2509	0.2271	Autosomal recessive cutis laxa type 2, classic type	ORPHA:357074
2512	0.2266	Spinocerebellar ataxia type 36	ORPHA:276198
2513	0.2254	Muscular dystrophy, limb-girdle, autosomal recessive 18	OMIM:615356
2514	0.2248	Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities	OMIM:617282
2515	0.2246	Macular degeneration, age-related, reduced risk of	OMIM:603075
2515	0.2246	?Macular degeneration, age-related	OMIM:603075
2515	0.2246	Familial drusen	ORPHA:75376
2515	0.2246	Familial drusen	ORPHA:75376
2515	0.2246	Familial drusen	ORPHA:75376
2515	0.2246	Macular degeneration, age-related, 1	OMIM:603075
2515	0.2246	Macular degeneration, age-related, reduced risk of	OMIM:603075
2515	0.2246	Congenital disorder of deglycosylation 1	OMIM:615273
2523	0.2245	Infantile convulsions and choreoathetosis	ORPHA:31709
2523	0.2245	Infantile convulsions and choreoathetosis	ORPHA:31709
2523	0.2245	Infantile convulsions and choreoathetosis	ORPHA:31709
2526	0.2242	3MC syndrome 1	OMIM:257920
2526	0.2242	Galactosialidosis	OMIM:256540
2526	0.2242	Nijmegen breakage syndrome	OMIM:251260
2526	0.2242	Immunodeficiency 96	OMIM:619774
2526	0.2242	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma	OMIM:618373
2531	0.2233	Choreoacanthocytosis	ORPHA:2388
2532	0.2223	Spinocerebellar ataxia 50	OMIM:620158
2533	0.2209	Leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome	OMIM:618877
2534	0.2202	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
2534	0.2202	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
2534	0.2202	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
2534	0.2202	Mitochondrial neurogastrointestinal encephalomyopathy	ORPHA:298
2538	0.2198	Mitochondrial DNA depletion syndrome 4B (MNGIE type)	OMIM:613662
2538	0.2198	Mitochondrial DNA depletion syndrome 1 (MNGIE type)	OMIM:603041
2538	0.2198	Spastic paraplegia 79B, autosomal recessive	OMIM:615491
2538	0.2198	Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation	ORPHA:453504
2542	0.2192	Mitochondrial DNA depletion syndrome 20 (MNGIE type)	OMIM:619780
2543	0.2188	Intellectual developmental disorder, autosomal dominant 53	OMIM:617798
2544	0.2185	Combined oxidative phosphorylation defect type 29	ORPHA:478029
2545	0.2183	HSD10 disease, infantile type	ORPHA:391428
2546	0.2182	Posterior column ataxia-retinitis pigmentosa syndrome	ORPHA:88628
2547	0.2178	Congenital short bowel syndrome	OMIM:615237
2548	0.2171	Paroxysmal non-kinesigenic dyskinesia	ORPHA:98810
2548	0.2171	Paroxysmal exertion-induced dyskinesia	ORPHA:98811
2548	0.2171	Paroxysmal exertion-induced dyskinesia	ORPHA:98811
2548	0.2171	Paroxysmal non-kinesigenic dyskinesia	ORPHA:98810
2548	0.2171	Neuroferritinopathy	ORPHA:157846
2553	0.217	Atypical Rett syndrome	ORPHA:3095
2553	0.217	Atypical Rett syndrome	ORPHA:3095
2553	0.217	Atypical Rett syndrome	ORPHA:3095
2553	0.217	Dentatorubral pallidoluysian atrophy	ORPHA:101
2553	0.217	Atypical Rett syndrome	ORPHA:3095
2553	0.217	Atypical Rett syndrome	ORPHA:3095
2559	0.2169	Intellectual developmental disorder, autosomal recessive 6	OMIM:611092
2560	0.2165	Huntington disease	ORPHA:399
2560	0.2165	Huntington disease	ORPHA:399
2562	0.2154	Alacrimia-choreoathetosis-liver dysfunction syndrome	ORPHA:404454
2563	0.2153	Spinal muscular atrophy-progressive myoclonic epilepsy syndrome	ORPHA:2590
2564	0.2151	Amyotrophic lateral sclerosis, susceptibility to, 13	OMIM:183090
2564	0.2151	Spinocerebellar ataxia 2	OMIM:183090
2564	0.2151	X-linked dystonia-parkinsonism	ORPHA:53351
2567	0.215	Basal ganglia calcification, idiopathic, 5	OMIM:615483
2567	0.215	Spinocerebellar ataxia type 2	ORPHA:98756
2567	0.215	Neurodevelopmental disorder with or without variable movement or behavioral abnormalities	OMIM:619725
2570	0.2147	Epilepsy, progressive myoclonic 4, with or without renal failure	OMIM:254900
2571	0.2145	X-linked Alport syndrome-diffuse leiomyomatosis	ORPHA:1018
2571	0.2145	X-linked Alport syndrome-diffuse leiomyomatosis	ORPHA:1018
2573	0.2144	6-pyruvoyl-tetrahydropterin synthase deficiency	ORPHA:13
2573	0.2144	Myopathy with extrapyramidal signs	OMIM:615673
2575	0.2143	Cranio-cervical dystonia with laryngeal and upper-limb involvement	ORPHA:420485
2576	0.2141	Pelizaeus-Merzbacher disease	OMIM:312080
2577	0.2129	Fragile X tremor/ataxia syndrome	OMIM:300623
2577	0.2129	Spinocerebellar ataxia type 12	ORPHA:98762
2579	0.2128	Spastic ataxia 2, autosomal recessive	OMIM:611302
2580	0.2127	Spinocerebellar ataxia type 15/16	ORPHA:98769
2581	0.2126	X-linked creatine transporter deficiency	ORPHA:52503
2582	0.2109	Essential tremor, hereditary, 5	OMIM:616736
2583	0.2099	Visceral myopathy 2	OMIM:619350
2584	0.2096	Autosomal recessive cerebellar ataxia due to STUB1 deficiency	ORPHA:412057
2585	0.2088	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
2585	0.2088	Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome	ORPHA:70595
2585	0.2088	Spastic paraplegia 46, autosomal recessive	OMIM:614409
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Paroxysmal kinesigenic dyskinesia	ORPHA:98809
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Neurodevelopmental disorder with involuntary movements	OMIM:617493
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Paroxysmal kinesigenic dyskinesia	ORPHA:98809
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Pontocerebellar hypoplasia type 7	ORPHA:284339
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Pontocerebellar hypoplasia type 7	ORPHA:284339
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2588	0.2087	Non-specific early-onset epileptic encephalopathy	ORPHA:442835
2642	0.2086	Atypical juvenile parkinsonism	ORPHA:391411
2642	0.2086	Atypical juvenile parkinsonism	ORPHA:391411
2642	0.2086	Atypical juvenile parkinsonism	ORPHA:391411
2642	0.2086	Proximal myopathy with extrapyramidal signs	ORPHA:401768
2646	0.2077	Developmental and epileptic encephalopathy 31B, autosomal recessive	OMIM:620352
2647	0.2068	Inherited Creutzfeldt-Jakob disease	ORPHA:282166
2647	0.2068	Myoclonus, intractable, neonatal	OMIM:617235
2647	0.2068	Intellectual developmental disorder 60 with seizures	OMIM:618587
2647	0.2068	Basal ganglia calcification, idiopathic, 1	OMIM:213600
2647	0.2068	Spinocerebellar ataxia, autosomal recessive 4	OMIM:607317
2647	0.2068	Dystonia-Parkinsonism, X-linked	OMIM:314250
2653	0.2067	Charcot-Marie-Tooth disease, axonal, type 2HH	OMIM:619574
2653	0.2067	Parkinsonism-dystonia 3, childhood-onset	OMIM:619738
2655	0.2065	Developmental and epileptic encephalopathy 6B, non-Dravet	OMIM:619317
2655	0.2065	Familial or sporadic hemiplegic migraine	ORPHA:569
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Myoclonus-dystonia syndrome	ORPHA:36899
2655	0.2065	Myoclonus-dystonia syndrome	ORPHA:36899
2655	0.2065	Familial or sporadic hemiplegic migraine	ORPHA:569
2655	0.2065	Familial or sporadic hemiplegic migraine	ORPHA:569
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Hyperphenylalaninemia, BH4-deficient, C	OMIM:261630
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Dentatorubral-pallidoluysian atrophy	OMIM:125370
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	?Myoclonus, familial, 1	OMIM:614937
2655	0.2065	Myoclonus-dystonia syndrome	ORPHA:36899
2655	0.2065	ATP13A2-related juvenile neuronal ceroid lipofuscinosis	ORPHA:314632
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Developmental and epileptic encephalopathy 37	OMIM:616981
2655	0.2065	Classic glucose transporter type 1 deficiency syndrome	ORPHA:71277
2655	0.2065	Methylmalonic aciduria and homocysteinemia, cblX type	OMIM:309541
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Spinocerebellar ataxia type 1	ORPHA:98755
2655	0.2065	Familial or sporadic hemiplegic migraine	ORPHA:569
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Developmental and epileptic encephalopathy 100	OMIM:619777
2655	0.2065	Myoclonus-dystonia syndrome	ORPHA:36899
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Neurodegeneration with brain iron accumulation 3	OMIM:606159
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Pyruvate dehydrogenase E1-alpha deficiency	OMIM:312170
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Early infantile epileptic encephalopathy	ORPHA:1934
2655	0.2065	Progressive myoclonic epilepsy type 3	ORPHA:263516
2694	0.2064	Intellectual developmental disorder, X-linked syndromic 13	OMIM:300055
2694	0.2064	Spinocerebellar ataxia 17	OMIM:607136
2694	0.2064	Epilepsy, progressive myoclonic, 8	OMIM:616230
2694	0.2064	Ataxia-telangiectasia-like disorder	ORPHA:251347
2694	0.2064	Autosomal dominant Charcot-Marie-Tooth disease type 2Z	ORPHA:466768
2694	0.2064	Neuropathy, hereditary motor and sensory, type VIB	OMIM:616505
2700	0.2063	Li-Campeau syndrome	OMIM:619189
2700	0.2063	Osteootohepatoenteric syndrome	OMIM:619377
2700	0.2063	Neuropathy, hereditary sensory and autonomic, type VIII	OMIM:616488
2700	0.2063	Intellectual developmental disorder, autosomal dominant 54	OMIM:617799
2700	0.2063	Myxoid/round cell liposarcoma	ORPHA:99967
2700	0.2063	Myxoid/round cell liposarcoma	ORPHA:99967
2700	0.2063	Wolfram-like syndrome	ORPHA:411590
2707	0.2062	Progressive myoclonic epilepsy type 1	ORPHA:308
2707	0.2062	Progressive myoclonic epilepsy type 1	ORPHA:308
2707	0.2062	Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	OMIM:607483
2707	0.2062	Progressive myoclonic epilepsy type 1	ORPHA:308
2707	0.2062	?Dystonia 34, myoclonic	OMIM:619724
2707	0.2062	Mitochondrial complex III deficiency, nuclear type 2	OMIM:615157
2713	0.2056	Infantile-onset generalized dyskinesia with orofacial involvement	ORPHA:494526
2713	0.2056	Dyskinesia, limb and orofacial, infantile-onset	OMIM:616921
2715	0.2054	Neurodevelopmental disorder with spasticity and poor growth	OMIM:618076
2716	0.2053	Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome	ORPHA:522077
2717	0.205	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
2717	0.205	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
2717	0.205	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
2717	0.205	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
2717	0.205	Juvenile amyotrophic lateral sclerosis	ORPHA:300605
2722	0.2046	Spinal muscular atrophy with progressive myoclonic epilepsy	OMIM:159950
2722	0.2046	Lower motor neuron syndrome with late-adult onset	ORPHA:276435
2724	0.2044	Essential tremor, hereditary, 1	OMIM:190300
2725	0.2043	Pontocerebellar hypoplasia type 1A	OMIM:607596
2725	0.2043	Pontocerebellar hypoplasia, type 7	OMIM:614969
2725	0.2043	?Spinocerebellar ataxia 40	OMIM:616053
2725	0.2043	Adult-onset autosomal recessive cerebellar ataxia	ORPHA:284289
2729	0.204	Spinocerebellar ataxia type 42	ORPHA:458803
2730	0.2036	?Intestinal dysmotility syndrome	OMIM:620045
2731	0.2027	Spinocerebellar ataxia with axonal neuropathy type 2	ORPHA:64753
2731	0.2027	Spinocerebellar ataxia with axonal neuropathy type 2	ORPHA:64753
2733	0.2024	Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis	OMIM:219700
2733	0.2024	Cystic fibrosis lung disease, modifier of	OMIM:219700
2733	0.2024	Cystic fibrosis	OMIM:219700
2736	0.202	Leukodystrophy, hypomyelinating, 2	OMIM:608804
2737	0.2011	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
2737	0.2011	?Megacystis-microcolon-intestinal hypoperistalsis syndrome 4	OMIM:619365
2737	0.2011	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
2737	0.2011	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
2737	0.2011	Megacystis-microcolon-intestinal hypoperistalsis syndrome	ORPHA:2241
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Tetralogy of Fallot	OMIM:187500
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	?Testicular anomalies with or without congenital heart disease	OMIM:615542
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Tetralogy of Fallot	OMIM:187500
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Tetralogy of Fallot	OMIM:187500
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Tetralogy of Fallot	OMIM:187500
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	?IVIC syndrome	OMIM:147750
2742	0.201	Acro-renal-ocular syndrome	ORPHA:959
2742	0.201	LEOPARD syndrome 3	OMIM:613707
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Microform holoprosencephaly	ORPHA:280200
2742	0.201	Sifrim-Hitz-Weiss syndrome	OMIM:617159
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	DiGeorge syndrome	OMIM:188400
2742	0.201	Velocardiofacial syndrome	OMIM:192430
2742	0.201	22q11.2 duplication syndrome	ORPHA:1727
2742	0.201	Tetralogy of Fallot	OMIM:187500
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Prune belly syndrome	ORPHA:2970
2742	0.201	Leukemia, megakaryoblastic, with or without Down syndrome, somatic	OMIM:190685
2742	0.201	Autosomal recessive Robinow syndrome	ORPHA:1507
2742	0.201	Rhizomelic chondrodysplasia punctata, type 2	OMIM:222765
2742	0.201	Floating-Harbor syndrome	ORPHA:2044
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	CHARGE syndrome	ORPHA:138
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	?Deafness, congenital heart defects, and posterior embryotoxon	OMIM:617992
2742	0.201	Tetralogy of Fallot	OMIM:187500
2742	0.201	Alagille syndrome 1	OMIM:118450
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	McKusick-Kaufman syndrome	ORPHA:2473
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Maternal phenylketonuria	ORPHA:2209
2742	0.201	Cornelia de Lange syndrome 4	OMIM:614701
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Meacham syndrome	OMIM:608978
2742	0.201	CHARGE syndrome	ORPHA:138
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Intellectual developmental disorder with hypotonia and behavioral abnormalities	OMIM:618748
2742	0.201	15q11.2 microdeletion syndrome	ORPHA:261183
2742	0.201	Townes-Brocks syndrome 1	OMIM:107480
2742	0.201	Townes-Brocks syndrome	ORPHA:857
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Craniofacial microsomia	OMIM:164210
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Coffin-Siris syndrome 1	OMIM:135900
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	?Cocoon syndrome	OMIM:613630
2742	0.201	TARP syndrome	ORPHA:2886
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Diamond-Blackfan anemia 7	OMIM:612562
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	WHIM syndrome	ORPHA:51636
2742	0.201	?WHIM syndrome 2	OMIM:619407
2742	0.201	Townes-Brocks syndrome	ORPHA:857
2742	0.201	CHIME syndrome	OMIM:280000
2742	0.201	CHIME syndrome	ORPHA:3474
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	SLC35A2-CDG	ORPHA:356961
2742	0.201	Tetralogy of Fallot	ORPHA:3303
2742	0.201	Frontonasal dysplasia 1	OMIM:136760
2742	0.201	Autosomal recessive Robinow syndrome	ORPHA:1507
2742	0.201	Neurocardiofaciodigital syndrome	OMIM:619869
2742	0.201	Warsaw breakage syndrome	OMIM:613398
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	15q11.2 microdeletion syndrome	ORPHA:261183
2742	0.201	Fryns syndrome	ORPHA:2059
2742	0.201	Coffin-Siris syndrome	ORPHA:1465
2742	0.201	Fanconi anemia	ORPHA:84
2742	0.201	15q11.2 microdeletion syndrome	ORPHA:261183
2742	0.201	Intellectual developmental disorder with cardiac defects and dysmorphic facies	OMIM:618316
2742	0.201	Orofaciodigital syndrome type 5	ORPHA:2919
2742	0.201	Orofaciodigital syndrome V	OMIM:174300
2742	0.201	?Orofaciodigital syndrome XVII	OMIM:617926
2742	0.201	?Short-rib thoracic dysplasia 20 with polydactyly	OMIM:617925
2742	0.201	Thrombocytopenia-absent radius syndrome	ORPHA:3320
2742	0.201	Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome	ORPHA:306542
2742	0.201	Renpenning syndrome	OMIM:309500
2742	0.201	Acrofacial dysostosis 1, Nager type	OMIM:154400
2862	0.2006	Spinal muscular atrophy-3	OMIM:253400
2862	0.2006	Spinal muscular atrophy, type III, modifier of	OMIM:253400
2864	0.2002	Peroxisome biogenesis disorder 8B	OMIM:614877
2865	0.1992	Neurooculorenal syndrome	OMIM:620305
2866	0.1983	Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	OMIM:271245
2866	0.1983	Huntington disease-like 1	ORPHA:157941
2866	0.1983	X-linked intellectual disability, Snyder type	ORPHA:3063
2866	0.1983	Parkinson disease 20, early-onset	OMIM:615530
2866	0.1983	Pontocerebellar hypoplasia, type 8	OMIM:614961
2866	0.1983	Spinocerebellar ataxia type 17	ORPHA:98759
2866	0.1983	Primary dystonia, DYT2 type	ORPHA:99657
2866	0.1983	Neurodevelopmental disorder with variable motor and speech impairment	OMIM:617804
2866	0.1983	?Chorea, childhood-onset, with psychomotor retardation	OMIM:616939
2866	0.1983	Huntington disease-like 2	ORPHA:98934
2876	0.1979	Developmental and epileptic encephalopathy 25, with amelogenesis imperfecta	OMIM:615905
2876	0.1979	Baker-Gordon syndrome	OMIM:618218
2876	0.1979	Dystonia 16	OMIM:612067
2876	0.1979	Basal ganglia calcification, idiopathic, 6	OMIM:616413
2876	0.1979	Episodic kinesigenic dyskinesia 3	OMIM:620245
2881	0.1975	Primary dystonia, DYT4 type	ORPHA:98805
2881	0.1975	Combined oxidative phosphorylation defect type 27	ORPHA:477774
2883	0.1964	Spinocerebellar ataxia with epilepsy	ORPHA:254881
2883	0.1964	Segawa syndrome, recessive	OMIM:605407
2883	0.1964	Hereditary hyperekplexia	ORPHA:3197
2883	0.1964	Developmental and epileptic encephalopathy 42	OMIM:617106
2883	0.1964	Juvenile Huntington disease	ORPHA:248111
2883	0.1964	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	OMIM:614254
2883	0.1964	D-glyceric aciduria	ORPHA:941
2883	0.1964	Hereditary hyperekplexia	ORPHA:3197
2883	0.1964	MEPAN syndrome	ORPHA:508093
2883	0.1964	Developmental and epileptic encephalopathy 17	OMIM:615473
2883	0.1964	Gerstmann-Straussler disease	OMIM:137440
2883	0.1964	Autosomal recessive cerebellar ataxia-movement disorder syndrome	ORPHA:95434
2883	0.1964	Spinocerebellar ataxia 48	OMIM:618093
2883	0.1964	Ritscher-Schinzel syndrome 4	OMIM:619435
2883	0.1964	Hereditary hyperekplexia	ORPHA:3197
2883	0.1964	Dystonia 28, childhood-onset	OMIM:617284
2883	0.1964	Hereditary hyperekplexia	ORPHA:3197
2883	0.1964	?Coenzyme Q10 deficiency, primary, 9	OMIM:619028
2883	0.1964	Autosomal recessive ataxia due to ubiquinone deficiency	ORPHA:139485
2883	0.1964	Coenzyme Q10 deficiency, primary, 4	OMIM:612016
2883	0.1964	Coenzyme Q10 deficiency, primary, 1	OMIM:607426
2883	0.1964	Generalized epilepsy-paroxysmal dyskinesia syndrome	ORPHA:79137
2883	0.1964	Spinocerebellar ataxia 7	OMIM:164500
2883	0.1964	Encephalopathy, progressive, with or without lipodystrophy	OMIM:615924
2883	0.1964	Epilepsy, progressive myoclonic 7	OMIM:616187
2883	0.1964	Dystonia-11, myoclonic	OMIM:159900
2883	0.1964	Parkinsonism-dystonia, infantile, 1	OMIM:613135
2883	0.1964	Spinal and bulbar muscular atrophy of Kennedy	OMIM:313200
2883	0.1964	Rett syndrome, congenital variant	OMIM:613454
2883	0.1964	Leukodystrophy, hypomyelinating, 11	OMIM:616494
2883	0.1964	WARS2-related combined oxidative phosphorylation defect	ORPHA:572798
2883	0.1964	Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures	OMIM:617710
2883	0.1964	Cerebral creatine deficiency syndrome 2	OMIM:612736
2883	0.1964	Guanidinoacetate methyltransferase deficiency	ORPHA:382
2883	0.1964	Adult-onset dystonia-parkinsonism	ORPHA:199351
2883	0.1964	Neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities, autosomal dominant	OMIM:619092
2883	0.1964	?Epilepsy, myoclonic, familial adult, 5	OMIM:615400
2883	0.1964	Developmental and epileptic encephalopathy 32	OMIM:616366
2883	0.1964	Neurodevelopmental disorder with hyperkinetic movements and dyskinesia	OMIM:619651
2883	0.1964	Dyskinesia with orofacial involvement, autosomal recessive	OMIM:619647
2883	0.1964	Developmental and epileptic encephalopathy 27	OMIM:616139
2883	0.1964	Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities	OMIM:620327
2883	0.1964	Spinocerebellar ataxia type 14	ORPHA:98763
2883	0.1964	Kufor-Rakeb syndrome	OMIM:606693
2883	0.1964	Intellectual developmental disorder with paroxysmal dyskinesia or seizures	OMIM:619150
2883	0.1964	Monomelic amyotrophy	ORPHA:65684
2883	0.1964	Sandhoff disease, adult form	ORPHA:309169
2883	0.1964	Ceroid lipofuscinosis, neuronal, 13 (Kufs type)	OMIM:615362
2883	0.1964	Epilepsy, progressive myoclonic 1B	OMIM:612437
2883	0.1964	Spinal muscular atrophy, late-onset, Finkel type	OMIM:182980
2883	0.1964	Autosomal dominant adult-onset proximal spinal muscular atrophy	ORPHA:209335
2883	0.1964	Autosomal recessive cerebellar ataxia-movement disorder syndrome	ORPHA:95434
2883	0.1964	Spinocerebellar ataxia 1	OMIM:164400
2883	0.1964	Epilepsy, progressive myoclonic 6	OMIM:614018
2883	0.1964	Epilepsy, progressive myoclonic 6	OMIM:614018
2883	0.1964	Neurodevelopmental disorder with dystonia and seizures	OMIM:619922
2883	0.1964	Epilepsy, familial adult myoclonic, 3	OMIM:613608
2883	0.1964	den Hoed-de Boer-Voisin syndrome	OMIM:619229
2883	0.1964	Atypical pantothenate kinase-associated neurodegeneration	ORPHA:216873
2883	0.1964	?Epilepsy, myoclonic, familial adult, 4	OMIM:615127
2883	0.1964	Combined oxidative phosphorylation deficiency 27	OMIM:616672
2883	0.1964	Hereditary hyperekplexia	ORPHA:3197
2883	0.1964	Mitochondrial complex I deficiency, nuclear type 19	OMIM:618241
2883	0.1964	CLCN4-related X-linked intellectual disability syndrome	ORPHA:485350
2883	0.1964	Combined SAP deficiency	OMIM:611721
2883	0.1964	Sialidosis type 1	ORPHA:812
2883	0.1964	Spinocerebellar ataxia type 37	ORPHA:363710
2883	0.1964	Spinal muscular atrophy, Jokela type	OMIM:615048
2883	0.1964	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	OMIM:208920
2883	0.1964	Monomelic amyotrophy	ORPHA:65684
2883	0.1964	Spinocerebellar ataxia 38	OMIM:615957
2883	0.1964	Epilepsy, familial adult myoclonic, 2	OMIM:607876
2883	0.1964	Neurodevelopmental disorder with impaired speech and hyperkinetic movements	OMIM:618425
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	Parkinson disease, late-onset, susceptibility to	OMIM:168600
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	Curry-Jones syndrome, somatic mosaic	OMIM:601707
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Parkinson disease 1	OMIM:168601
2956	0.1962	Lafora disease	ORPHA:501
2956	0.1962	Myoclonic-atonic epilepsy	OMIM:616421
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	?Glutathioninuria	OMIM:231950
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Immunodeficiency 23	OMIM:615816
2956	0.1962	PGM3-CDG	ORPHA:443811
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	Parkinson disease, susceptibility to	OMIM:168600
2956	0.1962	Neurodevelopmental disorder with epilepsy and brain atrophy	OMIM:619971
2956	0.1962	Intestinal pseudoobstruction, neuronal	OMIM:300048
2956	0.1962	Visceral neuropathy, familial, 1, autosomal recessive	OMIM:243180
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Parkinson disease, age of onset, modifier	OMIM:168600
2956	0.1962	Visceral myopathy 1	OMIM:155310
2956	0.1962	Epilepsy, juvenile myoclonic, susceptibility to, 6	OMIM:607682
2956	0.1962	Intellectual developmental disorder with or without epilepsy or cerebellar ataxia	OMIM:618060
2956	0.1962	Epilepsy, idiopathic generalized, susceptibility to, 15	OMIM:618357
2956	0.1962	?Epilepsy, progressive myoclonic, 9	OMIM:616540
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Parkinson disease, late-onset, susceptibility to	OMIM:168600
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Dravet syndrome	ORPHA:33069
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Lafora disease	ORPHA:501
2956	0.1962	Parkinson disease 17	OMIM:614203
2956	0.1962	Parkinson disease, susceptibility to	OMIM:168600
2956	0.1962	Huntington disease-like 2	OMIM:606438
2956	0.1962	Familial pancreatic carcinoma	ORPHA:1333
2956	0.1962	Parkinson disease, susceptibility to	OMIM:168600
2996	0.196	Spinocerebellar ataxia 19	OMIM:607346
2996	0.196	Alpers-Huttenlocher syndrome	ORPHA:726
2996	0.196	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
2996	0.196	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements	OMIM:618497
2996	0.196	Hyperphenylalaninemia, BH4-deficient, B	OMIM:233910
2996	0.196	Hyperphenylalaninemia, BH4-deficient, A	OMIM:261640
2996	0.196	Familial infantile bilateral striatal necrosis	ORPHA:225154
2996	0.196	Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	OMIM:302800
2996	0.196	Vitamin B12-unresponsive methylmalonic acidemia type mut0	ORPHA:289916
2996	0.196	Combined oxidative phosphorylation deficiency 32	OMIM:617664
2996	0.196	Epilepsy, rolandic, with paroxysmal exercise-induce dystonia and writer's cramp	OMIM:608105
2996	0.196	Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	OMIM:607694
2996	0.196	Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia	OMIM:618451
2996	0.196	Leukodystrophy, hypomyelinating, 6	OMIM:612438
2996	0.196	Agenesis of the corpus callosum with peripheral neuropathy	OMIM:218000
2996	0.196	Machado-Joseph disease	OMIM:109150
2996	0.196	Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	OMIM:612716
2996	0.196	Fatal infantile lactic acidosis with methylmalonic aciduria	ORPHA:17
2996	0.196	Familial infantile bilateral striatal necrosis	ORPHA:225154
2996	0.196	Spinocerebellar ataxia, autosomal recessive 31	OMIM:619422
2996	0.196	Familial infantile bilateral striatal necrosis	ORPHA:225154
2996	0.196	Benign adult familial myoclonic epilepsy	ORPHA:86814
2996	0.196	Spinocerebellar ataxia type 13	ORPHA:98768
2996	0.196	Mitochondrial complex I deficiency, nuclear type 12	OMIM:301020
2996	0.196	Developmental and epileptic encephalopathy 4	OMIM:612164
2996	0.196	Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures	OMIM:620224
2996	0.196	Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity	ORPHA:53583
2996	0.196	GLUT1 deficiency syndrome 1, infantile onset, severe	OMIM:606777
2996	0.196	GLUT1 deficiency syndrome 2, childhood onset	OMIM:612126
2996	0.196	Intellectual developmental disorder, X-linked syndromic, Wu type	OMIM:300699
2996	0.196	Amyotrophic lateral sclerosis 8	OMIM:608627
2996	0.196	Benign adult familial myoclonic epilepsy	ORPHA:86814
2996	0.196	3-methylglutaconic aciduria type 7	ORPHA:445038
2996	0.196	Spinocerebellar ataxia type 27	ORPHA:98764
2996	0.196	Proximal 16p11.2 microdeletion syndrome	ORPHA:261197
2996	0.196	Salt and pepper developmental regression syndrome	OMIM:609056
2996	0.196	Spinocerebellar ataxia, autosomal recessive 30	OMIM:619405
2996	0.196	Wilson disease	OMIM:277900
2996	0.196	Ceroid lipofuscinosis, neuronal, 5	OMIM:256731
2996	0.196	Autosomal recessive dopa-responsive dystonia	ORPHA:101150
2996	0.196	Neurodevelopmental disorder with epilepsy and hemochromatosis	OMIM:301072
2996	0.196	?Developmental and epileptic encephalopathy 40	OMIM:617065
2996	0.196	Benign adult familial myoclonic epilepsy	ORPHA:86814
2996	0.196	Neurodegeneration with brain iron accumulation 1	OMIM:234200
2996	0.196	Benign adult familial myoclonic epilepsy	ORPHA:86814
2996	0.196	Benign adult familial myoclonic epilepsy	ORPHA:86814
2996	0.196	Multiple congenital anomalies-hypotonia-seizures syndrome 1	OMIM:614080
2996	0.196	Oculopharyngodistal myopathy 4	OMIM:619790
2996	0.196	Hereditary motor and sensory neuropathy, Okinawa type	OMIM:604484
2996	0.196	Jaberi-Elahi syndrome	OMIM:617988
2996	0.196	Familial infantile bilateral striatal necrosis	ORPHA:225154
2996	0.196	Benign adult familial myoclonic epilepsy	ORPHA:86814
2996	0.196	Developmental and epileptic encephalopathy 49	OMIM:617281
3049	0.1959	Friedreich ataxia	ORPHA:95
3049	0.1959	Neurodevelopmental disorder with cerebellar atrophy and with or without seizures	OMIM:618056
3049	0.1959	Parkinsonian-pyramidal syndrome	ORPHA:171695
3049	0.1959	Spinocerebellar ataxia 34	OMIM:133190
3049	0.1959	Congenital disorder of glycosylation, type Ia	OMIM:212065
3049	0.1959	Neurodevelopmental disorder with central and peripheral motor dysfunction	OMIM:618356
3049	0.1959	Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	OMIM:614381
3049	0.1959	Autosomal recessive spastic paraplegia type 77	ORPHA:466722
3049	0.1959	Neurodegeneration with brain iron accumulation 2B	OMIM:610217
3049	0.1959	Epilepsy, progressive myoclonic, 11	OMIM:618876
3049	0.1959	Parkinsonian-pyramidal syndrome	ORPHA:171695
3049	0.1959	Cerebellar ataxia, impaired intellectual development, and dysquilibrium syndrome 2	OMIM:610185
3049	0.1959	Hereditary motor and sensory neuropathy, Okinawa type	ORPHA:90117
3049	0.1959	Alpha-methylacyl-CoA racemase deficiency	OMIM:614307
3049	0.1959	Gaucher disease, atypical	OMIM:610539
3049	0.1959	Spinocerebellar ataxia, autosomal recessive 10	OMIM:613728
3049	0.1959	Leukodystrophy, hypomyelinating, 15	OMIM:617951
3066	0.1958	Severe X-linked mitochondrial encephalomyopathy	ORPHA:238329
3066	0.1958	Combined oxidative phosphorylation deficiency 6	OMIM:300816
3068	0.1953	Pontocerebellar hypoplasia type 2B	OMIM:612389
3068	0.1953	Pontocerebellar hypoplasia type 2D	OMIM:613811
3068	0.1953	Pyruvate carboxylase deficiency	OMIM:266150
3068	0.1953	Neurodegeneration, childhood-onset, with progressive microcephaly	OMIM:619847
3068	0.1953	Developmental and epileptic encephalopathy 68	OMIM:618201
3068	0.1953	Spastic paraplegia 6, autosomal dominant	OMIM:600363
3068	0.1953	Spastic paraplegia 62	OMIM:615681
3068	0.1953	Allan-Herndon-Dudley syndrome	OMIM:300523
3068	0.1953	Asparagine synthetase deficiency	OMIM:615574
3077	0.195	?Mitochondrial DNA depletion syndrome 17	OMIM:618567
3078	0.1943	Cerebrotendinous xanthomatosis	ORPHA:909
3079	0.1942	Dystonia 27	OMIM:616411
3079	0.1942	Progressive external ophthalmoplegia, autosomal dominant 1	OMIM:157640
3079	0.1942	Dystonia, DOPA-responsive	OMIM:128230
3079	0.1942	Spinocerebellar ataxia 15	OMIM:606658
3079	0.1942	Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome	ORPHA:314404
3079	0.1942	Intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism	OMIM:619911
3079	0.1942	Spinocerebellar ataxia 12	OMIM:604326
3079	0.1942	Parkinson disease 7, autosomal recessive early-onset	OMIM:606324
3079	0.1942	Autosomal dominant optic atrophy and cataract	ORPHA:67036
3079	0.1942	Spinocerebellar ataxia, autosomal recessive 32	OMIM:619862
3079	0.1942	Classic galactosemia	ORPHA:79239
3079	0.1942	Essential tremor, hereditary, 4	OMIM:614782
3079	0.1942	Developmental and epileptic encephalopathy 1	OMIM:308350
3092	0.194	Autosomal recessive ataxia, Beauce type	ORPHA:88644
3092	0.194	Lopes-Maciel-Rodan syndrome	OMIM:617435
3092	0.194	Frontotemporal dementia and/or amyotrophic lateral sclerosis 6	OMIM:613954
3092	0.194	Spastic tetraplegia and axial hypotonia, progressive	OMIM:618598
3092	0.194	Spinocerebellar ataxia, autosomal recessive 16	OMIM:615768
3092	0.194	Spastic paraplegia 70, autosomal recessive	OMIM:620323
3092	0.194	Dystonia-parkinsonism-hypermanganesemia syndrome	ORPHA:521406
3092	0.194	Hypermanganesemia with dystonia 2	OMIM:617013
3092	0.194	Mohr-Tranebjaerg syndrome	ORPHA:52368
3092	0.194	?Spinocerebellar ataxia, X-linked 1	OMIM:302500
3092	0.194	X-linked non progressive cerebellar ataxia	ORPHA:314978
3103	0.1939	Cleft palate, cardiac defects, and impaired intellectual development	OMIM:600987
3103	0.1939	Immunodeficiency 70	OMIM:618969
3103	0.1939	Triple A syndrome	ORPHA:869
3103	0.1939	Dystonia-deafness syndrome 1	OMIM:607371
3103	0.1939	Developmental malformations-deafness-dystonia syndrome	ORPHA:79107
3103	0.1939	Pontocerebellar hypoplasia, type 1D	OMIM:618065
3103	0.1939	Spinocerebellar ataxia 36	OMIM:614153
3103	0.1939	Triple A syndrome	ORPHA:869
3103	0.1939	Ataxia, posterior column, with retinitis pigmentosa	OMIM:609033
3103	0.1939	Autoimmune disease, multisystem, infantile-onset, 1	OMIM:615952
3103	0.1939	Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome	ORPHA:436174
3103	0.1939	Triple A syndrome	ORPHA:869
3103	0.1939	Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia	OMIM:613435
3103	0.1939	Combined oxidative phosphorylation deficiency 11	OMIM:614922
3117	0.1937	Primary dystonia, DYT27 type	ORPHA:464440
3117	0.1937	Roussy-Levy syndrome	OMIM:180800
3117	0.1937	Roussy-Levy syndrome	OMIM:180800
3120	0.1934	Benign familial neonatal epilepsy	ORPHA:1949
3120	0.1934	Benign familial neonatal epilepsy	ORPHA:1949
3120	0.1934	Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome	ORPHA:447997
3123	0.1924	Autosomal dominant Charcot-Marie-Tooth disease type 2A2	ORPHA:99947
3123	0.1924	Spinocerebellar ataxia type 28	ORPHA:101109
3123	0.1924	Spinocerebellar ataxia type 18	ORPHA:98771
3123	0.1924	Dystonia 24	OMIM:615034
3127	0.1922	X-linked parkinsonism-spasticity syndrome	ORPHA:363654
3127	0.1922	Tremor-ataxia-central hypomyelination syndrome	ORPHA:447896
3127	0.1922	Spinocerebellar ataxia type 10	ORPHA:98761
3127	0.1922	Congenital myopathy 16	OMIM:618524
3127	0.1922	?Leukoencephalopathy with dystonia and motor neuropathy	OMIM:613724
3127	0.1922	X-linked cerebral adrenoleukodystrophy	ORPHA:139396
3127	0.1922	Spinocerebellar ataxia, autosomal recessive 7	OMIM:609270
3127	0.1922	Spinocerebellar ataxia 21	OMIM:607454
3127	0.1922	Leukodystrophy, hypomyelinating, 16	OMIM:617964
3136	0.1918	Leukodystrophy, hypomyelinating, 4	OMIM:612233
3137	0.1916	3-methylglutaconic aciduria, type IX	OMIM:617698
3137	0.1916	2,4-dienoyl-CoA reductase deficiency	OMIM:616034
3139	0.1905	Spinocerebellar ataxia 29, congenital nonprogressive	OMIM:117360
3139	0.1905	Leukodystrophy, hypomyelinating, 5	OMIM:610532
3141	0.1904	Autosomal spastic paraplegia type 18	ORPHA:209951
3141	0.1904	Allan-Herndon-Dudley syndrome	ORPHA:59
3143	0.1903	Spinal muscular atrophy-4	OMIM:271150
3143	0.1903	Spinal muscular atrophy-2	OMIM:253550
3143	0.1903	Charcot-Marie-Tooth disease type 4C	ORPHA:99949
3143	0.1903	Neuropathy, hereditary sensory and autonomic, type IA	OMIM:162400
3147	0.1902	Choreoacanthocytosis	OMIM:200150
3148	0.19	Gastrointestinal defects and immunodeficiency syndrome 2	OMIM:619708
3148	0.19	Leukodystrophy, hypomyelinating, 19, transient infantile	OMIM:618688
3150	0.1899	Anemia, sideroblastic, with ataxia	OMIM:301310
3151	0.1896	Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome	ORPHA:37042
3151	0.1896	Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	OMIM:304790
3151	0.1896	Cortical dysplasia, complex, with other brain malformations 11	OMIM:620156
3154	0.1894	Brown-Vialetto-Van Laere syndrome 1	OMIM:211530
3155	0.1887	Spinocerebellar ataxia 5	OMIM:600224
3155	0.1887	Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies	OMIM:619995
3157	0.1886	Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures	OMIM:618170
3158	0.1875	Combined oxidative phosphorylation defect type 7	ORPHA:254930
3158	0.1875	Combined oxidative phosphorylation deficiency 7	OMIM:613559
3160	0.1855	Severe neonatal-onset encephalopathy with microcephaly	ORPHA:209370
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	OMIM:617820
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome	ORPHA:572013
3160	0.1855	Lissencephaly 9 with complex brainstem malformation	OMIM:618325
3160	0.1855	Myasthenic syndrome, congenital, 21, presynaptic	OMIM:617239
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Meconium ileus	OMIM:614665
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome	ORPHA:572013
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Hyperphosphatasia with impaired intellectual development syndrome 4	OMIM:615716
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Cystic fibrosis	ORPHA:586
3160	0.1855	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures	OMIM:617171
3160	0.1855	Intellectual disability-epilepsy-extrapyramidal syndrome	ORPHA:468620
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3160	0.1855	Autosomal dominant nocturnal frontal lobe epilepsy	ORPHA:98784
3196	0.185	Amyotrophic lateral sclerosis 2, juvenile	OMIM:205100
3197	0.1838	Trichothiodystrophy 8, nonphotosensitive	OMIM:619691
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Developmental and epileptic encephalopathy 110	OMIM:620149
3198	0.1836	Intellectual developmental disorder, X-linked syndromic, Lubs type	OMIM:300260
3198	0.1836	Encephalopathy, neonatal severe	OMIM:300673
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	?Parkinsonism-dystonia, infantile, 2	OMIM:618049
3198	0.1836	Brain dopamine-serotonin vesicular transport disease	ORPHA:352649
3198	0.1836	Diabetes mellitus, permanent neonatal 3, with or without neurologic features	OMIM:618857
3198	0.1836	Cataract 11, multiple types	OMIM:610623
3198	0.1836	Episodic ataxia/myokymia syndrome	OMIM:160120
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Gaucher disease, type III	OMIM:231000
3198	0.1836	Microcephaly-capillary malformation syndrome	OMIM:614261
3198	0.1836	Mitochondrial DNA depletion syndrome 4A (Alpers type)	OMIM:203700
3198	0.1836	Neuronopathy, distal hereditary motor, type IID	OMIM:615575
3198	0.1836	?Epilepsy, progressive myoclonic, 10	OMIM:616640
3198	0.1836	Early-onset Lafora body disease	ORPHA:324290
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Dystonia-1, torsion	OMIM:128100
3198	0.1836	Congenital disorder of glycosylation, type Ij	OMIM:608093
3198	0.1836	HMG-CoA lyase deficiency	OMIM:246450
3198	0.1836	Spinocerebellar ataxia 42	OMIM:616795
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Alzheimer disease, type 3, with spastic paraparesis and apraxia	OMIM:607822
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Intrahepatic cholestasis of pregnancy	ORPHA:69665
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Frontotemporal dementia and/or amyotrophic lateral sclerosis 7	OMIM:600795
3198	0.1836	Developmental and epileptic encephalopathy 78	OMIM:618557
3198	0.1836	Methylmalonic aciduria, vitamin B12-responsive, cblA type	OMIM:251100
3198	0.1836	Tyrosinemia type 2	ORPHA:28378
3198	0.1836	Ceroid lipofuscinosis, neuronal, 3	OMIM:204200
3198	0.1836	Neutral lipid storage disease with myopathy	OMIM:610717
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Amyotrophic lateral sclerosis 5, juvenile	OMIM:602099
3198	0.1836	Cerebellar atrophy with seizures and variable developmental delay	OMIM:618501
3198	0.1836	Xeroderma pigmentosum, type F/Cockayne syndrome	OMIM:278760
3198	0.1836	Dystonia-12	OMIM:128235
3198	0.1836	Creutzfeldt-Jakob disease, variant, resistance to	OMIM:123400
3198	0.1836	Migraine, familial basilar	OMIM:602481
3198	0.1836	Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	OMIM:141500
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	Full schwannomatosis	ORPHA:93921
3198	0.1836	Full schwannomatosis	ORPHA:93921
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Myopathy, myofibrillar, 2	OMIM:608810
3198	0.1836	Mitochondrial complex V (ATP synthase) deficiency, nuclear type 6	OMIM:618683
3198	0.1836	Peroxisome biogenesis disorder 5B	OMIM:614867
3198	0.1836	Full schwannomatosis	ORPHA:93921
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Huntington disease	OMIM:143100
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Microhydranencephaly	OMIM:605013
3198	0.1836	Parkinson disease 13	OMIM:610297
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Mitochondrial complex II deficiency, nuclear type 1	OMIM:252011
3198	0.1836	DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect	ORPHA:330050
3198	0.1836	Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1	OMIM:614388
3198	0.1836	Neurodevelopmental disorder with language impairment and behavioral abnormalities	OMIM:618917
3198	0.1836	Sotos syndrome	ORPHA:821
3198	0.1836	Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy	OMIM:617186
3198	0.1836	Lathosterolosis	ORPHA:46059
3198	0.1836	Hyperekplexia 1	OMIM:149400
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	OMIM:254800
3198	0.1836	Amyotrophic lateral sclerosis 1	OMIM:105400
3198	0.1836	X-linked Charcot-Marie-Tooth disease type 4	ORPHA:101078
3198	0.1836	Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome	ORPHA:83629
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facies	OMIM:618527
3198	0.1836	Chorea, hereditary benign	OMIM:118700
3198	0.1836	Charcot-Marie-Tooth disease, type 1E	OMIM:118300
3198	0.1836	Farber disease	ORPHA:333
3198	0.1836	Cutis laxa, autosomal recessive, type IIIB	OMIM:614438
3198	0.1836	X-linked Charcot-Marie-Tooth disease type 1	ORPHA:101075
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements	OMIM:618760
3198	0.1836	GM1-gangliosidosis, type III	OMIM:230650
3198	0.1836	Insomnia, fatal familial	OMIM:600072
3198	0.1836	Creutzfeldt-Jakob disease	OMIM:123400
3198	0.1836	Huntington disease-like 1	OMIM:603218
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Hyperglycinemia, lactic acidosis, and seizures	OMIM:614462
3198	0.1836	Developmental and epileptic encephalopathy 29	OMIM:616339
3198	0.1836	Parkinson disease, juvenile, type 2	OMIM:600116
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Developmental and epileptic encephalopathy 2	OMIM:300672
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	OMIM:612073
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Schindler disease, type I	OMIM:609241
3198	0.1836	?Neurodegeneration with brain iron accumulation 8	OMIM:617917
3198	0.1836	Hyperekplexia 2	OMIM:614619
3198	0.1836	Metachromatic leukodystrophy	OMIM:250100
3198	0.1836	Epilepsy, progressive myoclonic 2B (Lafora)	OMIM:254780
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Hypoparathyroidism, familial isolated 1	OMIM:146200
3198	0.1836	Seizures, benign familial infantile, 5	OMIM:617080
3198	0.1836	Methylmalonic aciduria and homocystinuria, cblC type	OMIM:277400
3198	0.1836	Full schwannomatosis	ORPHA:93921
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Intrahepatic cholestasis of pregnancy	ORPHA:69665
3198	0.1836	Gabriele-de Vries syndrome	OMIM:617557
3198	0.1836	Gabriele-de Vries syndrome	ORPHA:506358
3198	0.1836	Epilepsy, idiopathic generalized, susceptibility to, 16	OMIM:618596
3198	0.1836	Paroxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy	OMIM:609446
3198	0.1836	Autoinflammatory syndrome, familial, Behcet-like 1	OMIM:616744
3198	0.1836	Galloway-Mowat syndrome 10	OMIM:619609
3198	0.1836	DDOST-CDG	ORPHA:300536
3198	0.1836	Intrahepatic cholestasis of pregnancy	ORPHA:69665
3198	0.1836	Glycine encephalopathy1	OMIM:605899
3198	0.1836	Intrahepatic cholestasis of pregnancy	ORPHA:69665
3198	0.1836	Marbach-Schaaf neurodevelopmental syndrome	OMIM:619680
3198	0.1836	?Alzheimer disease, protection against, due to APOE3-Christchurch	OMIM:607822
3198	0.1836	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	OMIM:300857
3198	0.1836	Frontotemporal dementia and/or amyotrophic lateral sclerosis 5	OMIM:619141
3198	0.1836	Behr syndrome	OMIM:210000
3198	0.1836	Salla disease	OMIM:604369
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Cerebellar ataxia	OMIM:604290
3198	0.1836	Juvenile absence epilepsy	ORPHA:1941
3198	0.1836	Charcot-Marie-Tooth disease, axonal, type 2A2A	OMIM:609260
3198	0.1836	Dystonia 6, torsion	OMIM:602629
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form	ORPHA:79351
3198	0.1836	DOORS syndrome	ORPHA:79500
3198	0.1836	Developmental and epileptic encephalopathy 16	OMIM:615338
3198	0.1836	Progressive myoclonic epilepsy with dystonia	ORPHA:352596
3198	0.1836	Infantile dystonia-parkinsonism	ORPHA:238455
3198	0.1836	Intellectual developmental disorder, X-linked 12	OMIM:300957
3198	0.1836	Charcot-Marie-Tooth disease, type 2B	OMIM:600882
3198	0.1836	?Pontocerebellar hypoplasia type 2C	OMIM:612390
3198	0.1836	Pontocerebellar hypoplasia type 4	ORPHA:166063
3198	0.1836	Pontocerebellar hypoplasia type 2A	OMIM:277470
3198	0.1836	Pontocerebellar hypoplasia type 4	OMIM:225753
3198	0.1836	Developmental and epileptic encephalopathy 92	OMIM:617829
3198	0.1836	Intellectual developmental disorder, autosomal dominant 56	OMIM:617854
3198	0.1836	Cutis laxa, autosomal recessive, type IIIA	OMIM:219150
3198	0.1836	Spastic paraplegia 9B, autosomal recessive	OMIM:616586
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Glycosylphosphatidylinositol biosynthesis defect 15	OMIM:617810
3198	0.1836	Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome	ORPHA:529665
3198	0.1836	?Peripheral neuropathy, myopathy, hoarseness, and hearing loss	OMIM:614369
3198	0.1836	Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome	ORPHA:397744
3198	0.1836	?Spinocerebellar ataxia 43	OMIM:617018
3198	0.1836	CIMDAG syndrome	OMIM:619273
3198	0.1836	?ACAT2 deficiency	OMIM:614055
3198	0.1836	Dopa-responsive dystonia due to sepiapterin reductase deficiency	ORPHA:70594
3198	0.1836	Amish nemaline myopathy	ORPHA:98902
3198	0.1836	Nemaline myopathy 5A, autosomal recessive, severe infantile	OMIM:605355
3198	0.1836	Acrodermatitis enteropathica	OMIM:201100
3198	0.1836	Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder	ORPHA:500180
3198	0.1836	Neurodegeneration, childhood-onset, with brain atrophy	OMIM:617672
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3	OMIM:618387
3198	0.1836	3-methylglutaconic aciduria, type I	OMIM:250950
3198	0.1836	Neuromyotonia and axonal neuropathy, autosomal recessive	OMIM:137200
3198	0.1836	Leukodystrophy, hypomyelinating, 21	OMIM:619310
3198	0.1836	Combined oxidative phosphorylation deficiency 14	OMIM:614946
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Spinocerebellar ataxia 47	OMIM:617931
3198	0.1836	Mitochondrial complex III deficiency, nuclear type 4	OMIM:615159
3198	0.1836	Mitochondrial complex IV deficiency, nuclear type 16	OMIM:619060
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	Encephalopathy, acute, infection-induced, susceptibility to, 9	OMIM:618426
3198	0.1836	Dementia, familial British	OMIM:176500
3198	0.1836	Childhood-onset spasticity with hyperglycinemia	ORPHA:401866
3198	0.1836	Brody myopathy	OMIM:601003
3198	0.1836	Infantile cerebellar-retinal degeneration	OMIM:614559
3198	0.1836	PEHO syndrome	OMIM:260565
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Niemann-Pick disease, type A	OMIM:257200
3198	0.1836	Crigler-Najjar syndrome type 1	ORPHA:79234
3198	0.1836	Spinocerebellar ataxia, autosomal recessive 2	OMIM:213200
3198	0.1836	Autosomal recessive cerebelloparenchymal disorder type 3	ORPHA:1170
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Joubert syndrome with ocular defect	ORPHA:220493
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Amyotrophic lateral sclerosis 18	OMIM:614808
3198	0.1836	Developmental and epileptic encephalopathy 46	OMIM:617162
3198	0.1836	Congenital cataracts, facial dysmorphism, and neuropathy	OMIM:604168
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	OMIM:616437
3198	0.1836	Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset	OMIM:617145
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Spinocerebellar ataxia 13	OMIM:605259
3198	0.1836	Episodic ataxia, type 5	OMIM:613855
3198	0.1836	Neuroectodermal melanolysosomal disease	ORPHA:33445
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Autosomal dominant spastic ataxia type 1	ORPHA:251282
3198	0.1836	Spinocerebellar ataxia, autosomal recessive 21	OMIM:616719
3198	0.1836	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
3198	0.1836	Autosomal recessive spastic paraplegia type 48	ORPHA:306511
3198	0.1836	3-methylglutaconic aciduria, type III	OMIM:258501
3198	0.1836	Optic atrophy 3 with cataract	OMIM:165300
3198	0.1836	Intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies	OMIM:619556
3198	0.1836	Intellectual developmental disorder, autosomal dominant 6, with or without seizures	OMIM:613970
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Developmental and epileptic encephalopathy 69	OMIM:618285
3198	0.1836	?Mitochondrial complex IV deficiency, nuclear type 21	OMIM:619065
3198	0.1836	Mitochondrial complex I deficiency, nuclear type 4	OMIM:618225
3198	0.1836	Methylmalonic aciduria and homocystinuria, cblC type, digenic	OMIM:277400
3198	0.1836	Generalized epilepsy with febrile seizures-plus	ORPHA:36387
3198	0.1836	Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation	ORPHA:289266
3198	0.1836	Kufor-Rakeb syndrome	ORPHA:306674
3198	0.1836	Adenylosuccinase deficiency	OMIM:103050
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	Pyridoxamine 5'-phosphate oxidase deficiency	OMIM:610090
3198	0.1836	Pyridoxal phosphate-responsive seizures	ORPHA:79096
3198	0.1836	Mohr-Tranebjaerg syndrome	OMIM:304700
3198	0.1836	Striatal degeneration, autosomal dominant	OMIM:616922
3198	0.1836	Childhood-onset benign chorea with striatal involvement	ORPHA:494541
3198	0.1836	Developmental and epileptic encephalopathy 84	OMIM:618792
3198	0.1836	Immunodeficiency due to purine nucleoside phosphorylase deficiency	OMIM:613179
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	OMIM:616439
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Amyotrophic lateral sclerosis, susceptibility to	OMIM:105400
3198	0.1836	Perry syndrome	OMIM:168605
3198	0.1836	Glycogen storage disease due to phosphoglycerate kinase 1 deficiency	ORPHA:713
3198	0.1836	?Optic atrophy 11	OMIM:617302
3198	0.1836	Spinocerebellar ataxia 23	OMIM:610245
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Dystonia 2, torsion, autosomal recessive	OMIM:224500
3198	0.1836	Neurodevelopmental disorder with or without seizures and gait abnormalities	OMIM:617864
3198	0.1836	Sotos syndrome	ORPHA:821
3198	0.1836	X-linked intellectual disability due to GRIA3 mutations	ORPHA:364028
3198	0.1836	Mitochondrial complex I deficiency, nuclear type 18	OMIM:618240
3198	0.1836	Xeroderma pigmentosum, group G	OMIM:278780
3198	0.1836	Saccharopinuria	ORPHA:3124
3198	0.1836	Hyperlysinemia	ORPHA:2203
3198	0.1836	Cystathioninuria	ORPHA:212
3198	0.1836	Spinocerebellar ataxia, autosomal recessive 13	OMIM:614831
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome	ORPHA:477673
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Neuronopathy, distal hereditary motor, type VIIA	OMIM:158580
3198	0.1836	?Birk-Aharoni syndrome	OMIM:620071
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Early myoclonic encephalopathy	ORPHA:1935
3198	0.1836	Nabais Sa-de Vries syndrome, type 2	OMIM:618829
3198	0.1836	Citrullinemia type II	ORPHA:247585
3198	0.1836	Developmental and epileptic encephalopathy 39	OMIM:612949
3198	0.1836	Intellectual developmental disorder, X-linked syndromic 35	OMIM:300998
3198	0.1836	Developmental and epileptic encephalopathy 54	OMIM:617391
3198	0.1836	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	OMIM:608030
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Spinocerebellar ataxia type 26	ORPHA:101112
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Combined oxidative phosphorylation deficiency 3	OMIM:610505
3198	0.1836	Hypermanganesemia with dystonia 1	OMIM:613280
3198	0.1836	DOORS syndrome	ORPHA:79500
3198	0.1836	Developmental and epileptic encephalopathy 64	OMIM:618004
3198	0.1836	Sandhoff disease, juvenile form	ORPHA:309162
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome	ORPHA:476126
3198	0.1836	Intellectual developmental disorder, autosomal dominant 44, with microcephaly	OMIM:617061
3198	0.1836	Leukoencephalopathy, cystic, without megalencephaly	OMIM:612951
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	Ceroid lipofuscinosis, neuronal, 2	OMIM:204500
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Amyotrophic lateral sclerosis, susceptibility to	OMIM:105400
3198	0.1836	Intellectual developmental disorder, X-linked syndromic 34	OMIM:300967
3198	0.1836	Striatal degeneration, autosomal dominant	OMIM:609161
3198	0.1836	Hyperphenylalaninemia, BH4-deficient, D	OMIM:264070
3198	0.1836	Pterin-4 alpha-carbinolamine dehydratase deficiency	ORPHA:1578
3198	0.1836	Joubert syndrome with ocular defect	ORPHA:220493
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1	OMIM:221770
3198	0.1836	Nasu-Hakola disease	ORPHA:2770
3198	0.1836	Basal ganglia calcification, idiopathic, 7, autosomal recessive	OMIM:618317
3198	0.1836	Encephalopathy, familial, with neuroserpin inclusion bodies	OMIM:604218
3198	0.1836	Folate malabsorption, hereditary	OMIM:229050
3198	0.1836	Hyperphosphatasia with impaired intellectual development syndrome 1	OMIM:239300
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Nasu-Hakola disease	ORPHA:2770
3198	0.1836	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2	OMIM:618193
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Ceroid lipofuscinosis, neuronal, 4 (Kufs type), autosomal dominant	OMIM:162350
3198	0.1836	Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome	ORPHA:411986
3198	0.1836	Radio-Tartaglia syndrome	OMIM:619312
3198	0.1836	Beta-propeller protein-associated neurodegeneration	ORPHA:329284
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Neurodegeneration with brain iron accumulation 5	OMIM:300894
3198	0.1836	Charcot-Marie-Tooth disease, axonal, type 2P	OMIM:614436
3198	0.1836	Immunodeficiency, developmental delay, and hypohomocysteinemia	OMIM:617744
3198	0.1836	Hereditary methemoglobinemia	ORPHA:621
3198	0.1836	?Amyotrophic lateral sclerosis, susceptibility to	OMIM:105400
3198	0.1836	Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities	OMIM:620270
3198	0.1836	Developmental and epileptic encephalopathy 44	OMIM:617132
3198	0.1836	Tonne-Kalscheuer syndrome	OMIM:300978
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Ceroid lipofuscinosis, neuronal, 1	OMIM:256730
3198	0.1836	Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia	OMIM:614299
3198	0.1836	Developmental and epileptic encephalopathy 97	OMIM:619561
3198	0.1836	Wolfram syndrome 1	OMIM:222300
3198	0.1836	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	ORPHA:137898
3198	0.1836	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	OMIM:611105
3198	0.1836	Congenital disorder of glycosylation, type In	OMIM:612015
3198	0.1836	Sotos syndrome	ORPHA:821
3198	0.1836	Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum	OMIM:618090
3198	0.1836	CLN5 disease	ORPHA:228360
3198	0.1836	Combined oxidative phosphorylation deficiency 18	OMIM:615578
3198	0.1836	GM2-gangliosidosis, AB variant	OMIM:272750
3198	0.1836	GM2 gangliosidosis, AB variant	ORPHA:309246
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Spinal muscular atrophy, lower extremity-predominant, 2A, autosomal dominant	OMIM:615290
3198	0.1836	Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome	ORPHA:500144
3198	0.1836	Encephalopathy, progressive, early-onset, with brain atrophy and spasticity	OMIM:617669
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Phosphoserine aminotransferase deficiency, infantile/juvenile form	ORPHA:284417
3198	0.1836	?Phosphoserine aminotransferase deficiency	OMIM:610992
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Parkinson disease 15, autosomal recessive	OMIM:260300
3198	0.1836	Young-onset Parkinson disease	ORPHA:2828
3198	0.1836	?Mitochondrial DNA depletion syndrome 19	OMIM:618972
3198	0.1836	Neurodevelopmental disorder with neonatal respiratory insufficiency, hypotonia, and feeding difficulties	OMIM:616158
3198	0.1836	Intellectual developmental disorder, autosomal dominant 55, with seizures	OMIM:617831
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	OMIM:253280
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Joubert syndrome with ocular defect	ORPHA:220493
3198	0.1836	Cerebellar ataxia and hypogonadotropic hypogonadism	OMIM:212840
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Orofaciodigital syndrome type 3	ORPHA:2752
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Mast syndrome	OMIM:248900
3198	0.1836	?PEHO syndrome-like	OMIM:617507
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Joubert syndrome with renal defect	ORPHA:220497
3198	0.1836	Epilepsy, familial adult myoclonic, 1	OMIM:601068
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature	OMIM:618342
3198	0.1836	Developmental and epileptic encephalopathy 67	OMIM:618141
3198	0.1836	Lennox-Gastaut syndrome	ORPHA:2382
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Joubert syndrome with renal defect	ORPHA:220497
3198	0.1836	Spastic ataxia 5, autosomal recessive	OMIM:614487
3198	0.1836	Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome	ORPHA:313772
3198	0.1836	Hyperekplexia 4	OMIM:618011
3198	0.1836	Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia	OMIM:618718
3198	0.1836	Joubert syndrome with ocular defect	ORPHA:220493
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	X-linked Charcot-Marie-Tooth disease type 5	ORPHA:99014
3198	0.1836	Charcot-Marie-Tooth disease, axonal, type 2Z	OMIM:616688
3198	0.1836	Cerebellar ataxia, impaired intellectual development and dysequilibrium syndrome 3	OMIM:613227
3198	0.1836	KINSSHIP syndrome	OMIM:619297
3198	0.1836	Epilepsy, progressive myoclonic, 12	OMIM:619191
3198	0.1836	Ceroid lipofuscinosis, neuronal, 6B (Kufs type)	OMIM:204300
3198	0.1836	Ceroid lipofuscinosis, neuronal, 8	OMIM:600143
3198	0.1836	Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome	ORPHA:254343
3198	0.1836	Microcephaly, Amish type	OMIM:607196
3198	0.1836	?Combined oxidative phosphorylation deficiency 51	OMIM:619057
3198	0.1836	Inclusion body myopathy and brain white matter abnormalities	OMIM:619733
3198	0.1836	?Neurodegeneration with brain iron accumulation 7	OMIM:617916
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
3198	0.1836	Pontocerebellar hypoplasia, type 1E	OMIM:619303
3198	0.1836	Spinocerebellar ataxia type 31	ORPHA:217012
3198	0.1836	Intellectual developmental disorder, autosomal recessive 48	OMIM:616269
3198	0.1836	Dystonia 26, myoclonic	OMIM:616398
3198	0.1836	Peripheral neuropathy with variable spasticity, exercise intolerance, and developmental delay	OMIM:616539
3198	0.1836	Neurogenic arthrogryposis multiplex congenita	ORPHA:1143
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Intellectual developmental disorder, X-linked syndromic 33	OMIM:300966
3198	0.1836	X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome	ORPHA:480907
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Aicardi-Goutieres syndrome 6	OMIM:615010
3198	0.1836	Early-onset autosomal dominant Alzheimer disease	ORPHA:1020
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Joubert syndrome with renal defect	ORPHA:220497
3198	0.1836	Epilepsy, progressive myoclonic 2A (Lafora)	OMIM:254780
3198	0.1836	Joubert syndrome with ocular defect	ORPHA:220493
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Encephalopathy due to prosaposin deficiency	ORPHA:139406
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Sialidosis, type II	OMIM:256550
3198	0.1836	Spinocerebellar ataxia 37	OMIM:615945
3198	0.1836	Developmental delay and seizures with or without movement abnormalities	OMIM:617836
3198	0.1836	Classic progressive supranuclear palsy syndrome	ORPHA:240071
3198	0.1836	Supranuclear palsy, progressive	OMIM:601104
3198	0.1836	Supranuclear palsy, progressive atypical	OMIM:260540
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Progressive supranuclear palsy-parkinsonism syndrome	ORPHA:240085
3198	0.1836	Myoclonic-astatic epilepsy	ORPHA:1942
3198	0.1836	Spinocerebellar ataxia type 21	ORPHA:98773
3198	0.1836	TRAPPC11-related limb-girdle muscular dystrophy R18	ORPHA:369840
3198	0.1836	Frontotemporal dementia with motor neuron disease	ORPHA:275872
3198	0.1836	Developmental and epileptic encephalopathy 109	OMIM:620145
3198	0.1836	Early myoclonic encephalopathy	ORPHA:1935
3198	0.1836	Spinocerebellar ataxia type 38	ORPHA:423296
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Intellectual developmental disorder with speech delay and axonal peripheral neuropathy	OMIM:619099
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Neurodegeneration with brain iron accumulation 4	OMIM:614298
3198	0.1836	Intellectual developmental disorder, X-linked syndromic, Cabezas type	OMIM:300354
3198	0.1836	X-linked intellectual disability, Cabezas type	ORPHA:85293
3198	0.1836	Hereditary methemoglobinemia	ORPHA:621
3198	0.1836	Neurodevelopmental disorder with eye movement abnormalities and ataxia	OMIM:620094
3198	0.1836	Intellectual developmental disorder, X-linked 104	OMIM:300983
3198	0.1836	Intellectual developmental disorder, autosomal dominant 42	OMIM:616973
3198	0.1836	Behavioral variant of frontotemporal dementia	ORPHA:275864
3198	0.1836	Spastic paraplegia-severe developmental delay-epilepsy syndrome	ORPHA:464282
3198	0.1836	Charcot-Marie-Tooth disease, axonal, type 2F	OMIM:606595
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome	ORPHA:502423
3198	0.1836	Myopathy, mitochondrial, and ataxia	OMIM:617675
3198	0.1836	Kallmann syndrome	ORPHA:478
3198	0.1836	FINCA syndrome	OMIM:618278
3198	0.1836	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	OMIM:213000
3198	0.1836	Infantile spasms syndrome	ORPHA:3451
3198	0.1836	Epilepsy, early-onset, 1, vitamin B6-dependent	OMIM:617290
3198	0.1836	Charcot-Marie-Tooth disease type 4B2	ORPHA:99956
3198	0.1836	Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome	ORPHA:496641
3198	0.1836	Orofaciodigital syndrome type 6	ORPHA:2754
3198	0.1836	Joubert syndrome	ORPHA:475
3198	0.1836	Mitochondrial complex I deficiency, nuclear type 31	OMIM:618251
3198	0.1836	Neurodevelopmental disorder with motor and speech delay and behavioral abnormalities	OMIM:619470
3198	0.1836	Kallmann syndrome	ORPHA:478
3663	0.1821	?Mitochondrial DNA depletion syndrome 18	OMIM:618811
3663	0.1821	PRUNE1-related neurological syndrome	ORPHA:544469
3665	0.1817	Autosomal recessive progressive external ophthalmoplegia	ORPHA:254886
3665	0.1817	Leukoencephalopathy with ataxia	OMIM:615651
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	NARP syndrome	ORPHA:644
3665	0.1817	Developmental and epileptic encephalopathy 99	OMIM:619606
3665	0.1817	Rapid-onset dystonia-parkinsonism	ORPHA:71517
3665	0.1817	Developmental and epileptic encephalopathy 56	OMIM:617665
3665	0.1817	Parkinson disease 18	OMIM:614251
3665	0.1817	Gerstmann-Straussler-Scheinker syndrome	ORPHA:356
3665	0.1817	Parkinson disease 6, early onset	OMIM:605909
3665	0.1817	?Parkinsonism with spasticity, X-linked	OMIM:300911
3665	0.1817	Intellectual developmental disorder, X-linked syndromic, Hedera type	OMIM:300423
3665	0.1817	X-linked intellectual disability, Hedera type	ORPHA:93952
3665	0.1817	Parkinson disease 8	OMIM:607060
3665	0.1817	Benign familial infantile epilepsy	ORPHA:306
3665	0.1817	Benign familial infantile epilepsy	ORPHA:306
3665	0.1817	?Myoclonus, familial, 2	OMIM:618364
3665	0.1817	Benign familial infantile epilepsy	ORPHA:306
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	Childhood absence epilepsy	ORPHA:64280
3665	0.1817	Benign familial infantile epilepsy	ORPHA:306
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	Myoclonic epilepsy, juvenile, susceptibility to, 1	OMIM:254770
3665	0.1817	Childhood absence epilepsy	ORPHA:64280
3665	0.1817	Lichtenstein-Knorr syndrome	OMIM:616291
3665	0.1817	Autosomal recessive progressive external ophthalmoplegia	ORPHA:254886
3665	0.1817	Familial infantile myoclonic epilepsy	ORPHA:352582
3665	0.1817	Childhood absence epilepsy	ORPHA:64280
3665	0.1817	Familial infantile myoclonic epilepsy	ORPHA:352582
3665	0.1817	Parkinsonism with polyneuropathy	OMIM:619279
3665	0.1817	Spastic paraplegia 9A, autosomal dominant	OMIM:601162
3665	0.1817	Megaloblastic anemia due to dihydrofolate reductase deficiency	OMIM:613839
3665	0.1817	Developmental and epileptic encephalopathy 103	OMIM:619913
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	Childhood absence epilepsy	ORPHA:64280
3665	0.1817	Spastic paraplegia 78, autosomal recessive	OMIM:617225
3665	0.1817	Parkinson disease 11	OMIM:607688
3665	0.1817	Childhood absence epilepsy	ORPHA:64280
3665	0.1817	Alexander disease type I	ORPHA:363717
3665	0.1817	Alexander disease type II	ORPHA:363722
3665	0.1817	Alexander disease	OMIM:203450
3665	0.1817	Parkinson disease 23, autosomal recessive, early onset	OMIM:616840
3665	0.1817	EAST syndrome	ORPHA:199343
3665	0.1817	Benign familial infantile epilepsy	ORPHA:306
3665	0.1817	Molybdenum cofactor deficiency B	OMIM:252160
3665	0.1817	?Urocanase deficiency	OMIM:276880
3665	0.1817	Urocanic aciduria	ORPHA:210128
3665	0.1817	Juvenile myoclonic epilepsy	ORPHA:307
3665	0.1817	Parkinson disease 24, autosomal dominant, susceptibility to	OMIM:619491
3665	0.1817	Waisman syndrome	OMIM:311510
3665	0.1817	Molybdenum cofactor deficiency A	OMIM:252150
3718	0.1807	Spastic paraplegia 11, autosomal recessive	OMIM:604360
3718	0.1807	Spastic paraplegia 10, autosomal dominant	OMIM:604187
3718	0.1807	Troyer syndrome	OMIM:275900
3718	0.1807	Spastic paraplegia 12, autosomal dominant	OMIM:604805
3722	0.1798	Episodic ataxia type 1	ORPHA:37612
3722	0.1798	Familial gestational hyperthyroidism	ORPHA:99819
3722	0.1798	Familial hyperthyroidism due to mutations in TSH receptor	ORPHA:424
3722	0.1798	Charcot-Marie-Tooth disease, axonal, type 2X	OMIM:616668
3722	0.1798	Developmental and epileptic encephalopathy 35	OMIM:616647
3722	0.1798	Alternating hemiplegia of childhood 2	OMIM:614820
3722	0.1798	Alternating hemiplegia of childhood 1	OMIM:104290
3722	0.1798	Charcot-Marie-Tooth disease type 4D	ORPHA:99950
3722	0.1798	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy	OMIM:614249
3722	0.1798	Lesch-Nyhan syndrome	OMIM:300322
3722	0.1798	Choreoathetosis, hypothyroidism, and neonatal respiratory distress	OMIM:610978
3722	0.1798	Roussy-Lévy syndrome	ORPHA:3115
3722	0.1798	Neurodevelopmental disorder with impaired language and ataxia and with or without seizures	OMIM:619580
3722	0.1798	Vitamin B12-unresponsive methylmalonic acidemia type mut-	ORPHA:79312
3722	0.1798	Brunner syndrome	OMIM:300615
3722	0.1798	Antisocial behavior	OMIM:300615
3722	0.1798	Pyruvate dehydrogenase E2 deficiency	OMIM:245348
3722	0.1798	Gillespie syndrome	OMIM:206700
3722	0.1798	Mitochondrial complex I deficiency, nuclear type 16	OMIM:618238
3722	0.1798	Roussy-Lévy syndrome	ORPHA:3115
3722	0.1798	Neuropathy, hereditary sensory and autonomic, type V	OMIM:608654
3722	0.1798	Charcot-Marie-Tooth disease, demyelinating, type 1G	OMIM:618279
3722	0.1798	Leukoencephalopathy, progressive, with ovarian failure	OMIM:615889
3722	0.1798	Autosomal dominant spastic paraplegia type 17	ORPHA:100998
3722	0.1798	Silver spastic paraplegia syndrome	OMIM:270685
3722	0.1798	Developmental and epileptic encephalopathy 74	OMIM:618396
3722	0.1798	Pontocerebellar hypoplasia type 2	ORPHA:2524
3722	0.1798	Pontocerebellar hypoplasia type 2	ORPHA:2524
3722	0.1798	Pontocerebellar hypoplasia type 2	ORPHA:2524
3722	0.1798	Congenital glucokinase-related hyperinsulinism	ORPHA:79299
3722	0.1798	Autosomal recessive spastic paraplegia type 9B	ORPHA:447760
3722	0.1798	Angelman syndrome	OMIM:105830
3722	0.1798	Spastic paraplegia 5A, autosomal recessive	OMIM:270800
3722	0.1798	Pettigrew syndrome	OMIM:304340
3722	0.1798	Pontocerebellar hypoplasia type 2	ORPHA:2524
3722	0.1798	Parkinson disease 19a, juvenile-onset	OMIM:615528
3722	0.1798	Neurodevelopmental disorder with hypotonia, neuropathy, and deafness	OMIM:617519
3722	0.1798	Autosomal spastic paraplegia type 72	ORPHA:401849
3722	0.1798	Striatonigral degeneration, infantile	OMIM:271930
3722	0.1798	Glutaricaciduria, type I	OMIM:231670
3722	0.1798	Progressive encephalopathy with leukodystrophy due to DECR deficiency	ORPHA:431361
3722	0.1798	Autosomal recessive spastic paraplegia type 46	ORPHA:320391
3722	0.1798	Pseudohyperkalemia, familial, 2, due to red cell leak	OMIM:609153
3722	0.1798	3-methylglutaconic aciduria type 3	ORPHA:67047
3722	0.1798	Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures	OMIM:620023
3722	0.1798	HSD10 mitochondrial disease	OMIM:300438
3722	0.1798	?Mitochondrial complex I deficiency, nuclear type 28	OMIM:618249
3722	0.1798	Mitochondrial complex I deficiency, nuclear type 26	OMIM:618247
3722	0.1798	Pelizaeus-Merzbacher disease, connatal form	ORPHA:280210
3722	0.1798	Cerebellar dysfunction with variable cognitive and behavioral abnormalities	OMIM:614756
3722	0.1798	?Epilepsy, familial adult myoclonic, 7	OMIM:618075
3722	0.1798	Combined oxidative phosphorylation defect type 13	ORPHA:319514
3722	0.1798	Combined oxidative phosphorylation deficiency 13	OMIM:614932
3722	0.1798	Dystonia 9	OMIM:601042
3722	0.1798	Snijders Blok-Fisher syndrome	OMIM:618604
3722	0.1798	Pontocerebellar hypoplasia type 2	ORPHA:2524
3722	0.1798	PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome	ORPHA:589905
3722	0.1798	Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia	ORPHA:284324
3722	0.1798	Joubert syndrome 1	OMIM:213300
3722	0.1798	Spinocerebellar ataxia 27B, late-onset	OMIM:620174
3722	0.1798	Spinocerebellar ataxia 27A	OMIM:193003
3722	0.1798	?Charcot-Marie-Tooth disease, X-linked dominant, 6	OMIM:300905
3722	0.1798	X-linked Charcot-Marie-Tooth disease type 6	ORPHA:352675
3722	0.1798	Mitochondrial complex IV deficiency, nuclear type 11	OMIM:619054
3722	0.1798	Sulfite oxidase deficiency	OMIM:272300
3722	0.1798	Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus	OMIM:619653
3722	0.1798	Dystonia 16	ORPHA:210571
3722	0.1798	Autosomal dominant spastic paraplegia type 6	ORPHA:100988
3722	0.1798	Autosomal recessive spastic paraplegia type 75	ORPHA:459056
3722	0.1798	Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy	OMIM:617862
3722	0.1798	Microcephaly, short stature, and impaired glucose metabolism 2	OMIM:616817
3722	0.1798	Galloway-Mowat syndrome 9	OMIM:619603
3722	0.1798	Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome	ORPHA:457212
3722	0.1798	Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures	OMIM:618088
3722	0.1798	Intellectual developmental disorder, autosomal recessive 77	OMIM:619988
3722	0.1798	Focal segmental glomerulosclerosis and neurodevelopmental syndrome	OMIM:619428
3722	0.1798	Intellectual developmental disorder, autosomal recessive 58	OMIM:617270
3722	0.1798	Autosomal recessive spastic paraplegia type 15	ORPHA:100996
3722	0.1798	Mitochondrial membrane protein-associated neurodegeneration	ORPHA:289560
3722	0.1798	Spastic paraplegia 86, autosomal recessive	OMIM:619735
3722	0.1798	3-methylglutaconic aciduria type 3	ORPHA:67047
3722	0.1798	Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression	OMIM:618416
3722	0.1798	?Epilepsy, familial adult myoclonic, 6	OMIM:618074
3805	0.1781	Cowden syndrome 6	OMIM:615109
3805	0.1781	Cowden syndrome 1	OMIM:158350
3805	0.1781	Spinocerebellar ataxia type 6	ORPHA:98758
3805	0.1781	Spinocerebellar ataxia 6	OMIM:183086
3805	0.1781	Cowden syndrome 5	OMIM:615108
3805	0.1781	Peroxisome biogenesis disorder 6B	OMIM:614871
3805	0.1781	Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	OMIM:614458
3805	0.1781	Ververi-Brady syndrome	OMIM:617982
3805	0.1781	Spinocerebellar ataxia, autosomal recessive 28	OMIM:618800
3805	0.1781	Cerebellar ataxia, Cayman type	ORPHA:94122
3805	0.1781	Ataxia, cerebellar, Cayman type	OMIM:601238
3805	0.1781	X-linked progressive cerebellar ataxia	ORPHA:1175
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Spinocerebellar ataxia type 29	ORPHA:208513
3805	0.1781	Spastic paraplegia 79A, autosomal dominant	OMIM:620221
3805	0.1781	RARS-related autosomal recessive hypomyelinating leukodystrophy	ORPHA:438114
3805	0.1781	Leukodystrophy, hypomyelinating, 9	OMIM:616140
3805	0.1781	Spinocerebellar ataxia, autosomal recessive 17	OMIM:616127
3805	0.1781	Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency	ORPHA:453521
3805	0.1781	Wiedemann-Rautenstrauch syndrome	OMIM:264090
3805	0.1781	?Spastic paraplegia 44, autosomal recessive	OMIM:613206
3805	0.1781	Spinocerebellar ataxia 10	OMIM:603516
3805	0.1781	Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1	OMIM:224050
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Intellectual developmental disorder, autosomal recessive 14	OMIM:614020
3805	0.1781	Autosomal recessive axonal neuropathy with neuromyotonia	ORPHA:324442
3805	0.1781	Spectrin-associated autosomal recessive cerebellar ataxia	ORPHA:352403
3805	0.1781	Spinocerebellar ataxia, autosomal recessive 14	OMIM:615386
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Perrault syndrome 1	OMIM:233400
3805	0.1781	?Intellectual developmental disorder, autosomal recessive 79	OMIM:620393
3805	0.1781	Dementia, familial Danish	OMIM:117300
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Congenital cataracts-facial dysmorphism-neuropathy syndrome	ORPHA:48431
3805	0.1781	Combined immunodeficiency with facio-oculo-skeletal anomalies	ORPHA:221139
3805	0.1781	Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome	ORPHA:466794
3805	0.1781	Glutathione synthetase deficiency	OMIM:266130
3805	0.1781	Boucher-Neuhauser syndrome	OMIM:215470
3805	0.1781	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
3805	0.1781	Paroxysmal nonkinesigenic dyskinesia 1	OMIM:118800
3805	0.1781	Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome	ORPHA:504476
3805	0.1781	X-linked intellectual disability-cerebellar hypoplasia syndrome	ORPHA:137831
3805	0.1781	Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1	OMIM:213980
3805	0.1781	Non-progressive cerebellar ataxia with intellectual disability	ORPHA:314647
3805	0.1781	Ataxia, intention tremor, and hypotonia syndrome, childhood-onset	OMIM:619352
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Convulsions, familial infantile, with paroxysmal choreoathetosis	OMIM:602066
3805	0.1781	Episodic kinesigenic dyskinesia 1	OMIM:128200
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Combined immunodeficiency with facio-oculo-skeletal anomalies	ORPHA:221139
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Trichothiodystrophy	ORPHA:33364
3805	0.1781	Spinocerebellar ataxia 35	OMIM:613908
3805	0.1781	Spinocerebellar ataxia type 35	ORPHA:276193
3805	0.1781	Spinocerebellar ataxia type 40	ORPHA:423275
3805	0.1781	Autosomal recessive spastic ataxia of Charlevoix-Saguenay	ORPHA:98
3805	0.1781	?Intellectual developmental disorder, autosomal dominant 69	OMIM:617863
3805	0.1781	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	OMIM:612674
3805	0.1781	Autosomal dominant Charcot-Marie-Tooth disease type 2F	ORPHA:99940
3805	0.1781	Retinal dystrophy with leukodystrophy	OMIM:618863
3805	0.1781	Facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome	OMIM:618381
3805	0.1781	?Spinocerebellar ataxia, autosomal recessive 22	OMIM:616948
3868	0.1731	Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy	OMIM:617560
3868	0.1731	NKX6-2-related autosomal recessive hypomyelinating leukodystrophy	ORPHA:527497
3868	0.1731	Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome	ORPHA:370022
3871	0.1715	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
3871	0.1715	Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline	OMIM:618868
3871	0.1715	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
3871	0.1715	Spastic paraplegia 53, autosomal recessive	OMIM:614898
3871	0.1715	Autosomal recessive spastic paraplegia type 53	ORPHA:319199
3871	0.1715	3-methylglutaconic aciduria type 9	ORPHA:505216
3871	0.1715	Autosomal dominant spastic paraplegia type 37	ORPHA:171612
3871	0.1715	Microcephaly, postnatal progressive, with seizures and brain atrophy	OMIM:613668
3871	0.1715	Mutilating hereditary sensory neuropathy with spastic paraplegia	ORPHA:139578
3871	0.1715	Neuropathy, hereditary sensory, with spastic paraplegia	OMIM:256840
3871	0.1715	Pontocerebellar hypoplasia, type 9	OMIM:615809
3871	0.1715	?Spastic paraplegia 63	OMIM:615686
3871	0.1715	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
3871	0.1715	?Congenital disorder of glycosylation, type IIz	OMIM:620201
3871	0.1715	Autosomal dominant spastic paraplegia type 12	ORPHA:100993
3871	0.1715	Developmental delay with hypotonia, myopathy, and brain abnormalities	OMIM:620240
3871	0.1715	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
3871	0.1715	Autosomal dominant spastic paraplegia type 12	ORPHA:100993
3871	0.1715	Autosomal dominant spastic paraplegia type 8	ORPHA:100989
3871	0.1715	Osteopetrosis, autosomal recessive 5	OMIM:259720
3871	0.1715	Autosomal recessive spastic paraplegia type 62	ORPHA:401785
3871	0.1715	Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	OMIM:238970
3871	0.1715	Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome	ORPHA:415
3871	0.1715	Intellectual developmental disorder, autosomal recessive 61	OMIM:617773
3871	0.1715	Glycine encephalopathy with normal serum glycine	OMIM:617301
3871	0.1715	Autosomal dominant spastic paraplegia type 42	ORPHA:171863
3871	0.1715	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
3871	0.1715	Amyotrophic lateral sclerosis 4, juvenile	OMIM:602433
3871	0.1715	Congenital muscular dystrophy with cerebellar involvement	ORPHA:370959
3871	0.1715	Spastic paraplegia 15, autosomal recessive	OMIM:270700
3871	0.1715	Developmental and epileptic encephalopathy 55	OMIM:617599
3871	0.1715	Developmental and epileptic encephalopathy 14	OMIM:614959
3871	0.1715	Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies	OMIM:617481
3871	0.1715	Leukodystrophy, hypomyelinating, 13	OMIM:616881
3871	0.1715	Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome	ORPHA:477993
3871	0.1715	Oculocerebrorenal syndrome of Lowe	ORPHA:534
3907	0.1699	Spastic paraplegia 55, autosomal recessive	OMIM:615035
3908	0.1577	Striatonigral degeneration, childhood-onset	OMIM:617054
3908	0.1577	Autosomal recessive spastic paraplegia type 5A	ORPHA:100986
3908	0.1577	Immunodeficiency, X-linked, with hyper-IgM	OMIM:308230
3908	0.1577	Autosomal dominant spastic paraplegia type 4	ORPHA:100985
3908	0.1577	Microcephaly, developmental delay, and brittle hair syndrome	OMIM:618891
3908	0.1577	Spastic paraplegia 88, autosomal dominant	OMIM:620106
3908	0.1577	Developmental and epileptic encephalopathy 90	OMIM:301058
3908	0.1577	Mitochondrial complex I deficiency, nuclear type 2	OMIM:618222
3908	0.1577	Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction	ORPHA:506353
3908	0.1577	Spastic paraplegia 81, autosomal recessive	OMIM:618768
3908	0.1577	Cortical dysplasia, complex, with other brain malformations 14A, (bilateral frontoparietal)	OMIM:606854
3908	0.1577	Autosomal recessive spastic paraplegia type 76	ORPHA:488594
3908	0.1577	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly	OMIM:616657
3908	0.1577	Spastic paraplegia 84, autosomal recessive	OMIM:619621
3908	0.1577	Autosomal recessive spastic paraplegia type 20	ORPHA:101000
3908	0.1577	Autosomal recessive spastic paraplegia type 35	ORPHA:171629
3908	0.1577	Spastic paraplegia 35, autosomal recessive	OMIM:612319
3908	0.1577	Spastic paraplegia, optic atrophy, and neuropathy	OMIM:609541
3908	0.1577	Spastic paraplegia 18, autosomal recessive	OMIM:611225
3908	0.1577	Hijazi-Reis syndrome	OMIM:301094
3908	0.1577	Autosomal dominant spastic paraplegia type 3	ORPHA:100984
3908	0.1577	Spastic paraplegia 31, autosomal dominant	OMIM:610250
3908	0.1577	Warburg micro syndrome 3	OMIM:614222
3908	0.1577	Spastic paraplegia 30, autosomal dominant	OMIM:610357
3908	0.1577	Multiple congenital anomalies-hypotonia-seizures syndrome 3	OMIM:615398
3908	0.1577	Ataxia-pancytopenia syndrome	OMIM:159550
3908	0.1577	Spastic paraplegia 33, autosomal dominant	OMIM:610244
3935	0.1565	Mitochondrial complex I deficiency, nuclear type 1	OMIM:252010
3935	0.1565	Spinal muscular atrophy-1	OMIM:253300
3935	0.1565	Charcot-Marie-Tooth disease, type 4C	OMIM:601596
3935	0.1565	?Congenital myopathy 9A with respiratory insufficiency and bone fractures	OMIM:618822
3935	0.1565	Congenital myopathy 9B, proximal, with minicore lesions	OMIM:618823
3935	0.1565	Dejerine-Sottas disease	OMIM:145900
3935	0.1565	Intellectual disability, Birk-Barel type	ORPHA:166108
3935	0.1565	Dejerine-Sottas disease	OMIM:145900
3935	0.1565	Pontocerebellar hypoplasia type 1	ORPHA:2254
3935	0.1565	Pontocerebellar hypoplasia, type 1B	OMIM:614678
3935	0.1565	Pontocerebellar hypoplasia type 1	ORPHA:2254
3935	0.1565	Pontocerebellar hypoplasia type 1	ORPHA:2254
3935	0.1565	Pontocerebellar hypoplasia, type 1C	OMIM:616081
3935	0.1565	Pontocerebellar hypoplasia type 1	ORPHA:2254
3935	0.1565	Dejerine-Sottas disease	OMIM:145900
3935	0.1565	Spinal muscular atrophy, X-linked 2, infantile	OMIM:301830
3935	0.1565	Infantile-onset X-linked spinal muscular atrophy	ORPHA:1145
3935	0.1565	Neuropathy, hereditary motor, with myopathic features	OMIM:619216
3935	0.1565	Amyotrophic lateral sclerosis 27, juvenile	OMIM:620285
3935	0.1565	?Leukodystrophy, hypomyelinating, 24	OMIM:619851
3935	0.1565	Dejerine-Sottas disease	OMIM:145900
3935	0.1565	Pontocerebellar hypoplasia type 1	ORPHA:2254
3935	0.1565	Congenital myopathy 10A, severe variant	OMIM:614399
3935	0.1565	Pontocerebellar hypoplasia type 1	ORPHA:2254
3935	0.1565	Neurodegeneration, childhood-onset, with cerebellar atrophy	OMIM:618276
3935	0.1565	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum	OMIM:617193
3935	0.1565	Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects	OMIM:620007
3935	0.1565	Brown-Vialetto-Van Laere syndrome 2	OMIM:614707
